Page last updated: 2024-08-23

paclitaxel and Coronary Artery Disease

paclitaxel has been researched along with Coronary Artery Disease in 620 studies

Research

Studies (620)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	200 (32.26)	29.6817
2010's	369 (59.52)	24.3611
2020's	51 (8.23)	2.80

Authors

Authors	Studies
Escuer, J; Martínez, MA; McGinty, S; Peña, E; Schmidt, AF	1
Yalta, K; Yalta, T; Yetkın, E	1
Alfonso, F; Byrne, RA	1
Boersma, E; Cheng, JM; den Heijer, P; Gho, B; Ijsselmuiden, AJJ; Meuwissen, M; Oemrawsingh, RM; Polad, J; Vlieger, S; Weevers, APJD	1
Fu, G; Han, X; Han, Y; Jing, Q; Li, H; Li, Y; Liu, B; Ma, G; Tong, Q; Xu, K; Yang, Q; Zhang, J; Zhou, Y	1
Akao, H; Akita, S; Kajinami, K; Kawai, Y; Kitayama, M; Nakagawa, T; Oda, M; Takama, S; Takamura, TA; Tsuchiya, T	1
Cao, G; He, Q; Kang, H; Yu, H	1
Abizaid, A; Alfonso, F; Cortese, B; de la Torre Hernandez, JM; Greco, A; Mehran, R; Rigattieri, S; Sciahbasi, A	1
Bhalraam, U; Corballis, N; Eccleshall, SC; Gilbert, T; Gunawardena, T; Maart, C; Mamas, MA; Merinopoulos, I; Mohamed, MO; Richardson, P; Ryding, A; Sarev, T; Sawh, C; Sulfi, S; Vassiliou, VS; Wickramarachchi, U; Wistow, T	1
Bartuś, K; Bartuś, S; Bryniarski, L; Chyrchel, M; Januszek, R; Kasprzycki, K; Malinowski, KP; Rzeszutko, Ł; Sabatowski, K; Siłka, W; Surdacki, A	1
Chen, Y; Fu, G; Ge, J; He, B; He, Y; Ji, F; Jin, H; Li, C; Li, L; Liu, F; Ma, G; Nie, S; Qian, J; Sun, Y; Wang, H; Wang, J; Wei, M; Wu, Y; Xia, Y; Xu, B; Yin, J; Zeng, H	1
Bianchini Massoni, C; Epifani, E; Freyrie, A; Gasbarro, V; Paladini, I; Strozzi, F; Tusini, N; Ucci, A; Zenunaj, G	1
Cortese, B; Serruys, PW	1
Ito, Y; Koizumi, T; Osawa, T	1
Alfonso, F; Cuculi, F; Díaz, VAJ; Gaede, L; Leibundgut, G; Nuruddin, AA; Otto, S; Pyxaras, S; Rittger, H; Rosenberg, M; Schulze, C; Steen, P; Waliszewski, MW; Wan Ahmad, WA; Weilenmann, D; Wöhrle, J	1
Aoki, H; Hisauchi, I; Ishikawa, T; Itabashi, Y; Kobayashi, S; Kondo, Y; Mizutani, Y; Nakahara, S; Nakamura, H; Shimura, M; Taguchi, I; Ukaji, T; Yamada, K	1
Amara, WB; Boukhris, M; Delaunay, R; Kasbaoui, S; Payot, L; Taldir, G; Zabalawi, A	1
Alfonso, F; Cortese, B; Erriquez, A; Rivero, F; Testa, G	1
Sabaté, M	1
Cortese, B; El Khoury, A; Lazar, L	1
Andrés Morist, A; Arnold, RJ; Cano-García, M; de la Torre Hernández, JM; Garcia Camarero, T; Gutierrez, H; Lezcano, EJ; Lozano Ruiz-Poveda, F; Molina, E; Pinar, E; Saez, R; Sánchez Pérez, I; Torres, A; Urbano-Carrillo, CA; Zueco, J	1
Funatsu, A; Kobayashi, T; Mizobuchi, M; Nagai, T; Nakamura, S	1
Funayama, N; Katou, Y; Kawahatsu, K; Miyata, M; Muratsubaki, S; Oikawa, T	1
Chung, JH; Doh, JH; Her, AY; Koo, BK; Lee, JM; Nam, CW; Shin, ES	1
Gugerell, A; Gyöngyösi, M; Hemetsberger, R; Lukovic, D; Mandic, L; Pavo, N; Spannbauer, A; Traxler, D; Winkler, J; Zlabinger, K	1
Antoniucci, D; Berland, J; Berti, S; Carrié, D; Dibié, A; Hauptmann, KE; Maupas, E; Musto, C; Schofer, J; Verheye, S; Vrolix, M	1
Abizaid, A; Bouras, G; Garcia-Lithgow, C; Grubman, D; Javier, JJ; Lansky, AJ; Mustapha, JA; Shah, T; Tirziu, D; Zhou, S	1
Colombo, A; Durante, A; Gallone, G; Giannini, F; Iannopollo, G; Montorfano, M; Pagliaro, B; Ponticelli, F; Tzanis, G	1
Case, BC; Forrestal, BJ; Garcia-Garcia, HM; Torguson, R; Waksman, R; Weintraub, WS; Yerasi, C	1
Cong, HL; Cong, ZC; Gao, CY; Gao, LL; Han, YL; Jiang, TM; Jing, QM; Li, H; Li, JX; Li, ZQ; Wang, DM; Wang, G; Yang, P; Zhang, Z; Zhao, X; Zheng, Y	1
Masuda, S; Nagamine, S; Shibui, T; Tsuchiyama, T	1
Case, BC; Dan, K; Forrestal, BJ; Garcia-Garcia, HM; Kolm, P; Torguson, R; Waksman, R; Weintraub, WS; Yerasi, C	1
Athukorala, S; Basavarajaiah, S; Bhatia, G; Freestone, B; Kalogeras, K; Lee, K; Loku Waduge, BH; Ment, J; Panoulas, V; Pitt, M; Pulikal, G; Watkin, R	1
Jeger, RV; Kaiser, C; Kleber, FX; Mangner, N; Scheller, B	1
Funatsu, A; Ikeda, T; Iwasaki, Y; Ko, T; Kobayashi, T; Koike, J; Nakamura, S	1
Eccleshall, SC; Gilbert, T; Gunawardena, T; Maart, C; Merinopoulos, I; Perperoglou, A; Richardson, P; Ryding, A; Sarev, T; Sawh, C; Sreekumar, S; Vassiliou, VS; Wickramarachchi, U; Wistow, T	1
Garg, S; Jun, EJ; Shin, ES; Yuan, SL	1
Garg, S; Jun, EJ; Kim, MH; Shin, ES; Yuan, SL	1
Colombo, A; Cortese, B; Doshi, M; Hara, H; Katagiri, Y; Kawashima, H; Kogame, N; Ono, M; Onuma, Y; Piek, JJ; Serruys, PW; Sharif, F; Takahashi, K; Wykrzykowska, JJ	1
Bhak, Y; Choi, BJ; Garg, S; Hao, J; Hui, L; Jun, EJ; Kim, TH; Kun, L; Qiang, T; Shin, ES; Sohn, CB; Yuan, SL; Zhentao, S; Zhi, W	1
Abellan-Huerta, J; Jurado-Roman, A; Lopez-Lluva, MT; Lozano-Ruiz-Poveda, F; Perez-Diaz, P; Pinilla-Echeverri, N; Piqueras-Flores, J; Sanchez-Perez, I	1
Akabame, S; Fukui, K; Kato, Y; Kitajima, H; Koide, M; Matoba, S; Nakamura, T; Sogabe, K; Zen, K	1
Ji, F; Wang, F; Wang, X; Xu, F; Yang, C; Yu, X; Zhang, W	1
Ando, K; Hiramori, S; Kuramitsu, S; Shinozaki, T; Soga, Y; Tomoi, Y	1
Aggarwal, A; Escuer, J; Kennedy, S; McCormick, C; McGinty, S; McQueen, A; Oldroyd, K	1
Amico, F; Ceravolo, R; Contarini, M; Del Maestro, M; Forlani, D; Galli, S; Ielasi, A; Montorsi, P; Niccoli, G; Pasquetto, G; Sommariva, L; Tespili, M; Troiano, S	1
Hong, YJ; Jang, AY; Kang, WC; Kim, BO; Kim, SW; Kim, YH; Lee, SR; Lee, SY; Oh, PC; Oh, SJ; Park, SM; Shin, ES; Won, H; Yu, CW	1
Li, Y; Liu, H; Mao, Q; Zhao, J; Zhou, D	1
Abbott, JD; Allocco, DJ; Bachinsky, W; Batchelor, W; Bateman, C; Dohad, S; Kirtane, AJ; Stoler, R; Tremmel, JA; Underwood, P; Yeh, RW	1
Ahn, JM; Hyun, J; Kang, DY; Kim, JH; Kim, SO; Lee, J; Lee, PH; Park, DW; Park, H; Park, SJ	1
Agostoni, P; Dens, J; Kedhi, E; Lancellotti, P; Latib, A; Patterson, M; Schotborgh, C; Shen, C; Stella, P; Tam, FCC; Testa, L; Wetzels, G	1
Fitzgerald, PJ; Honda, Y; Huang, CC; Kawarada, O; Kitahara, H; Matsuyama, Y; Muramatsu, T; Nakamura, M; Nakatani, D; Nanto, S; Sakamoto, K; Sakata, K; Waseda, K; Yamada, R; Yock, PG; Yokoi, H	1
Fujita, H; Momomura, SI; Sakakura, K; Taniguchi, Y; Wada, H; Yamamoto, K	1
Barbieri, LR; Carvalho, PO; Gutierrez, PS; Lourenço-Filho, DD; Maranhão, RC; Stolf, NAG; Tavares, ER	1
Beale, CE; Dawn Abbott, J	1
Dawkins, KD; Head, SJ; Holmes, DR; Kappetein, AP; Mack, MJ; Milojevic, M; Mohr, FW; Morice, MC; Serruys, PW	1
Bellone, P; Benfari, G; Botta, M; Cordone, S; Cuman, M; Fede, A; Ghione, M; Lunardi, M; Pacchioni, A; Reimers, B; Ribichini, FL; Zivelonghi, C	1
Ando, K; Asano, R; Funatsu, A; Habara, S; Inoue, N; Iwabuchi, M; Kozuma, K; Mitsudo, K; Nakamura, M; Nakamura, S; Nanto, S; Saito, S	1
AbdelWahab, A; Boshra, H; El-Mokadem, M; El-Ramly, M; Hassan, A	1
Hlinomaz, O; Kukla, P; Pleva, L; Zapletalova, J	1
Arambam, P; Bangalore, S; Bhagwat, A; Goel, PK; Jagtap, P; Kaul, U; Pinto, B; Sathe, S; Wander, GS	1
Cui, Y; Fan, X; Kong, J; Li, J; Liu, P; Wen, J; Ye, Z; Zhang, J; Zhen, Y; Zheng, X	1
Krajcer, Z; Shatila, W	1
Ashikaga, T; Fukushima, T; Hatano, Y; Isobe, M; Ueshima, D; Yamamoto, T; Yasuhiro, M; Yoshikawa, S	1
Chang, S; Choi, BW; Han, K; Hong, YJ; Hur, J; Im, DJ; Kim, JY; Kim, YJ; Lee, HJ; Suh, YJ	1
Wang, Q; Wang, X; Xu, X; Zhang, X; Zhu, J	1
Cheng, J; Gao, C; Liu, Y; Qi, D; Wang, Z; Zheng, X	1
Arshad, MKM; Ho, HH; Jafary, FH; Loh, JKK; Ong, PJL; Tan, CK; Tin, ZL; Watson, T	1
Abellas-Sequeiros, RA; Agarrado Luna, A; Asmarats, L; Benezet, J; Cieza, T; DeLarochellière, R; Déry, JP; Duocastella, L; Gomez, A; Molina, M; Oneto Otero, J; Pelletier-Beaumont, E; Puri, R; Rodés-Cabau, J	1
Brugaletta, S; Filipiak, KJ; Jąkała, J; Kochman, J; Kołtowski, Ł; Malinowski, K; Ochijewicz, D; Opolski, G; Pietrasik, A; Proniewska, K; Rdzanek, A; Tomaniak, M	1
Hahn, JY; Han, JK; Hwang, D; Jeon, KH; Kim, HL; Kim, HS; Kim, SH; Koo, BK; Lee, JM; Park, J; Park, KW; Rhee, TM; Shin, ES; Yang, HM	1
Dean, LS; Nakamura, K	1
Kobayashi, I; Niwa, A; Onishi, T; Onishi, Y; Umezawa, S	1
Ahmed, J; Bauersachs, J; Berliner, D; Bressollette, E; Cortese, B; Doutrelant, L; Eccleshall, S; Graf, K; Levesque, S; Piraino, D; Roguin, A; Scheller, B; Stella, PR; Widder, JD; Zavalloni, D	1
Ji, F; Lu, D; Wang, F; Wang, X; Xu, F; Yang, C; Yu, X; Zhang, W	1
Abizaid, A; Meneguz-Moreno, RA; Ribamar Costa, J	1
Arkenbout, EK; Baan, J; Boerlage-van Dijk, K; Claessen, BE; Dirkali, A; Gosselink, ATM; Henriques, JPS; Meuwissen, M; Piek, JJ; van der Schaaf, RJ; van Royen, N; van Wely, MH; Vendrik, J	1
Almalla, M; Burgmaier, M; Reith, S; Schröder, J; Vogt, F	1
Eränen, J; Kärkkäinen, JM; Mäntylä, P; Mustonen, J; Rissanen, TT; Siljander, A; Uskela, S	2
Cheng, Y; Liu, F; Liu, X; Ma, X; Sun, Y; Zhang, D; Zhao, Y; Zhou, Y	1
Cao, F; Chen, H; Chen, L; Chen, S; Chen, Y; Fu, G; Gao, L; Guan, C; Guo, J; Jin, Q; Jin, Z; Li, H; Li, W; Li, X; Qin, Q; Sun, Z; Wang, L; Wang, Y; Xu, B; Zhang, J; Zhang, Z; Zhao, Y; Zheng, Y	1
Cannon, LA; Dawkins, KD; Grady, TP; Hill, R; Kimmelstiel, CD; Myers, PR; Underwood, P; White, A	1
Funatsu, A; Kobayashi, T; Mizobuchi, M; Nakamura, S	1
Mani, K; Saratzis, A; Zayed, H	1
Ahn, CM; Choi, D; Hong, MK; Hong, SJ; Jang, Y; Kim, BK; Kim, C; Kim, JS; Ko, YG; Nguyen, VPT	1
Amor, M; Belle, L; Boughalem, K; Cayla, G; Faurie, B; Godin, M; Huret, B; Karsenty, B; Leclercq, F; Piot, C; Roncalli, J; Shayne, J	1
Deng, LX; Guo, WY; Hu, T; Li, JY; Li, Y; Liu, Y; Mou, FJ; Tao, L; Wang, Q; Yin, ZY; Zhang, YJ	1
Chung, JH; Doh, JH; Eun Lee, K; Garg, S; Her, AY; Koo, BK; Lee, JM; Nam, CW; Shin, ES	1
Eränen, J; Kärkkäinen, JM; Mäntylä, P; Minkkinen, MJ; Olli, A; Pietilä, M; Rissanen, TT; Romppanen, H; Siljander, A; Tervo, J; Uskela, S	1
Banning, AP; Dawkins, KD; Head, SJ; Kappetein, AP; Mack, MJ; Mohr, FW; Morice, MC; Serruys, PW	1
Bittl, JA	2
Dudea, SM; Hagau, AM; Hagau, N; Hagau, R	1
Chen, J; Chen, JL; Gao, RL; Hu, FH; Liu, SW; Qiao, SB; Wu, YJ; Xu, B; Yang, YJ; Yuan, JQ	1
Abizaid, A; Dens, J; Fajadet, J; Macours, N; Mauri, L; Ormiston, JA; Qureshi, AC; Schofer, J; Spaulding, C; Thuesen, L; Verheye, S	1
Du, Z; Généreux, P; Lu, S; Wong, SC; Xu, B; Yang, Y; Yuan, Z	1
Bajwa, HS; Ball, MW; Coleman, PS; Cutlip, DE; Kandzari, DE; Kirtane, AJ; Leon, MB; Mauri, L; Papadakos, S; Sketch, MH; Stoler, RC	1
Hillegass, WB	4
Chang, SH; Chen, CC; Hsieh, IC; Hsieh, MJ; Lee, CH; Lin, FC; Wang, CY	1
Awata, M; Iida, O; Ishihara, T; Nanto, K; Nanto, S; Uematsu, M	1
Araújo Gonçalves, P; Calé, R; Campante Teles, R; Martins, C; Mendes, M; Mesquita Gabriel, H; Pereira, E; Pereira, H; Raposo, L; Sousa Almeida, M; Sousa, PJ; Vinhas, H; Vitorino, S	1
Bae, JH; Cha, TJ; Choi, JW; Chung, WY; Hur, SH; Hyon, MS; Jeon, HK; Kang, HJ; Kang, SH; Kim, BO; Kim, DI; Kim, HS; Kim, SJ; Kim, SW; Koo, BK; Lee, HY; Lee, SG; Moon, KW; Park, JS; Park, KS; Park, KW; Seo, JB; Yang, HM; Yoo, CW; Youn, TJ	1
Archangelidi, O; De Palma, R; Fröhlich, GM; Ko, DT; Lansky, AJ; Meier, P; Timmis, A	1
Kim, DI; Kim, DK; Seol, SH; Song, PS	1
Leitão Marques, A	1
Barioli, A; Buja, P; D'Amico, G; Facchin, M; Frigo, AC; Iliceto, S; Isabella, G; Napodano, M; Tarantini, G	1
Kutcher, MA	1
Levy, MS; Parikh, PP	1
Bangalore, S; Burke, DA; Cutlip, DE; Kandzari, DE; Leon, MB; Mauri, L; Pencina, MJ; Vardi, M	1
Colmenarez, H; Escaned, J; Fernández, C	1
Araújo Gonçalves, P; Campante Teles, R; Dores, H; Leal, S; Machado, C; Mendes, M; Mesquita Gabriel, H; Raposo, L; Sousa Almeida, M	1
Badr, S; Barbash, IM; Chen, F; Dvir, D; Kent, KM; Kitabata, H; Loh, JP; Minha, S; Pendyala, LK; Pichard, AD; Satler, LF; Suddath, WO; Torguson, R; Waksman, R	1
Baars, T; Erbel, R; Heusch, G; Hildebrandt, HA; Kahlert, P; Kleinbongard, P	1
Boudriot, E; Dänschel, W; Desch, S; Erbs, S; Heinz, A; Kleinertz, K; Lauer, B; Linke, A; Schloma, D; Schuler, G; Stiermaier, T; Thiele, H	1
Ito, T; Matsuda, O; Murase, S; Murata, A; Suzuki, Y; Yamaguchi, T	1
García, E; Guarinos, J; Ioannidis, K; Larman, M; Moreu, J; Ortas, MR; Piqué, N; Puigfel, B; Rincón, A; Rumoroso, JR; Serra, A; Zueco, JJ	1
Choi, D; Hong, MK; Jang, Y; Kim, BK; Kim, JS; Ko, YG; Shin, DH	1
Afari, M; Buszman, PP; Cheng, Y; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Milewski, K; Stenoien, M; Tellez, A	1
Bourantas, CV; Colombo, A; Dawkins, KD; de Vries, T; Farooq, V; Feldman, T; Girasis, C; Holmes, DR; James, S; Kappetein, AP; Mack, M; Mohr, FW; Morel, MA; Morice, MC; Serruys, PW; Ståhle, E; Vranckx, P	1
Basavarajaiah, S; Carlino, M; Chieffo, A; Colombo, A; Fujino, Y; Godino, C; Hasegawa, T; Ielasi, A; Latib, A; Montorfano, M; Naganuma, T; Nakamura, S; Shannon, J; Takagi, K	1
Cao, S; Cutlip, DE; Dangas, GD; Hermiller, J; Kereiakes, DJ; Lansky, AJ; Newman, W; Rizvi, A; Serruys, PW; Smith, RS; Stone, GW; Sudhir, K; Theodoropoulos, K	1
Amico, F; Bartorelli, A; Belli, R; Beqaraj, F; Berni, A; Cabianca, E; Cappi, B; Caramanno, G; Della Rovere, F; Fiscella, A; Indolfi, C; La Vecchia, L; Lopera Quijada, MJ; Loschiavo, P; Milazzo, D; Musarò, S; Pironi, B; Ribaldi, L; Ribichini, F; Rigattieri, S; Rolandi, A; Romano, M; Rosiello, R; Sangiorgio, P; Sheiban, I; Spaccarotella, C; Trabattoni, D; Vassanelli, C; Villani, R	1
Ackermann, H; Boxberger, M; Buerke, M; Cremers, B; Degenhardt, R; Figulla, HR; Hardt, S; Heuer, H; Kleber, FX; Leschke, M; Scheller, B; Unverdorben, M; Vallbracht, C	1
Bedogni, F; Berti, S; Biondi-Zoccai, G; Colombo, A; Cortese, B; Cremonesi, A; Limbruno, U; Sgueglia, GA	1
Finn, AV; Foerst, J; Kolodgie, FD; Kutys, R; Ladich, E; Nakano, M; Newell, JB; Otsuka, F; Sakakura, K; Virmani, R; Vorpahl, M	1
Amoroso, N; Bangalore, S; Faxon, DP; Feit, F; Fusaro, M; Hannan, EL; Kumar, S; Toklu, B	1
Cutlip, DE; Gada, H; Hermiller, JB; Hou, L; Kirtane, AJ; Koo, K; Mahaffey, KW; Newman, W; Sanz, M; Stone, GW; Sudhir, K	1
Bae, JH; Cho, JH; Cho, MC; Choi, YJ; Hur, SH; Hwang, JY; Jeong, MH; Jo, JH; Jung, KH; Jung, KT; Kang, TS; Kim, DI; Kim, KS; Kim, MH; Kim, TI; Kim, U; Kim, W; Kim, YJ; Lee, CH; Lee, HW; Lee, JH; Lee, SH; Lee, SW; Park, HS; Park, JS; Shin, DG; Son, JW	1
Brener, SJ; Caputo, R; Cutlip, DE; Kereiakes, DJ; Mastali, K; Newman, W; Rizvi, A; Simonton, CA; Smith, RS; Stone, GW; Wang, JC; Ying, SW	1
Alidoosti, M; Dietz, U; Faurie, B; Ferrari, M; Gastmann, O; Heang, TN; Ong, PJ; Palmieri, C; Spiecker, M; Waliszewski, M; Zeymer, U	1
Calderas, C; Condado, JA; Condado, JF; Fitzgerald, P; Flores, A; Honda, Y; Mueller, A; Nakatani, D; Thomas, J; Waseda, K	1
Byrne, RA; Kastrati, A; Laugwitz, KL; Massberg, S; Mehilli, J; Schulz, S; Seyfarth, M; Tiroch, K; Vorpahl, M	1
Campos, CM; Garcia-Garcia, HM; Haude, M; Iqbal, J; Lemos, PA; Muramatsu, T; Onuma, Y; Serruys, PW; Warnack, B; Zhang, YJ	1
Bourantas, CV; Dawkins, KD; Diletti, R; Farooq, V; Feldman, TE; Girasis, C; Holmes, DR; Morel, MA; Morice, MC; Muramatsu, T; Onuma, Y; Serruys, PW; van Es, GA	1
Costa, RA; Feres, F	1
de la Torre Hernández, JM; Garcia-Camarero, T; Lee, DH; Sainz Laso, F; Zueco, J	1
Almeida, M; Campante Teles, R; de Araújo Gonçalves, P; Dores, H; Leal, S; Machado, C; Mendes, M; Mesquita Gabriel, H; Raposo, L	1
Loh, JP; Sangiorgi, G; Silber, S; Stahnke, S; Stella, PR; Torguson, R; von Strandmann, RP; Waksman, R	1
Bansilal, S; Mehran, R	1
Albanese, A; Amrani, M; Benedetto, U; Ilsley, CD; Jothidasan, A; Raja, SG; Soliman, RF	1
Hauschild, T; Kleber, FX; Schulz, A	1
Gao, L; Hou, Y; Hu, X; Xue, Q	1
Antoniucci, D; Fernandez-Pereira, C; Mieres, JR; Palacios, I; Pauletto, R; Rodriguez, AE; Rodriguez-Granillo, AM; Serruys, PW; Solorzano, L; Tarragona, S	1
Alfonso, F; Bañuelos, C; Gonzalo, N; Jimenez-Quevedo, P; Medina, M	1
Baumgartner, S; Garcia-Garcia, HM; Jüni, P; Justiz, J; Kalesan, B; Meier, B; Moschovitis, A; Pilgrim, T; Räber, L; Taniwaki, M; Wenaweser, P; Windecker, S; Zanchin, T	1
Chae, IH; Choi, DJ; Kim, HS; Kim, JH; Lim, WH; Park, KW; Shin, DH	1
Kitabata, H; Laynez-Carnicero, A; Loh, JP; Pichard, AD; Sardi, GL; Satler, LF; Torguson, R; Waksman, R; Xue, Z	1
Choi, JW; Colombo, A; Dawkins, KD; Feldman, TE; Holmes, DR; Huang, J; Kappetein, AP; Mack, MJ; Mohr, F; Morice, MC; Religa, G; Roy, K; Ruzyllo, W; Serruys, PW; Ståhle, E	1
Tian, J; Yu, B	1
Badr, S; Barbash, IM; Ben-Dor, I; Loh, JP; Minha, S; Pichard, AD; Satler, LF; Torguson, R; Waksman, R	1
Lim, GB	1
Cuisset, T; Ferrero, V; Hamilos, M; Karanovic, N; Orlic, D; Ostojic, MC; Ribichini, F; Sarno, G; Vardas, PE; Vassanelli, C; Wijns, W	1
Chen, J; Feng, G; He, S; Jiang, X; Kislauskis, E; Laham, R; Lan, Z; Lyu, Y; McCarthy, S; Wang, S; Wu, T; Xiao, J; Zhang, Y; Zheng, X	1
Basavarajaiah, S; Bertoldi, L; Carlino, M; Chieffo, A; Colombo, A; Costopoulos, C; Figini, F; Latib, A; Montorfano, M; Naganuma, T; Shannon, J; Sticchi, A	1
Li, P; Liu, JP	1
Ho, HH; Ong, PJ; Tan, J; Waliszewski, M; Zeymer, U	1
Chen, Q; Li, G; Xie, J; Xu, B; Zhang, X	1
García-García, HM; Muramatsu, T; Serruys, PW; Verheye, S; Waksman, R	1
Asano, R; Awata, M; Fujita, H; Hozawa, H; Kawai, K; Matsuyama, Y; Miyamoto, A; Mukawa, H; Muramatsu, T; Nakamura, M; Nanto, S; Ochiai, M; Ogawa, T; Ohira, H; Okada, H; Shiode, N; Suwa, S; Takashima, H; Tsukamoto, Y; Yamada, T; Yasumura, Y; Yokoi, H	1
Ishikawa, T; Mutoh, M; Nakano, Y; Tsutsumi, J; Yoshimura, M	1
Daida, H; Kasai, T; Konishi, H; Miyauchi, K; Naito, R; Ogita, M; Okazaki, S; Tamura, H; Tsuboi, S	1
Albertal, M; Belardi, JA	2
Ackermann, H; Antoni, D; Bocksch, W; Boxberger, M; Cremers, B; Degenhardt, R; Hengstenberg, C; Heuer, H; Kleber, FX; Leschke, M; Maikowski, C; Scheller, B; Speck, U; Unverdorben, M; Vallbracht, C; Werner, GS	1
Fujii, K; Hao, H; Hirayama, A; Hirota, S; Imanaka, T; Ishibashi-Ueda, H; Kawakami, R; Kawano, T; Masuyama, T; Takayama, T	1
Baek, K; Chun, K; Lee, S	1
Böhm, M; Clever, YP; Cremers, B; Dietz, U; Hauschild, T; Kleber, FX; Scheller, B; Schulz, A; Waliszewski, M	1
Figulla, HR; Gassdorf, J; Goebel, B; Janiak, F; Jung, C; Nitsche, K; Otto, S; Poerner, TC; Scheller, B	1
Angel, CY; Brenot, P; Houyel, L; Tho, NT; Waliszewski, MW	1
Figulla, HR; Gassdorf, J; Goebel, B; Janiak, F; Jung, C; Nitsche, K; Otto, S; Poerner, TC	1
Chae, IH; Cho, GY; Cho, YS; Choi, DJ; Lee, S; Oh, IY; Suh, JW; Yoon, CH; Youn, TJ	1
Chunming, W; Guozhong, C; Haibo, L; Jie, Y; Junbo, G; Limei, Z; Wangjun, Y; Xiaofang, G; Yingchun, B; Yong, C; Yu, F	1
Brodie, BR; Duffy, PL; Kang, SJ; Kirtane, AJ; Maehara, A; Metzger, DC; Mintz, GS; Rinaldi, MJ; Shimizu, T; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Xu, K	1
Buszman, PE; Buszman, PP; Janas, A; Kiesz, RS; Martin, JL; Szewc, RG; Trela, B; Wiernek, BK; Wiernek, SL	1
Scheller, B; Sgueglia, GA	1
Briguori, C; Donahue, M; Focaccio, A; Kawamoto, H; Mitomo, S; Nakamura, S; Visconti, G	1
Buffoli, F; Castriota, F; Colombo, A; Cremonesi, A; De Felice, F; Latib, A; Marchese, A; Menozzi, A; Micari, A; Naganuma, T; Panoulas, VF; Presbitero, P; Sgueglia, GA; Tamburino, C; Tespili, M; Varbella, F	1
Banning, AP; Bourantas, CV; Campos, CM; Colombo, A; Garcia-Garcia, HM; Grech, ED; Holmes, DR; Iqbal, J; Kappetein, AP; Mack, MJ; Mohr, FW; Morice, MC; Onuma, Y; Serruys, PW; Steyerberg, EW; van Klaveren, D; Zhang, YJ	1
Addo, T; Banerjee, S; Brilakis, ES; Chao, H; Christakopoulos, GE; Christopoulos, G; de Lemos, JA; Guerra, A; Haagen, D; Han, H; Obel, O; Rangan, BV; Roesle, M; Sosa, A; Tarar, MN	1
Hibi, K; Ikari, Y; Inoue, N; Ishiwata, S; Isshiki, T; Kozuma, K; Kyono, H; Nakayama, M; Ohta, H; Otsuka, M; Sano, K; Suematsu, N; Suzuki, N; Tanabe, K; Uehara, Y; Yamane, M; Yamauchi, Y; Yokoi, H	1
Abe, S; Inoue, T; Kageyama, M; Komatsu, T; Nasuno, T; Sakuma, M; Taguchi, I; Tokura, M; Toyoda, S	1
Fortuin, FD; Kanakadandi, U; Lassar, T; Lee, JZ; Lee, KS; Low, SW; Ortega, G; Singh, N	1
Byrne, RA; Cassese, S; Fusaro, M; Hoppmann, P; Kastrati, A; Kufner, S; Laugwitz, KL; Neumann, FJ; Schulz-Schüpke, S; Schunkert, H; Valeskini, M	1
Alfonso, F; Cuesta, J	1
Bouchez, D; Briguori, C; Commeau, P; Eberli, FR; Galatius, S; IJsselmuiden, AJ; Möllmann, H; Mudra, H; Naber, CK; Nef, H; Pyxaras, SA; Rieber, J; Schlundt, C; van Geuns, RJ; Wykrzykowska, J	1
Chibana, H; Fukumoto, Y; Ikeno, F; Itaya, N; Mitsutake, Y; Nakayoshi, T; Sasaki, K; Sasaki, M; Ueno, T; Yokoyama, S	1
Buffoli, F; Castriota, F; Colombo, A; Cremonesi, A; De Felice, F; Latib, A; Marchese, A; Menozzi, A; Micari, A; Presbitero, P; Ruparelia, N; Sgueglia, GA; Tamburino, C; Tespili, M; Varbella, F	1
Joesoef, KS; McFadden, EP; Royaards, KJ; Smits, PC; van de Ent, M; van Mieghem, C; Vlachojannis, GJ; Wassing, J	1
Boxberger, M; Buszman, PE; Buszman, PP; Gąsior, P; Gorycki, B; Granada, JF; Janas, A; Kondys, M; Michalak, M; Milewski, KP; Peppas, A; Żurakowski, A	1
Ho, HH; Jafary, FH; Loh, JK; Ong, PJ; Ooi, YW; Sinaga, DA; Tan, JK; Waliszewski, M; Zeymer, U	1
Aoki, H; Fukuzawa, T; Hanaki, Y; Kato, K; Watanabe, T; Yumoto, K	1
Abizaid, A; Böhm, M; Bonaventura, K; Chamie, D; Clever, YP; Costa, R; Cremers, B; Fontaine, T; Généreux, P; Gershony, G; Hoffmann, S; Kelsch, B; Kutschera, M; Mangner, N; Scheller, B; Speck, U	1
Ann, SH; Balbir Singh, G; Kleber, FX; Koo, BK; Lim, KH; Shin, ES	1
Abe, H; Aizawa, T; Gotoh, R; Hozawa, H; Kadotani, M; Kashima, Y; Kawaguchi, R; Mibiki, Y; Nakagawa, Y; Nasu, K; Oikawa, Y; Okamura, A; Ota, H; Serikawa, T; Shirai, S; Suzuki, M; Suzuki, T; Takeda, Y; Tanabe, M; Tohara, S; Tsuji, T; Ujiie, Y; Usui, S; Yamashita, J	1
Abhaichand, RK; Abhaychand, RK; Abhyankar, A; Arambam, P; Bahuleyan, CG; Bangalore, S; Banker, D; Jain, R; Kaul, U; Kumar, PR; Mullasari, AS; Patel, TM; Seth, A; Shah, S	1
Achenbach, S; Birkemeyer, R; Brachmann, J; Brugger, A; Daniel, WG; Hohenforst-Schmidt, W; Kurowski, V; Lonke, S; Markovic, S; Ohlow, M; Rittger, H; Schlundt, C; Thiele, H; von Cranach, M; Waliszewski, M; Wöhrle, J; Zimmermann, S	1
Birkemeyer, R; Brachmann, J; Jung, W; Markovic, S; Rittger, H; Rottbauer, W; Seeger, J; Wöhrle, J	1
Arat, A; Coskun, U; Ersanli, M; Gürmen, T; Kilickesmez, KO; Kocaş, B; Yildiz, A	1
Abdel-Wahab, M; Allali, A; Büttner, HJ; de Waha, S; Geist, V; Khattab, AA; Neumann, FJ; Richardt, G; Toelg, R	1
Agostoni, P; Belkacemi, A; Doevendans, PA; Nathoe, HM; Nijhoff, F; Samim, M; Stella, PR; Troost, MS; Voskuil, M	1
Bernelli, C; Guagliumi, G; Komukai, K; Sirbu, V	1
Adam, J; Boudriot, E; Erbs, S; Linke, A; Mangner, N; Möbius-Winkler, S; Sandri, M; Schuler, GC; Uhlemann, M; Woinke, M	1
Dirksen, MT; Kiemeneij, F; Laarman, G; Patterson, MS; Slagboom, T; Suttorp, MJ; Vink, MA; Vos, NS	1
Ako, J; Fitzgerald, PJ; Honda, Y; Kume, T; Waseda, K	1
Berland, J; Brenot, P; Dupouy, P; Fajadet, J; Guerin, P; Lefèvre, T; Motreff, P; Schandrin, C	1
Basavarajaiah, S; Carlino, M; Chieffo, A; Ciconte, G; Colombo, A; Latib, A; Montorfano, M; Naganuma, T; Panoulas, V; Sticchi, A	1
Cox, D; Lasala, J; Lee, MS; Yang, T	1
Abbott, JD	1
Abizaid, A; Costa, RA; Grube, E; Hauptmann, KE; Magalhães, MA; Mehran, R; Parise, H; Schofer, J; Schuler, GC	1
Chen, F; Chen, J; Chen, Y; Gao, R; Ge, J; Qian, J; Wang, J; Wei, M; Xu, B; Yang, Y	1
Ann, SH; Balbir Singh, G; Koo, BK; Lim, KH; Shin, ES	1
Lee, CW; Park, SJ	1
Ann, SH; Garg, S; Her, AY; Kim, YH; Koo, BK; Shin, ES; Singh, GB; Yoo, SY	1
Daida, H; Dohi, T; Isoda, K; Kasai, T; Katoh, Y; Konishi, H; Kurata, T; Miyauchi, K; Miyazaki, T; Naito, R; Ogita, M; Okai, I; Okazaki, S; Tamura, H; Tsuboi, S; Yokoyama, K	1
Agarrado, A; Benezet, J; Del Río, A; Gamaza, S; Gutiérrez-Barrios, A; Oneto, J; Ruiz-Fernández, D	1
Bienek, S; Breinl, J; Jaguszewski, M; Löchel, M; Schnorr, J; Speck, U; Stolzenburg, N; Taupitz, M; Wagner, S	1
Egami, Y; Makino, N; Mori, N; Nishino, M; Okamoto, N; Sakata, Y; Shutta, R; Tanaka, A; Tanouchi, J; Yano, M	1
Figulla, HR; Gassdorf, J; Goebel, B; Gutiérrez-Chico, JL; Kryvanos, A; Nitsche, K; Otto, S; Poerner, TC	1
Hlinomaz, O; Kukla, P; Kusnierova, P; Pleva, L; Zapletalova, J	1
Cao, Z; Du, X; Li, Y; Wang, C; Wang, K; Zuo, G	1
Fernández-Nofreiras, E; Martín, P; Oategui, I; Routledge, H; Rumoroso, JR; Suarez de Lezo, J; Tizón-Marcos, H; Vaquerizo, B	1
Hannan, E; Kheocha-On, T; Qian, F; Zhong, Y	1
Bil, J; Costa, RA; Gil, KE; Gil, RJ; Vassiliev, D	1
Duderstadt, C; Figulla, HR; Goebel, B; Kretzschmar, D; Otto, S; Poerner, TC	1
Fujikake, A; Kobayashi, S; Komatsu, S; Komatsu, T; Kuroyanagi, T; Nakahara, S; Nakamura, H; Nishiyama, N; Taguchi, I; Yamada, K	1
Byrne, RA; Cassese, S; Fusaro, M; Ibrahim, T; Kastrati, A; Kreutzer, J; Kufner, S; Laugwitz, KL; Mehilli, J; Ndrepepa, G; Schunkert, H; Tada, T; Tiroch, K; Tölg, R; Valgimigli, M; Xhepa, E	1
Chibana, H; Fukumoto, Y; Ishimatsu, T; Itaya, N; Kimura, T; Mitsutake, Y; Nakayoshi, T; Ohtsuka, M; Sasaki, KI; Sasaki, M; Ueno, T; Yokoyama, S	1
Awata, M; Fujita, H; Hara, H; Hozawa, H; Iijima, R; Kawai, K; Matsuyama, Y; Mukawa, H; Muramatsu, T; Nakamura, M; Nanto, S; Ochiai, M; Okada, H; Suwa, S; Yokoi, H	1
Ann, SH; Chang, K; Chung, WS; Her, SH; Kim, DB; Kim, PJ; Koh, YS; Lee, JM; Park, CS; Park, HJ; Seo, SM; Seung, KB; Shin, DI	1
Gobić, D; Lulić, D; Tomulić, V; Zaputović, L; Židan, D	1
Fujii, K; Fujino, A; Hao, H; Hirota, S; Imanaka, T; Ishihara, M; Kawakami, R; Saita, T; Tsuchida, YA	1
Achilles, A; Afzal, S; Assadi-Schmidt, A; Bönner, F; Dannenberg, L; Horn, P; Kelm, M; Levkau, B; Liebsch, E; Mohring, A; Pöhl, M; Polzin, A; Sansone, R; Veulemans, V; Zeus, T	1
Ancona, MB; Buffoli, F; Castriota, F; Colombo, A; Costopoulos, C; Cremonesi, A; De Felice, F; Giannini, F; Latib, A; Marchese, A; Menozzi, A; Micari, A; Presbitero, P; Ruparelia, N; Sgueglia, GA; Tamburino, C; Tespili, M; Varbella, F	1
Abildgaard, U; Bligaard, N; Christiansen, EH; Engstrøm, T; Galløe, AM; Hansen, HS; Hansen, PR; Jensen, JS; Jeppesen, JL; Kelbæk, H; Lassen, JF; Ravkilde, J; Stephansen, G; Thuesen, L	1
Hannan, EL; Qian, F; Zhong, Y	1
Amini, R; Bavry, AA; Bhatt, DL; Brener, SJ; Ellis, SG; Kapadia, SR; Raymond, RE; Shishehbor, MH; Whitlow, PL	1
Kawamura, A; Miura, S; Saku, K	1
Kaneshige, K; Kent, KM; Lindsay, J; Okabe, T; Pichard, AD; Pinto Slottow, TL; Roy, P; Satler, LF; Steinberg, DH; Suddath, WO; Sushinsky, SJ; Waksman, R; Weissman, NJ; Xue, Z	1
Ang, L; Bromberg-Marin, G; Creanga, D; Demaria, AN; Mahmud, E; Palakodeti, V	1
Akdemir, R; Arinc, H; Gunduz, H; Uyan, C	1
Biondi-Zoccai, G; Chieffo, A; Colombo, A; Cook, S; De Servi, S; Garcia-Garcia, HM; Gonzalo, N; Maree, AO; Marra, S; Meliga, E; Moretti, C; Palacios, IF; Serruys, PW; Sheiban, I; Valgimigli, M; van Domburg, R; Windecker, S	1
Biondi-Zoccai, GG; Lotrionte, M; Moretti, C; Sheiban, I	1
Baim, DS; Cox, DA; Dobies, D; Katopodis, JN; Lasala, JM; Muhlestein, JB; Revtyak, G	1
Angiolillo, DJ; Barbagallo, R; Bass, TA; Capranzano, P; Dimopoulos, K; Galassi, AR; Guzman, LA; La Manna, A; Mangiafico, S; Tagliareni, F; Tamburino, C	1
Bailey, SR	1
Kornowski, R	2
Ahmed, WH; Al Naeemi, A; Al-Rashdan, I; Mascioli, S; Saeed, FA; Zambahari, R	1
Li, JJ; Qin, XW; Xiang, XP; Yan, HB; Zhang, CY	1
Chen, J; Chen, JL; Gao, LJ; Gao, RL; Liu, HB; Qiao, SB; Qin, XW; Wu, YJ; Xu, B; Yang, YJ; Yao, M; Yuan, JQ	1
Burtt, D; Chodosh, A; Korr, KS	1
Fukuyama, T; Gotou, Y; Ikeda, S; Kawasaki, T; Koga, H; Koga, N; Mito, T; Orita, Y; Serikawa, T; Shintani, Y; Tanaka, A; Tanaka, H	1
Bhatia, R; Chieffo, A; Colombo, A; Latib, A; Lee, MS; Sheiban, I; Sillano, D; Tobis, J; Zoccai, GB	1
Morrison, DA	3
Jukema, JW; Pires, NM	1
Fang, Q; Jin, XF; Liu, ZY; Shen, JZ; Shen, ZJ; Wang, CH; Xie, HZ; Zeng, Y; Zhang, SY	1
Barberis, G; Belli, G; Gasparini, GL; Lisignoli, V; Morenghi, E; Pagnotta, P; Presbitero, P; Rossi, ML; Scatturin, M; Zavalloni, D	1
Legrand, V; Nyssen, A; Scheen, AJ	1
Chen, T; Han, Y; Jing, Q; Li, Y; Liu, H; Luan, B; Ma, Y; Wang, D; Wang, G; Wang, S; Wang, Z	1
Daemen, J; Garcia-Garcia, HM; Kukreja, N; Onuma, Y; Serruys, PW; van Domburg, R	1
Bertrand, OF	1
Bergheanu, SC; Hassan, AK; Plevier, JW; Schalij, MJ; Snoep, JD; Stijnen, T; van der Hoeven, BL; Wouter Jukema, J	1
Applegate, R; Caputo, R; Cutlip, DE; Farhat, N; Gordon, P; Hermiller, JB; Midei, M; Newman, W; Petersen, JL; Sanz, M; Stone, GW; Sudhir, K; White, RM; Williams, J; Xenopoulos, N	1
Bonacina, E; Bruschi, G; Colombo, P; Guildford, A; Klugmann, S; Santin, M	1
Johnson, TW; Kay, IP; Ormiston, JA	1
Park, SJ	1
Angiolillo, DJ; Bass, TA; Capranzano, P; Di Salvo, M; Galassi, AR; Guzman, LA; La Manna, A; Tamburino, C; Ussia, G	1
Banerjee, S; Berger, P; Bissett, JK; Brilakis, ES; de Lemos, JA; Fasseas, P; Gadiparthi, C; Haagen, D; Kar, B; Karyofillis, P; Lichtenwalter, C; Obel, O; Roesle, M; Rossen, J; Sachdeva, R; Saeed, B; Voudris, VV	1
Austin, D; Oldroyd, KG; Pell, JP	1
Boersma, E; Daemen, J; de Jaegere, P; Kukreja, N; Serruys, PW; van Domburg, RT; van Twisk, PH	1
Chae, IH; Cho, YS; Choi, DJ; Chung, WY; Kang, HJ; Kim, HS; Kim, YS; Koo, BK; Lee, HY; Oh, BH; Park, JS; Park, KW; Park, YB; Seo, JB; Suh, JW	1
Banning, A; Colombo, A; Dawkins, K; Grube, E; Guagliumi, G; Hauptman, K; Joshi, A; Marco, J; Mascioli, S; Thuesen, L; Wijns, W; Zmudka, K	1
Hartenthaler, B; Hofmann, R; Hönig, S; Kammler, J; Kerschner, K; Kypta, A; Lambert, T; Leisch, F; Steinwender, C	1
Carlsson, J; Fröbert, O; James, SK; Lagerqvist, B; Lindbäck, J; Stenestrand, U	1
Bruskina, O; Byrne, RA; Dirschinger, J; Iijima, R; Kastrati, A; Laugwitz, KL; Massberg, S; Mehilli, J; Pache, J; Schömig, A; Schulz, S; Seyfarth, M	1
Alfonso, F	1
Barbagallo, R; Capodanno, D; Ciriminna, S; Colombo, GL; di Matteo, S; Recchia, M; Tamburino, C	1
Aoki, J; Cannon, L; Greenberg, J; Grube, E; Koglin, J; Mandinov, L; Mann, JT; Masud, AR; Mintz, GS; Stone, GW; Weissman, NJ	1
Igarashi, K; Maehara, A; Maiolino, G; Mintz, GS; Ochiai, M; Poon, M; Sugaya, T; Tsujita, K	1
Barrano, G; Capodanno, D; Galassi, AR; Tamburino, C; Tomasello, SD; Ussia, GP	1
Agostoni, P; Carrie, D; Cohen, SA; Dawkins, KD; Dens, J; Dubois, CL; Fitzgerald, PJ; Lansky, AJ; Lotan, C; Rutsch, W; Schofer, J; Verheye, S	1
Chen, JP; Chronos, NA; Geva, S; Hou, D; King, SB; Li, J; Pendyala, LK; Robinson, KA; Shinke, T; Yin, X	1
Bruskina, O; Byrne, RA; Iijima, R; Kastrati, A; Mehilli, J; Pinieck, S; Schömig, A	1
Finn, AV; Kolodgie, FD; Nakazawa, G; Virmani, R	1
Awata, M; Iida, O; Kotani, J; Minamiguchi, H; Morozumi, T; Nagata, S; Nanto, S; Onishi, T; Sera, F; Uematsu, M; Watanabe, T	1
Tarantini, G	1
Cao, S; Cristea, E; Doostzadeh, J; Guiran, JB; Lansky, AJ; Midei, M; Mutlu, H; Newman, W; Ng, VG; Sanz, M; Sood, P; Stone, GW; Su, X; Sudhir, K; White, R	1
Allocco, DJ; Baim, DS; Dawkins, KD; Leon, MB	1
Coin, K; Dippel, E; Jerin, M; Parikh, A; Robken, J; Shammas, GA; Shammas, NW; Sharis, P	1
Baim, DS; Chhabra, A; Cox, DA; Dawkins, KD; Haas, RC; Lasala, JM; Lewis, SJ; Mascioli, SR; Schweiger, MJ; Starzyk, RM; Tadros, PN; Untereker, WJ	1
Eindhoven, J; Girasis, C; Kukreja, N; Onuma, Y; Piazza, N; Schenkeveld, L; Serruys, PW; van Domburg, R	1
Habara, M; Katoh, O; Kinoshita, Y; Nasu, K; Rathore, S; Suzuki, T; Terashima, M	1
Hong, MK; Kim, YH; Lee, CW; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC	1
Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Kandzari, DE; Leon, MB; Miyazawa, A; Sakurai, R; Tsujino, I; Waseda, K; Yock, PG	1
Doganov, A; Formuszewicz, R; Gil, RJ; Rusicka-Piekarz, T; Vassilev, D	1
Heldman, AW; Hennebry, TA; Latif, F	1
Cutlip, DE; Doostzadeh, J; Lansky, AJ; Nikolsky, E; Piana, R; Simonton, CA; Stone, GW; Su, X; Sudhir, K; White, R	1
Baim, DS; Banning, AP; Colombo, A; Drzewiecki, J; Dudek, D; Grube, E; Hauptmann, K; Silber, S	1
Akin, I; Fetsch, T; Kuck, KH; Nienaber, CA; Richardt, G; Sabin, GV; Schneider, S; Senges, J; Silber, S; Stumpf, J; Tebbe, U; Willich, SN	1
Balducelli, M; Grilli, R; Guastaroba, P; Manari, A; Maresta, A; Marzaroli, P; Marzocchi, A; Menozzi, A; Ortolani, P; Passerini, F; Piovaccari, G; Rossi, R; Sangiorgio, P; Tarantino, F; Tondi, S	1
Cho, YK; Han, SW; Hur, SH; Kim, DI; Kim, DK; Kim, DS; Kim, H; Kim, KB; Kim, YJ; Kim, YN; Nam, CW; Park, HJ; Park, JS; Shim, BS; Shin, DG; Yang, TH	1
Cho, YK; Han, SW; Hur, SH; Kim, H; Kim, HT; Kim, IC; Kim, KB; Kim, YN; Nam, CW; Park, HS; Yoon, HJ	1
Fergus, T; Hermiller, JB; Pierson, W; Sood, P; Stone, GW; Su, X; Sudhir, K	1
Ishibashi-Ueda, H; Ito, K; Ito, Y; Shimokawa, H; Shiroto, T; Takahashi, J; Tsuburaya, R; Yasuda, S	1
Nickenig, G; Sinning, JM	1
Airoldi, F; Briguori, C; Carlino, M; Chieffo, A; Colombo, A; Foglieni, C; Latib, A; Maseri, A; Michev, I; Montorfano, M; Nodari, RL; Sangiorgi, G	1
Gothwal, R; Kumar, A	1
Choi, D; Fan, C; Hong, MK; Jang, Y; Kim, JS; Kim, TH; Kim, W; Ko, YG; Lee, JM	1
Canan, T; Lee, MS	1
Chen, JP; Chronos, N; Geva, S; Goodchild, T; Hou, D; Jabara, R; Li, J; Pendyala, L; Robinson, K; Shinke, T; Ueno, T	1
Almonacid, A; Kirtane, A; Leon, MB; Mauri, L; McLaurin, B; O'Shaughnessy, C; Overlie, P; Popma, JJ	1
Baim, DS; Cox, DA; Dawkins, KD; Ellis, SG; Forman, DE; Joshi, AA; Lasala, JM; Ormiston, JA; Stone, GW; Turco, MA; Wei, JY	1
Cook, S; Wenaweser, P	1
Bachinsky, WB; Baim, DS; Baran, K; Breall, JA; Cox, DA; Dawkins, KD; Dobies, D; Lasala, JM; Lewis, DH; Mascioli, SR; Rogers, EW; Song, A; Starzyk, RM	1
Beijk, MA; Claessen, BE; Henriques, JP; Legrand, V; Manari, A; Miquel-Hebert, K; Piek, JJ; Ruzyllo, W; Serruys, PW; Suttorp, MJ; Tijssen, JG; Varenne, O; Veldhof, S	1
Gruene, S; Huegl, B; Korn, HV; Lauer, B; Ohlow, MA; Petek, O; Schulte, W; Wagner, A; Wassmer, G; Yu, J	1
Austin, PC; Blackhouse, G; Chiu, M; Cohen, EA; Goeree, R; Ko, DT; Tu, JV; Velianou, JL	1
Abbasi, A; Alidoosti, M; Dehkordi, MR; Kassaian, SE; Nematipoor, E; Poorhosseini, H; Salarifar, M; Sheikhfathollahi, M; Zeinali, AM	1
Allocco, DJ; Britt, A; Cannon, LA; Dawkins, KD; Heil, JE; Kereiakes, DJ; Nersesov, A; Wehrenberg, S	1
Buller, NP; Chue, CD; Doshi, SN; Epstein, AC; Ludman, PF; Routledge, HC; Townend, JN	1
Banning, AP; Berti, S; Dawkins, KD; Glauber, M; Kappetein, AP; Kellett, MA; Kramer, RS; Leadley, K; Mohr, FW; Morice, MC; Serruys, PW; Westaby, S	1
García de Lara, J; Hurtado, JA; Lacunza, J; Pinar, E; Ramón Gimeno, J; Valdés Chávarri, M; Valdesuso, R	1
Aronow, WS; Kakar, P; Kalapatapu, K; Lal, P; Mohan, D; Monsen, CE; Palaniswamy, C; Pucillo, AL; Singh, T; Sorbera, C; Sukhija, R; Weiss, MB	1
Chen, JP; Chronos, N; Hou, D; Li, J; Pendyala, LK; Yin, X	1
Boland, J; Dorange, C; Garcia, E; Garg, S; Huber, K; Miquel-Hébert, K; Onuma, Y; Serruys, P; Sudhir, K; te Riele, JA; Veldhof, S	1
Anstrom, KJ; Cutlip, DE; Douglas, JS; Eisenstein, EL; Kandzari, DE; Kirtane, AJ; Leon, MB; Mauri, L; McLaurin, BT; Nikolsky, E; O'Shaughnessy, C; Overlie, PA; Popma, JJ; Solomon, SL	1
Baim, DS; Bergin, PJ; Bowman, TS; Caputo, R; Cox, DA; Ellis, SG; Hermiller, J; Mann, T; O'Shaughnessy, C; Stone, GW; Turco, M	1
Dawkins, KD; Doi, H; Ellis, SG; Grube, E; Maehara, A; Mandinov, L; Mintz, GS; Ormiston, JA; Popma, JJ; Stone, GW; Turco, MA; Wang, H; Weissman, NJ; Yu, A	1
Bass, EJ; Colombo, A; Dawkins, KD; Feldman, TE; Girasis, C; Holmes, DR; Leadley, K; Morice, MC; Onuma, Y; Serruys, PW	1
Christ, G; Huber, K; Kastl, SP; Katsaros, KM; Maurer, G; Speidl, WS; Wojta, J; Zorn, G	1
Blundo, A; Bucalo, R; Caggegi, A; Capodanno, D; Capranzano, P; Conti, G; Ruperto, C; Sanfilippo, A; Tamburino, C	1
Ball, MW; Caputo, RP; Cutlip, DE; Douglas, JS; Fitzgerald, PJ; Jain, A; Kandzari, DE; Kirtane, AJ; Leon, MB; Mauri, L; McLaurin, BT; Nikolsky, E; O'Shaughnessy, C; Overlie, PA; Popma, JJ; Reen, BM; Solomon, SL; Thompson, K; Tolleson, TR	1
Kastrati, A	1
Gasior, M	1
Battes, L; Boersma, E; de Boer, S; Magro, M; Onuma, Y; Serruys, PW; Simsek, C; van Domburg, RT	1
Dawkins, KD	1
Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Jang, Y; Jeong, MH; Kim, HS; Lee, SH; Park, SJ; Rha, SW; Seong, IW; Seung, KB; Song, YB; Tahk, SJ; Yang, JY; Yoon, JH	1
Allocco, DJ; Curzen, N; Dawkins, KD; Grube, E; Hauptmann, KE; Nickenig, G; Schofer, J	1
Gutiérrez-Chico, JL; van Geuns, RJ; Wykrzykowska, JJ	1
Lee, SS; Levisay, JP; Miller, L; Price, MJ; Shaba, W; Stinis, CP; Teirstein, PS	1
Cao, S; Caputo, R; Cutlip, DE; Doostzadeh, J; Kereiakes, DJ; Lansky, AJ; Mastali, K; Newman, W; Rizvi, A; Simonton, CA; Stone, GW; Sudhir, K; Wang, JC	1
Hillis, LD; Lange, RA	1
Girasis, C; Kukreja, N; Onuma, Y; Serruys, P; van Domburg, R; Wong, CK	1
Siminiak, T	1
Applegate, R; Cao, S; Doostzadeh, J; Gordon, P; Hermiller, J; Lansky, A; Simonton, C; Stone, G; Su, X; Sudhir, K; Williams, J	1
Colombo, A; Dawkins, KD; Feldman, TE; Holmes, DR; Kappetein, AP; Leadley, K; Mack, MJ; Mohr, F; Morice, MC; Serruys, PW; Ståhle, E; Torracca, L; van Es, GA	1
Hansen, KN; Jensen, LO; Johnsen, SP; Kaltoft, A; Lassen, JF; Madsen, M; Maeng, M; Ravkilde, J; Sørensen, HT; Thayssen, P; Thuesen, L; Tilsted, HH	1
Antoniucci, D; Barbagallo, R; Cera, M; Chieffo, A; Colombo, A; Di Mario, C; Furuichi, S; Godino, C; Goktekin, O; Grube, E; Latib, A; Mueller, R; Parodi, G; Reimers, B; Sangiorgi, GM; Tamburino, C	1
Allocco, DJ; Dawkins, KD; Grube, E; Lefèvre, T; Ormiston, JA	1
Cho, YK; Hong, GR; Hur, SH; Kim, DI; Kim, DK; Kim, DS; Kim, HS; Kim, KB; Kim, U; Kim, YJ; Lee, SH; Nam, CW; Park, JS; Seol, SH; Shin, DG; Yang, TH	1
Akin, I; Bufe, A; Eckardt, L; Kuck, KH; Nienaber, CA; Reinecke, H; Richardt, G; Schneider, S; Senges, J	1
Bartorelli, AL; Miquel-Hébert, K; Pierson, W; Serruys, PW; Stone, GW; Yu, S	1
Ahn, T; Choi, D; Han, SH; Jang, Y; Jeon, DW; Kang, WC; Kim, BK; Kim, JS; Ko, YG; Lee, K; Moon, CI; Oh, SJ; Shin, EK; Yang, JY	1
Altay, H; Binici, S; Ciçek, D; Kalay, N; Müderrisoğlu, H; Pekdemir, H	1
Chen, LL; Lin, CG; Lin, QF; Luo, YK; Peng, YF; Zhen, XC	1
Allocco, DJ; Aprile, A; Bezerra, HG; Costa, MA; Dawkins, KD; Fiocca, L; Guagliumi, G; Kyono, H; Lortkipanidze, N; Matiashvili, A; Musumeci, G; Popma, JJ; Sirbu, V; Valsecchi, O; Vassileva, A	1
Ben-Dor, I; Collins, SD; Gaglia, MA; Gonzalez, MA; Hanna, NN; Kaneshige, K; Kent, KM; Maluenda, G; Pichard, AD; Satler, LF; Suddath, WO; Syed, AI; Torguson, R; Waksman, R; Xue, Z	1
Choi, D; Hong, BK; Hong, MK; Jang, Y; Jeon, DW; Kim, BK; Kim, JS; Ko, YG; Kwon, HM; Lee, BK; Min, PK; Oh, SJ; Yang, JY; Yoon, YW	1
Kedhi, E; Stone, GW	1
Baan, J; Beijk, MA; Claessen, BE; de Winter, RJ; Henriques, JP; Koch, KT; Meesterman, M; Piek, JJ; Tijssen, JG; Vis, MM	1
Applegate, RJ; Doostzadeh, J; Hermiller, JJ; Lansky, AJ; Pierson, W; Sanz, M; Stone, GW; Su, X; Sudhir, K	1
Anthopoulos, PL; Antonelis, I; Gavaliatsis, I; Gavrielatos, G; Ifantis, G; Pappas, LK; Salachas, A	1
Ahn, T; Choi, D; Hong, MK; Jang, Y; Jeon, DW; Kang, WC; Kim, BK; Kim, JS; Ko, YG; Oh, SJ; Park, SM; Yang, JY	1
Boersma, E; Gaspersz, MP; Magro, M; Nauta, ST; Onuma, Y; Serruys, PW; Simsek, C; van der Giessen, WJ; van Domburg, RT	1
Choi, D; Hong, MK; Jang, Y; Kim, BK; Kim, JS; Kim, TH; Ko, YG	1
Airaksinen, JK; Karjalainen, PP; Nammas, W; Ylitalo, A	1
Rathore, S	1
Cheng, JM; Nuis, RJ; Onuma, Y; Piazza, N; Serruys, PW; Van Domburg, RT	1
Abizaid, A; Cebrian, A; Dens, J; Dubois, C; Fajadet, J; Fitzgerald, PJ; Hoffmann, R; Macours, N; Mauri, L; Ormiston, JA; Popma, JJ; Rogers, C; Schofer, J; Spaulding, C; Spertus, J; Stoll, HP; Thuesen, L; Verheye, S; Wijns, W	1
Bianchi, CF; Buchholz, B; Gao, F; Gu, Z; Laham, R; Ma, X; McCarthy, S; Oyamada, S; Robich, MP; Sellke, FW; Wang, X; Wu, H; Wu, T	1
Applegate, RJ; Cutlip, DE; Farhat, N; Kereiakes, DJ; Rizvi, A; Simonton, CA; Sood, P; Stone, GW; Su, G; Su, X; Sudhir, K; Wang, J; Yaqub, M	1
Ako, J; Fitzgerald, PJ; Hirata, K; Honda, Y; Ikeno, F; Miyoshi, N; Otake, H; Shinke, T; Shite, J; Teramoto, T	1
Dong, L; Ge, J; Qian, J; Zhang, F	1
Muraoka, Y; Okazaki, M; Otsuji, Y; Sonoda, S; Tanaka, S; Tsuda, Y	1
Hayashi, Y; Hirao, H; Kawase, T; Masaoka, Y; Mito, S; Motoda, C; Muraoka, Y; Okimoto, T; Otsuka, M; Takeda, R; Tamekiyo, H; Toyofuku, M; Ueda, H; Watanabe, N	1
Barry, JJ; Cheng, R; Eppihimer, MJ; Lavigne, MC	1
Alexopoulos, D; Davlouros, PA; Hahalis, G; Karantalis, V; Mavronasiou, E; Tsigkas, G; Xanthopoulou, I	1
Caixeta, A; Gordon, P; Hermiller, JB; Jonnavithula, L; Lansky, AJ; Miquel-Hebert, K; Onuma, Y; Ruygrok, P; Serruys, PW; Sood, P; Stone, GW; Su, X; Sudhir, K; Veldhof, S; Yaqub, M	1
Ferguson, J; Gordon, PC; Hermiller, JB; Kereiakes, DJ; Lansky, AJ; Sood, P; Stone, GW; Su, X; Sudhir, K; Yakubov, S; Yaqub, M	1
Baim, DS; Colombo, A; Cox, DA; Ellis, SG; Gerber, RT; Joshi, AA; Lasala, JM; Mikhail, GW; Ormiston, JA; Stone, GW; Turco, MA	1
Kini, AS; Mehran, R	1
Altay, H; Binici, S; Ciçek, D; Haberal, C; Kalay, N; Müderrisoğlu, H; Pekdemir, H	1
Applegate, RJ; Caputo, R; Cutlip, DE; Doostzadeh, J; Farhat, N; Hermiller, JB; Lansky, AJ; Sood, P; Stone, GW; Sudhir, K; Williams, JE; Yaqub, M; Yu, S	1
Avanzas, P; Lozano, I; Rondan, J	1
Arashi, H; Hagiwara, N; Higashitani, M; Hoshi, H; Kojika, A; Minami, Y; Mori, F; Ogawa, H; Takagi, A; Yamada, N; Yamaguchi, J; Yamauchi, T	1
Bhindi, R; Khachigian, LM; Li, Y	1
Kang, SJ; Kim, PJ; Kim, WJ; Kim, YH; Lee, CW; Lee, JY; Lee, SH; Park, DW; Park, HJ; Park, SJ; Park, SW; Seung, KB	1
Cannon, LA; Dawkins, KD; Kellett, MA; Kereiakes, DJ; Lee, TC; Mann, T; McGarry, T; Mishkel, GJ; Mooney, MR; Orlow, S; Popma, JJ; Ring, ME; Stuckey, TD; Underwood, P; Wilson, BH	1
Abe, M; Kasahara, Y; Kataoka, Y; Kokubu, N; Otsuka, Y; Yagi, N	1
Ahmed, W; Mirza, J; Shah, MA; Thaver, AM	1
Abizaid, A; Ako, J; Cohen, SA; Courtney, BK; Fitzgerald, PJ; Honda, Y; Macours, N; Ormiston, JA; Otake, H; Popma, JJ; Rogers, C; Shimohama, T; Spaulding, C; Waseda, K	1
Capodanno, D; Tamburino, C	1
Cortese, B; Danzi, GB; Limbruno, U; Pitì, A; Severi, S	1
Egami, Y; Hara, M; Kato, H; Makino, N; Nishino, M; Shutta, R; Taniike, M; Tanouchi, J; Yamada, Y	1
Calvo-Orbe, L; Martín-Reyes, R; Moreno, R	1
Bowman, TS; Brilakis, ES; Cox, DA; Dawkins, KD; Lasala, JM; Starzyk, RM	1
Ben-Dor, I; Delhaye, C; Gaglia, MA; Gonzalez, MA; Kent, KM; Mahmoudi, M; Maluenda, G; Pichard, AD; Satler, LF; Suddath, WO; Torguson, R; Wakabayashi, K; Waksman, R; Xue, Z	1
Alexopoulos, D; Damelou, A; Davlouros, P; Karantalis, V; Mitropoulou, G; Xanthopoulou, I	1
Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Hong, KP; Lee, SH; Park, JE; Ryu, DR; Song, PS; Song, YB	1
Baan, J; Beijk, MA; de Winter, RJ; Henriques, JP; Klomp, M; Koch, KT; Piek, JJ; Tijssen, JG; van Geloven, N; Vis, MM	1
Marx, N	1
Ahn, Y; Cho, MC; Jeong, MH; Kim, DW; Kwon, JS; Park, RK; Shim, TJ	1
Bleuit, JS; Colombo, A; Dawkins, KD; Ellis, SG; Grube, E; Popma, JJ; Russell, ME; Stone, GW; Uchida, T	1
Almalla, M; Hoffmann, R; Marx, N; Pross, V; Schröder, JW; Stegemann, E	1
Choi, D; Hong, MK; Jang, Y; Kim, BK; Kim, JS; Ko, YG; Oh, C	1
Karanasos, A; Lerakis, S; Stathogiannis, K; Stefanadis, C; Synetos, A; Toutouzas, K; Triantafyllou, G; Tsiamis, E	1
Duckers, H; Garg, S; Gutiérrez-Chico, JL; Regar, E; Schultz, C; Serruys, PW; van Geuns, RJ; van Mieghem, N	1
Cutlip, DE	1
Cook, S; Eberli, F; Jüni, P; Kalesan, B; Lüscher, TF; Meier, B; Moschovitis, A; Räber, L; Seiler, C; Togni, M; Vogel, R; Wandel, S; Wenaweser, P; Wigger, M; Windecker, S; Wohlwend, L	1
Cho, JM; Choi, D; Choi, SY; Hong, MK; Jang, Y; Kim, BK; Kim, DM; Kim, JS; Ko, YG; Yoon, JH	1
Bressers, M; Campo, G; Dawkins, KD; de Vries, T; Garcia-Garcia, HM; Garg, S; Girasis, C; Räber, L; Sarno, G; Serruys, PW; Swart, M; Valgimigli, M; van Es, GA; Vranckx, P; Windecker, S	1
Boersma, E; Magro, M; Nauta, S; Onuma, Y; Serruys, P; Simsek, C; Valstar, G; van der Giessen, W; van Domburg, R; van Geuns, RJ	1
Doshi, SN; Raja, Y; Townend, JN	1
Fahy, M; Kedhi, E; Kereiakes, DJ; Parise, H; Serruys, PW; Smits, PC; Stone, GW	1
Kastrati, A; Massberg, S; Ndrepepa, G	1
De Vroey, F; Kandzari, DE; Ormiston, JA; Webster, MW	1
Agostoni, P; Belkacemi, A; Stella, PR	1
Caputo, R; Farhat, N; Hermiller, JB; Koo, K; Lansky, AJ; Sanz, M; Smith, RS; Sood, P; Stone, GW; Sudhir, K; Williams, JE; Yaqub, M	1
Bertoletti, A; Cortese, B	1
Baldinger, SH; Hess, N; Hess, OM; Jüni, P; Laube, E; Lauterburg, A; Limacher, A; Lötscher, S; Meier, B; Moschovitis, A; Räber, L; Wenaweser, P	1
Carrié, D; Colombo, A; Dawkins, KD; Feldman, TE; Fournial, G; Holmes, DR; James, S; Kappetein, AP; Leadley, K; Mack, MJ; Mohr, F; Morel, MA; Morice, MC; Serruys, PW; Ståhle, E; van den Brand, M	1
Hamamdzic, D; Huibregtse, BA; Keane, MG; Llano, R; Patel, DB; Seifert, PS; Wang, H; Wilensky, RL; Wilson, GJ; Winsor-Hines, D	1
Briguori, C; de Waha, A; Dibra, A; Galloe, AM; Kastrati, A; Kim, MH; Kufner, S; Lee, SW; Lim, DS; Maeng, M; Park, SW; Schömig, A; Tomai, F	1
Duckers, H; Gutiérrez-Chico, JL; Koch, KT; Koolen, JJ; Regar, E; Serruys, PW; van Geuns, RJ	1
Buja, P; Favaretto, E; Iliceto, S; Isabella, G; Lanzellotti, D; Napodano, M; Panfili, M; Tarantini, G	1
Amano, T; Aoyama, T; Ishii, H; Kamoi, D; Kawamura, Y; Kawashima, K; Matsubara, T; Murohara, T; Takahashi, H; Tanaka, M; Toriyama, T; Uetani, T; Yoshikawa, D	1
Cho, YK; Hong, GR; Hur, SH; Jang, JS; Kim, DI; Kim, DK; Kim, DS; Kim, HS; Kim, KB; Kim, U; Kim, YJ; Lee, SH; Nam, CW; Park, JS; Seol, SH; Shin, DG; Yang, TH	1
Laule, M; Rutsch, W; Scheller, B; Speck, U; Stangl, V	1
Cortese, B	1
Bonaventura, K; Boxberger, M; Kleber, FX; Mathey, DG; Wendig, I	1
Agostoni, P; Belkacemi, A; Stella, PR; Voskuil, M	1
Danzer, C; Ferrari, M; Figulla, HR; Gassdorf, J; Janiak, F; Otto, S; Poerner, TC	1
Chen, Z; Ge, J; Ma, J; Qian, J	1
Cheong, SS; Cho, BR; Kim, HS; Lee, K; Lee, NH; Lee, SG; Lee, SW; Park, DW; Park, SJ; Park, SW	1
Bumeistere, K; Erglis, A; Grave, A; Jegere, S; Kumsars, I; Mintale, I; Narbute, I; Sondore, D; Zakke, I	1
Applegate, RJ; Cao, S; Gordon, PC; Hermiller, JB; Sood, P; Stone, GW; Su, X; Sudhir, K; Yaqub, M	1
Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Kume, T; Sakata, K; Shimohama, T; Tsujino, I; Waseda, K; Yamasaki, M	1
Ahmed, WH; Fava, CM; Lev, GA; Mendiz, OA; R Thomas, M; Valdivieso, LR; vom Dahl, J	1
Ateş, AH; Aytemir, K; Canpolat, U; Dural, M; Kabakcı, G; Kaya, EB; Oto, A; Sunman, H; Tokgözoğlu, L; Yorgun, H	1
Antoniucci, D; Berland, J; Berti, S; Carrié, D; Dibie, A; Hauptmann, KE; Maupas, E; Schofer, J; Verheye, S; Violini, R; Vrolix, M	1
Dangas, GD; Sergie, Z	1
Barbash, IM; Ben-Dor, I; Dvir, D; Kent, KM; Maluenda, G; Pichard, AD; Satler, LF; Suddath, WO; Torguson, R; Waksman, R; Xue, Z	1
Boldt, LH; Bonaventura, K; Dorenkamp, M; Haverkamp, W; Kleber, FX; Leber, AW; Roser, M; Sohns, C	1
Akin, I; Bergmann, MW; Hochadel, M; Khattab, AA; Kuck, KH; Nienaber, CA; Richardt, G; Schneider, S; Senges, J; Tölg, R	1
Chen, YQ; Ling, ZY; Liu, G; She, Q; Su, L; Yin, YH; Yuan, J; Zhang, L; Zhong, JP	1
Bae, JH; Hur, SH; Jang, Y; Jeong, MH; Kim, HS; Park, JS; Park, K; Park, KW; Rha, SW; Yoon, JH	1
Abdel-Wahab, M; Akin, I; Ferenc, M; Hochadel, M; Kuck, KH; Mostafa, AE; Nienaber, CA; Richardt, G; Sabin, G; Senges, J; Silber, S; Tebbe, U	1
Aghajani, H; Alidoosti, M; Amirzadegan, AR; Hajizeinali, AM; Hakki-Kazazi, E; Kassaian, SE; Nematipour, E; Poorhosseini, H; Salarifar, M; Shafiee, N; Sheikhfathollahi, M; Tokaldany, ML	1
Adriaenssens, T; Agostoni, P; Belkacemi, A; Dens, J; Doevendans, P; Dubois, C; Naber, C; Nathoe, H; Stella, PR; van Belle, E	1
Ahn, JM; Cho, SW; Choo, SJ; Chung, CH; Han, S; Hwang, KW; Jung, SH; Kang, SJ; Kim, WJ; Kim, YG; Kim, YH; Kim, YR; Lee, CH; Lee, CW; Lee, JW; Lee, JY; Lee, SW; Lee, WS; Park, DW; Park, GM; Park, SJ; Park, SW; Song, HG; Sun, BJ	1
Abdel-Wahab, M; Baev, R; Dieker, P; Geist, V; Kassner, G; Khattab, AA; Richardt, G; Sulimov, D; Toelg, R	1
Abizaid, A; Abizaid, AS; Berland, J; Brenot, P; Costa, RA; Fajadet, J; Garcia del Blanco, B; Lesiak, M; Petrov, I; Royer, T; Rubino, P; van Guens, RJ	1
Applegate, RJ; Brar, SS; Hermiller, JB; Jankovic, I; Koo, K; Lansky, AJ; Lazar, D; Sood, P; Stone, GW; Sudhir, K; Yaqub, M	1
Barbash, IM; Hauville, C; Laynez, A; Pakala, R; Pichard, AD; Sardi, G; Satler, LF; Torguson, R; Waksman, R; Xue, Z	1
Desale, S; Ellis, SG; Grube, E; Laynez-Carnicero, A; Mintz, GS; Ormiston, JA; Pakala, R; Pichard, AD; Romaguera, R; Sardi, G; Stone, GW; Turco, MA; Wakabayashi, K; Waksman, R; Weissman, NJ; Xue, Z	1
Arnold, SV; Cohen, DJ; Kappetein, AP; Magnuson, EA; Mohr, FW; Serruys, PW; Wang, K	1
Horinaka, S; Ishimitsu, T; Yagi, H; Yano, H	1
Brancati, MF; Burzotta, F; Coluccia, V; Crea, F; De Maria, G; Leone, AM; Niccoli, G; Porto, I; Schiavoni, G; Tommasino, A; Trani, C	1
Arruda, JA; Barbosa, MR; Brito, FS; Caramori, PR; Lemos, PA; Lima, AA; Lima, VC; Medeiros, CR; Moulin, B; Oliveira, LA; Perin, MA; Ribeiro, EE	1
Amoroso, N; Attubato, MJ; Bangalore, S; Bhatt, DL; Feit, F; Fusaro, M; Kumar, S; Slater, J	1
Amorosi, SL; Dawkins, KD; Kansal, AR; Lissovoy, GD; Stern, S; Turco, MA; Underwood, PL	1
Amin, AP; Cohen, DJ; Durtschi, AJ; Lei, Y; Magnuson, EA; Reynolds, MR; Simonton, CA; Stone, GW; Vilain, K	1
Akkerhuis, KM; Boersma, E; Daemen, J; de Boer, SP; de Jaegere, P; Marcolino, MS; Serruys, PW; Simsek, C; van Domburg, RT; van Geuns, RJ	1
Bouchard, A; Guy, LG; Hsu, S; Lema, P; Polyakov, I; Savard, C; Sheehy, A; Tai, J	1
Dobies, D; Ghali, M; Goodroe, R; Kaneshige, K; McGarry, T; Ring, M; Ryan, T; Shammas, N; Steinberg, DH; Swymelar, S; Torguson, R; Turco, M; Waksman, R	1
Ako, J; Funayama, H; Kubo, N; Momomura, S; Naito, R; Sakakura, K; Sugawara, Y; Wada, H	1
Dobrzycki, S; Formuszewicz, R; Gil, RJ; Kardaszewicz, P; Kern, A; Lekston, A; Lesiak, M; Michalek, A; Vassilev, D; Wójcik, J	1
Borges, AC; Bräutigam, M; Clever, Y; Cremers, B; Dietz, U; Richter, W; Rutsch, W; Scheller, B; Speck, U	1
Jang, SJ; Kang, SJ; Kim, WJ; Kim, YH; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC	1
Buja, P; Facchin, M; Frigo, AC; Meliga, E; Menozzi, A; Musumeci, G; Saia, F; Sardella, G; Tamburino, C; Tarantini, G	1
Fitzgerald, PJ; Fujii, K; Fujita, H; Hirayama, H; Honda, Y; Igarashi, K; Isshiki, T; Kikuchi, T; Kimura, T; Lansky, AJ; Mitsudo, K; Nakamura, M; Nakamura, S; Nonogi, H; Saito, K; Saito, S; Stone, GW; Sudhir, K; Waseda, K	1
Akyurek, O; Altin, T; Candemir, B; Durdu, S; Ede, H; Ozcan, OU	1
Baumgartner, S; Buellesfeld, L; Garcia, HM; Garcia-Garcia, HM; Jüni, P; Justiz, J; Kalesan, B; Khattab, AA; Meier, B; Moschovitis, A; Pilgrim, T; Räber, L; Serruys, PW; Wenaweser, P; Windecker, S	1
Antoniucci, D; Carrabba, N; Dovellini, EV; Migliorini, A; Parodi, G; Valenti, R; Vergara, R	1
Fortuna, R; Ho, PC; Lee, AC	1
Chen, SL; Ding, SQ; Fu, Q; Kan, J; Kwan, TW; Mintz, G; Paiboon, C; Santoso, T; Xu, YW; Ye, F; Zhang, JJ; Zhou, Y	1
Angioi, M	1
Baszko, A; Kałmucki, P; Link, R; Siminiak, T; Wołoszyn, M	1
Ako, J; Fitzgerald, PJ; Hasegawa, T; Honda, Y; Lima-Filho, MO; Sakurai, R; Shimohama, T; Stone, GW; Sudhir, K; Tsujino, I; Waseda, K; Yamasaki, M	1
Abe, H; Araki, M; Kamezaki, F; Kashiyama, K; Muraoka, Y; Okazaki, M; Otsuji, Y; Sonoda, S; Takeuchi, M; Tamura, M; Tsuda, Y	1
Fitzgerald, PJ; Honda, Y; Kume, T; Nakatani, D; Otake, H; Sakata, K; Waseda, K; Yock, PG	1
Gomes, ME; Harnek, J; James, S; Kedhi, E; Lagerqvist, B; Olivecrona, GK; Omerovic, E; Smith, JG	1
Abbott, JD; Faxon, D; Holper, E; Kelsey, S; Khandhar, S; Kip, KE; Kutcher, M; Lee, JS; Marroquin, OC; Mulukutla, SR; Selzer, F; Smith, C; Toma, C; Vlachos, HA; Williams, DO	1
Cannon, LA; Charles, O; Dawkins, KD; Hall, JJ; Mann, T; McGarry, T; Mishkel, GJ; Ormiston, JA; Underwood, PL; Webster, MW	1
Cho, HJ; Kang, DY; Kang, HJ; Kim, HS; Koo, BK; Lee, HY; Park, JB; Park, KW; Yang, HM	1
Abdel-Wahab, M; Geist, V; Joachim Büttner, H; Khattab, AA; King, L; Meinertz, T; Neumann, FJ; Richardt, G; Schofer, J; Toelg, R	1
Abdul-Jawad Altisent, O; Alfonso, F; Aragon, V; Bosa, F; Bullones, JA; Calviño, R; De la Torre Hernandez, JM; Elizaga, J; Fernandez Diaz, JA; Gallardo, A; Garcia Camarero, T; Gimeno, F; Hernandez, F; Jimenez Navarro, MF; Masotti, M; Moreu, J; Perez de Prado, A; Rivero, F; Roura, G; Ruiz Arroyo, JR; Rumoroso, JR; Sanchez Recalde, A	1
Böse, D; Degen, H; Erbel, R; Erne, P; Haude, M; Koolen, J; Prati, F; Verheye, S; Vermeersch, P; Waksman, R; Weissman, N; Wijnbergen, I	1
Cutlip, DE; Pride, YB	1
Claessen, BE; Dangas, GD; Mehran, R; Stone, GW; Xu, K	1
Miquel-Hebert, K; Onuma, Y; Serruys, PW	1
Hur, SH; Jang, JS; Kim, DI; Kim, DK; Kim, DS; Kim, KB; Kim, U; Kim, YJ; Nam, CW; Park, JS; Seol, SH; Son, JW; Yang, TH	1
Basavarajaiah, S; Colombo, A; Figini, F; Hasegawa, T; Kawaguchi, M; Latib, A; Naganuma, T; Rezq, A; Takagi, K	1
Chieffo, A; Colombo, A; Stankovic, G	1
Gershlick, A; Hogrefe, K; Javed, Q; Swanson, N	1
Buellesfeld, L; Gerckens, U; Grube, E	1
Buellesfeld, L; Gerckens, U; Grube, E; Hauptmann, KE; Mueller, R; Russell, ME; Silber, S	1
Fearnot, NE; Han, KH; Hong, MK; Kang, DH; Kim, JJ; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Song, JK; Song, JM; Weissman, NJ	1
Liakishev, AA	1
Lim, MC	1
Hung, JS; Johan, A; Lau, KW; Sigwart, U	1
Wagstaff, AJ; Waugh, J	1
Halkin, A; Stone, GW	1
Accapezzato, D; Di Roma, A; Di Russo, C; Fedele, F; Francavilla, V; Giacomelli, L; Iannucci, G; Paroli, M; Sardella, G; Sirinian, MI	1
Benoît, A; Goy, JJ; Seydoux, C; Siegenthaler, M; Stauffer, JC	1
Perin, EC	1
Kereiakes, DJ; Williams, DO	1
Rogers, CD	1
Finn, AV; Gold, HK; Kastrati, A; Palacios, IF	1
Bavry, AA; Bhatt, DL; Helton, TJ; Kumbhani, DJ	1
Aoki, J; de Feyter, P; de Jaegere, PP; Hoye, A; McFadden, EP; Ong, AT; Regar, E; Rodriguez Granillo, GA; Serruys, PW; Sianos, G; Sonnenschein, K; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA	1
Alfonso, F; Angiolillo, DJ; Bañuelos, C; Escaned, J; Fernández, C; Fernández-Ortiz, A; Hernández, R; Macaya, C; Moreno, R; Sabaté, M	1
Yamaguchi, T	3
Aoki, J; de Feyter, PJ; de Jaegere, PP; Hoye, A; McFadden, EP; Ong, AT; Regar, E; Rodriguez-Granillo, GA; Serruys, PW; Sianos, G; Sonnenschein, K; Valgimigli, M; van der Ent, M; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA	1
Katsamakis, CD; Klein, LW; Kozinski, M	1
Airoldi, F; Chieffo, A; Colombo, A; Corvaja, N; Ge, L; Iakovou, I; Michev, I; Montorfano, M; Sangiorgi, GM; Tsagalou, E	1
Colombo, A; Iakovou, I	1
Aoki, J; de Feyter, P; Hoye, A; McFadden, E; Ong, AT; Rodriguez-Granillo, G; Serruys, PW; Tsuchida, K; Valgimigli, M; van Mieghem, CA	1
Dibra, A; Eberle, S; Goy, JJ; Kastrati, A; Mehilli, J; Schömig, A; Suárez de Lezo, J; Ulm, K	1
Cannon, L; DeMaio, S; Ellis, SG; Greenberg, JD; Hall, P; Koglin, J; Mann, JT; O'Shaughnessy, CD; Popma, JJ; Russell, ME; Spriggs, D; Stone, GW	1
Colombo, A; Cosgrave, J	1
Buellesfeld, L; Gerckens, U; Grube, E; Lim, V; Mueller, R	1
Chen, GH; Peng, J; Song, D; Su, X; Wan, HY; Wang, RP; Zhu, GY	1
Nawarskas, JJ; Osborn, LA	1
Cho, SY; Choi, D; Chung, N; Hwang, KC; Jang, Y; Kim, JY; Ko, YG; Park, S; Shim, CY; Shim, WH	1
Cheong, SS; Han, KH; Hong, MK; Kim, JJ; Kim, YH; Lee, CW; Park, DW; Park, KM; Park, SJ; Park, SW; Yang, TH	1
Banning, AP; Colombo, A; Dawkins, KD; Grube, E; Guagliumi, G; Hauptman, K; Koglin, J; Marco, J; Popma, JJ; Russell, ME; Thuesen, L; Wijns, W; Zmudka, K	1
Berland, J; Blanchard, D; Carrié, D; Chevalier, B; Eltchaninoff, H; Gilard, M; Hanssen, M; Louvard, Y	1
Gwon, HC; Hong, MK; Jang, Y; Kim, YH; Koo, BK; Lee, CW; Lee, MM; Oh, DJ; Park, SJ; Park, SW; Seung, KB; Tahk, SJ; Yoon, J	1
Cheong, SS; Han, KH; Hong, MK; Kang, DH; Kim, JJ; Kim, YH; Lee, BK; Lee, CW; Mintz, GS; Park, DW; Park, KM; Park, SJ; Park, SW; Song, JK; Song, JM	1
Doggrell, SA	1
Ekman, M; James, S; Sjögren, I	1
Aoki, J; De Feyter, P; de Jaegere, P; Garcia-Garcia, HM; Ligthart, JM; Malagutti, P; Ong, AT; Regar, E; Rodriguez Granillo, GA; Serruys, PW; Sianos, G; Valgimigli, M; Van Domburg, RT; van Mieghem, CA	1
Akkus, N; Aytacoglu, BN; Camdeviren, H; Camsari, A; Cicek, D; Cin, VG; Doven, O; Ozcan, TI; Ozeren, M	1
Giazitzoglou, E; Karabinos, I; Karvouni, E; Katritsis, DG; Korovesis, S; Theodorou, S; Voridis, E	1
Brodie, BR	1
Colombo, A; Guagliumi, G; Meier, B; Morice, MC; Serruys, P; Sousa, E; Stoll, HP; Tamburino, C	1
Brener, SJ	1
Kaiser, R; Motz, W	1
Elsässer, A; Hamm, CW; Möllmann, H; Nef, HM	1
Arbit, B; Curran, PJ; Currier, JW; Kobashigawa, JA; Li, H; Takano, Y; Tanaka, K; Tobis, JM; Yeatman, LA	1
Citone, C; Gaspardone, A; Gioffrè, G; Proietti, I; Skossyreva, O; Tomai, F; Versaci, F	1
Angiolillo, DJ; Bystron, M; Cervinka, P; Costa, MA; Futamatsu, H; Futamatsu, K; Kvasnák, M; Nanda, H; Spacek, R; Veselka, J	1
Chu, WW; Clavijo, LC; Kent, KM; Kuchulakanti, PK; Pichard, AD; Satler, LF; Suddath, WO; Torguson, R; Waksman, R; Wang, B	1
Holmes, DR; Kappetein, AP; Kleijne, J; Koglin, J; Mack, MJ; Mohr, FW; Morel, MA; Morice, MC; Ong, AT; Russell, ME; Serruys, PW; van den Brand, M; van Es, GA	1
Lee, CH; Lim, J; Lim, YT; Low, A; Tan, HC; Wong, HB	1
Strauss, BH	1
Dibra, A; Elezi, S; Kastrati, A; Mehilli, J; Pache, J; Schömig, A; Wessely, R	1
Iijima, R; Kastrati, A; Mehilli, J; Schömig, A	1
Briguori, C; Cabbavale, M; Pagnotta, P	1
Colombo, A; Dawkins, KD; Ellis, S; Grube, E; Koglin, J; Lasala, JM; Serruys, PW; Stone, GW	1
Briel, M; Bucher, HC; Nordmann, AJ	1
Bennett, DH; Brooks, NH; Kumar, S; Lee, HS; Levy, RD; Prendergast, BD; Ray, SG; Suresh, V; Wicks, P	1
Moliterno, DJ	1
Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Seong, IW; Yun, SC	2
Choi, CU; Kim, EJ; Kim, JW; Oh, DJ; Park, CG; Rha, SW; Seo, HS; Suh, SY	1
Anstrom, KJ; Califf, RM; Eisenstein, EL; Harrington, RA; Kandzari, DE; Kong, DF; Kramer, JM; Mark, DB; Matchar, DB; Peterson, ED; Schulman, KA; Shaw, LK; Tuttle, RH	1
Beijk, MA; Piek, JJ	1
Aragon, J; Forrester, J; Jurewitz, D; Kar, S; Lee, MS; Makkar, RR	1
Kereiakes, DJ	2
Ligon, RW; Markwell, SJ; Mishkel, GJ; Moore, AL	1
Avila, A; Brosius, S; Byrd, J; Dippel, EJ; Farland, L; Gehbauer, L; Jerin, M; Majetic, L; Robken, J; Shammas, G; Shammas, NW; Sharis, P; Stoakes, P; Winter, M	1
Applegate, RJ	1
Buchbinder, M; Colombo, A; Galassi, AR; Grasso, C; Tamburino, C; Tomasello, SD; Ussia, GP	1
Fontos, G	1
Htay, T; Liu, MW	1
Hong, MK; Hwang, ES; Jeong, YH; Kim, JJ; Kim, YH; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW; Suh, IW	1
Hong, MK; Kim, JJ; Kim, YH; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW	1
Costantini, CO; Costantini, CR; Ike, A; Miller, N; Mori, K; Nishikawa, H; Saku, K; Shirai, K; Tsuchiya, Y; Urata, H; Yanagi, D; Zhang, B	1
Burelli, C; Cassin, M; De Biasio, M; Driussi, M; Macor, F; Nicolosi, GL; Vendrametto, F	1
Desai, N; Heuser, R; Hilton, D; Klinke, P; Margolis, J; McDonald, J; Virmani, R; Waksman, R	1
Bates, ER; Boyden, TF; Chan, PS; Chetcuti, SJ; Grossman, PM; Gurm, HS; Moscucci, M; Nallamothu, BK; Tsai, TT	1
Underwood, MJ; Wan, S; Wong, SH	1
Burzotta, F; Choi, JH; Colombo, A; Gwon, HC; Hahn, JY; Romagnoli, E; Trani, C	1
Buch, AN; Chu, WW; Javaid, A; Kent, KM; Pichard, AD; Satler, LF; Smith, K; Torguson, R; Waksman, R; Xue, Z	1
Ballari, GP; Marra, WG; Meliga, E; Moretti, C; Omedè, P; Sciuto, F; Sheiban, I; Trevi, GP	1
Harland, LC; Hartmann, F; Radke, PW; Remmel, M; Schunkert, H	1
Bocksch, W; Boxberger, M; Degenhardt, R; Gross, M; Horstkotte, D; Nienaber, C; Schneider, H; Unverdorben, M; Vallbracht, C; Wiemer, M	1
Daemen, J; Serruys, PW	1
Coolong, A; Kuntz, RE	1
Biondi Zoccai, GG; Chechi, T; Falchetti, E; Giuliani, G; Lilli, A; Margheri, M; Spaziani, G; Vecchio, S; Vittori, G	1
Hahalis, G; Kounis, NG; Theoharides, TC	1
Brodie, B; Cheek, B; Duffy, P; Hermiller, J; Humphrey, A; Juk, S; Krainin, F; Laurent, S; Metzger, C; Nussbaum, M; Simonton, CA	1
Di Lorenzo, E; Dibra, A; Goy, JJ; Jüni, P; Kaiser, C; Kastrati, A; Lee, JH; Mehilli, J; Meier, B; Park, SJ; Pfisterer, ME; Schömig, A; Suárez de Lezo, J; Windecker, S; Wu, J	1
Banning, AP; Buellesfeld, L; Colombo, A; Dawkins, KD; Grube, E; Guagliumi, G; Hauptman, K; Koglin, J; Marco, J; Popma, JJ; Russell, ME; Thuesen, L; Wijns, W; Zmudka, K	1
Habig, T; Hombach, V; Kestler, HA; Kochs, M; Krause, BJ; Mottaghy, FM; Nusser, T; Reske, SN; Wöhrle, J	1
Büttner, HJ; Neumann, FJ	1
Gawaz, M; Geisler, T; Göhring-Frischholz, K; Haase, KK; Helber, U; Herdeg, C; May, A	1
Daemen, J; de Jaegere, PP; García-García, HM; Kukreja, N; Ong, AT; Serruys, PW; Sianos, G; Tanimoto, S; Tsuchida, K; Vaina, S; van Domburg, RT	1
de Vries, ST; Fokkert, MJ; Maas, AH; Nadal, F; Niella, M; Slingerland, RJ; van 't Hof, AW; van Enst, GC	1
Kang, HJ; Kim, HS; Kim, YS; Koo, BK; Lee, HY; Oh, BH; Park, KW; Park, YB; Sohn, DW	1
Jobe, RL; Mann, JT; Saylors, EK; Schneider, JE; Wood, FO	1
Colombo, A	1
Chen, J; Chen, JL; Dai, J; Gao, RL; Huang, JH; Li, JJ; Liu, HB; Qiao, SB; Qin, XW; Wu, YJ; Xu, B; Yang, YJ; Yao, M; You, SJ; Yuan, JQ	1
Chen, SL; Chen, YD; Fang, WY; Hu, DY; Kwan, TW; Lin, S; Liu, ZZ; Sun, XW; Tian, NL; Ye, F; Zhang, JJ; Zhu, ZS	1
Batchelor, WB; Buchbinder, M; Dubois, CL; Fitzgerald, PJ; Gammon, R; Garg, J; Hasselblad, V; Hermiller, JB; Kereiakes, DJ; Krucoff, MW; Lansky, AJ; Mehran, R; O'Shaughnessy, CD; Petersen, JL; Schofer, J; Simonton, CA; Turco, MA; Verheye, S; Wijns, W	1
Cutlip, DE; Farhat, N; Fitzgerald, PJ; Hermiller, JB; Lansky, AJ; Mahaffey, KW; Midei, M; Newman, W; Sanz, M; Sood, P; Stone, GW; Su, X; Williams, J	1
Holmes, DR; Patel, MR	1
Agostoni, P; Biondi-Zoccai, G; Laudito, A; Lotrionte, M; Moretti, C; Sheiban, I; Sillano, D	1
Biondi-Zoccai, G; Moretti, C; Sheiban, I; Sillano, D	1
Böhm, M; Maack, C; Maier, LS; Ritter, O	1
Bartels, A; Breithardt, G; Hohage, H; Plenz, G; Schmidt, A; Sindermann, JR; Skaletz-Rorowski, A	1
Fremes, SE; Ruel, M; Tam, DY	1
Newby, LK	1
Bhindi, R; De Silva, K; Ward, M	1
Shamekhi, J; Sinning, JM	1
Devidutta, S; Jagia, P; Sharma, G	1
Gersh, BJ; Gulati, R; Rihal, CS	1
Chevalier, B; Dorange, C; Džavík, V; Grube, E; Guagliumi, G; Kaul, U; Papeleu, P; Smits, PC; Stuteville, M	1

Reviews

66 review(s) available for paclitaxel and Coronary Artery Disease

Article	Year
Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 2020, 03-10, Volume: 75, Issue:9 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents; Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus	2020
Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease. Cardiovascular revascularization medicine : including molecular interventions, 2020, Volume: 21, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2020
Long-term Outcomes of Paclitaxel-Eluting Versus Sirolimus-Eluting Stent for Percutaneous Coronary Intervention: AMeta-Analysis. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2017, Volume: 27, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Cause of Death; Coronary Artery Disease; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome	2017
[Comparison of limus-eluting stent with paclitaxel-eluting stent for patients with coronary small vessel disease:a systematic review and meta-analysis]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2017, 05-25, Volume: 46, Issue:3 Topics: Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel; Sirolimus; Treatment Outcome	2017
Drug-Coated Balloons: Hope or Hot Air: Update on the Role of Coronary DCB. Current cardiology reports, 2018, 08-31, Volume: 20, Issue:10 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Equipment Failure; Foreign-Body Migration; Humans; Neointima; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Treatment Outcome	2018
Drug eluting balloons for de novo coronary lesions - a systematic review and meta-analysis. BMC medicine, 2013, May-08, Volume: 11 Topics: Cardiovascular Agents; Coronary Artery Disease; Drug Delivery Systems; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Treatment Outcome	2013
Impact of technological developments in drug-eluting stents on patient-focused outcomes: a pooled direct and indirect comparison of randomised trials comparing first- and second-generation drug-eluting stents. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:8 Topics: Antineoplastic Agents; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Patient Outcome Assessment; Percutaneous Coronary Intervention; Prosthesis Design; Randomized Controlled Trials as Topic; Sirolimus	2014
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of P JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:9 Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2013
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ (Clinical research ed.), 2013, Nov-08, Volume: 347 Topics: Anti-Infective Agents; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Polymers; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome	2013
Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease. International journal of molecular sciences, 2013, Dec-16, Volume: 14, Issue:12 Topics: Alloys; Antibiotics, Antineoplastic; Coronary Artery Disease; Drug-Eluting Stents; Humans; Magnesium; Paclitaxel; Sirolimus	2013
Long time clinical outcomes of limus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary artery intervention: A meta-analysis of randomized controlled clinical trials. Cardiology journal, 2014, Volume: 21, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Follow-Up Studies; Humans; Immunosuppressive Agents; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Randomized Controlled Trials as Topic; Sirolimus; Time Factors; Treatment Outcome	2014
Long-term risk of late and very late stent thrombosis in patients treated with everolimus against paclitaxel-eluting stents: an updated meta-analysis. Coronary artery disease, 2014, Volume: 25, Issue:5 Topics: Age Factors; Cardiovascular Agents; Chi-Square Distribution; Comorbidity; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Humans; Odds Ratio; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2014
Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies. PloS one, 2014, Volume: 9, Issue:5 Topics: Cause of Death; Coronary Artery Disease; Drug-Eluting Stents; Humans; Observational Studies as Topic; Odds Ratio; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome	2014
Composite outcomes in 2.25-mm drug eluting stents: a systematic review. Cardiovascular revascularization medicine : including molecular interventions, 2015, Volume: 16, Issue:4 Topics: Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Sirolimus	2015
Drug-eluting balloons in the treatment of de-novo coronary lesions: a meta-analysis of randomized-controlled trials. Coronary artery disease, 2016, Volume: 27, Issue:6 Topics: Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Humans; Metals; Myocardial Infarction; Odds Ratio; Paclitaxel; Randomized Controlled Trials as Topic; Risk Factors; Stents; Time Factors; Treatment Outcome	2016
Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis. Journal of the American College of Cardiology, 2008, Jun-24, Volume: 51, Issue:25 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Odds Ratio; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Risk Assessment; Risk Factors; Sirolimus; Treatment Outcome	2008
Safety of drug-coated stents. Expert opinion on drug safety, 2008, Volume: 7, Issue:5 Topics: Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Humans; Paclitaxel; Patient Compliance; Risk Factors; Sirolimus; Time Factors	2008
Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. European heart journal, 2010, Volume: 31, Issue:10 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Tubulin Modulators	2010
Incomplete stent apposition after coronary stent implantation: myth or reality? Journal of interventional cardiology, 2009, Volume: 22, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Confidence Intervals; Coronary Artery Disease; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Incidence; Odds Ratio; Paclitaxel; Risk Factors; Sirolimus; Tomography, Optical Coherence; Ultrasonography, Interventional	2009
Drug-eluting stent fracture: incidence, contributing factors, and clinical implications. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Feb-01, Volume: 75, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Equipment Failure Analysis; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Prosthesis Failure; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2010
The first-generation drug-eluting stents and coronary endothelial dysfunction. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:12 Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Humans; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2009
Small coronary vessel angioplasty: outcomes and technical considerations. Vascular health and risk management, 2010, Oct-21, Volume: 6 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Humans; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2010
Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease. Annals of medicine, 2011, Volume: 43, Issue:1 Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome; Tubulin Modulators	2011
Anti-proliferative compounds for the prevention of restenosis. Current pharmaceutical design, 2010, Volume: 16, Issue:36 Topics: Cell Proliferation; Constriction, Pathologic; Coronary Artery Disease; Humans; Paclitaxel; Stents	2010
Recent developments in drug-eluting stents. Journal of molecular medicine (Berlin, Germany), 2011, Volume: 89, Issue:6 Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Polymers; Sirolimus; Thrombosis; Treatment Outcome	2011
Differences in drug-eluting stents used in coronary artery disease. The American journal of the medical sciences, 2011, Volume: 342, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Sirolimus; Treatment Outcome	2011
Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus. Circulation, 2011, Aug-23, Volume: 124, Issue:8 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Diabetic Angiopathies; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Tubulin Modulators	2011
Paclitaxel coated balloons for coronary artery interventions: a comprehensive review of preclinical and clinical data. International journal of cardiology, 2012, Nov-01, Volume: 161, Issue:1 Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel	2012
A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease. American heart journal, 2011, Volume: 162, Issue:4 Topics: Coronary Artery Disease; Diabetic Angiopathies; Drug-Eluting Stents; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus	2011
Sirolimus- versus paclitaxel-eluting stents for coronary bifurcations intervention: a meta-analysis of five clinical trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Oct-01, Volume: 80, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Odds Ratio; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2012
[Use of drug-eluting balloons for coronary interventions: current indications and perspectives]. Annales de cardiologie et d'angeiologie, 2012, Volume: 61, Issue:6 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Treatment Outcome	2012
Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses. Circulation. Cardiovascular interventions, 2012, Volume: 5, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Linear Models; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2012
Modern strategies to prevent coronary restenosis. Italian heart journal : official journal of the Italian Federation of Cardiology, 2002, Volume: 3 Suppl 4 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents; Atherectomy, Coronary; Brachytherapy; Coronary Artery Disease; Coronary Restenosis; Humans; Paclitaxel; Sirolimus; Stents; Ultrasonography, Interventional	2002
Drug-eluting stents: clinical experiences and perspectives. Minerva cardioangiologica, 2002, Volume: 50, Issue:5 Topics: Angiogenesis Inhibitors; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Follow-Up Studies; Humans; Immunosuppressive Agents; Multicenter Studies as Topic; Paclitaxel; Pharmaceutical Preparations; Randomized Controlled Trials as Topic; Safety; Sirolimus; Stents; Time Factors	2002
Drug-eluting stents: the panacea for restenosis? Singapore medical journal, 2004, Volume: 45, Issue:7 Topics: Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Antineoplastic Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Cost-Benefit Analysis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Polymers; Randomized Controlled Trials as Topic; Sirolimus; Stainless Steel; Stents	2004
A stent is not just a stent: Stent construction and design do matter in its clinical performance. Singapore medical journal, 2004, Volume: 45, Issue:7 Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Cost-Benefit Analysis; Drug Delivery Systems; Humans; Paclitaxel; Polymers; Prosthesis Design; Randomized Controlled Trials as Topic; Sirolimus; Stainless Steel; Stents	2004
The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2004, Volume: 4, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Reoperation; Stents	2004
Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials. Journal of interventional cardiology, 2004, Volume: 17, Issue:5 Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug Implants; Humans; Paclitaxel; Pilot Projects; Polymers; Randomized Controlled Trials as Topic; Stents; Treatment Outcome	2004
Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS. Reviews in cardiovascular medicine, 2005, Volume: 6 Suppl 1 Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Humans; Immunosuppressive Agents; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Time Factors	2005
Safety and efficacy of drug-eluting stents. Reviews in cardiovascular medicine, 2005, Volume: 6 Suppl 1 Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Safety; Sirolimus; Stents; Treatment Outcome	2005
Drug-eluting stents: clinical perspectives on drug and design differences. Reviews in cardiovascular medicine, 2005, Volume: 6 Suppl 1 Topics: Blood Vessel Prosthesis Implantation; Cell Cycle; Coated Materials, Biocompatible; Coronary Artery Disease; Drug Design; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Prosthesis Design; Stents	2005
Drug-eluting stents for diabetes mellitus: a rush to judgment? Journal of the American College of Cardiology, 2005, Feb-15, Volume: 45, Issue:4 Topics: Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetic Angiopathies; Drug Delivery Systems; Humans; Paclitaxel; Sirolimus; Stents	2005
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. Journal of the American College of Cardiology, 2005, Mar-15, Volume: 45, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2005
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. Journal of the American College of Cardiology, 2005, Mar-15, Volume: 45, Issue:6 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Equipment Design; Follow-Up Studies; Humans; Paclitaxel; Postoperative Complications; Risk Factors; Sirolimus; Statistics as Topic; Stents; Treatment Outcome	2005
[New generation of percutaneous coronary intervention: drug-eluting stent]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-10, Volume: 94, Issue:2 Topics: Angioplasty; Antineoplastic Agents; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Humans; Immunosuppressive Agents; Paclitaxel; Polymers; Sirolimus; Stents; Thrombosis	2005
[Recent progress and problems in percutaneous coronary intervention]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-20, Volume: 94 Suppl Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Polymers; Sirolimus; Stents; Thrombosis; Warfarin	2005
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA, 2005, Aug-17, Volume: 294, Issue:7 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents	2005
Paclitaxel-eluting stents in coronary artery disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Nov-01, Volume: 62, Issue:21 Topics: Antineoplastic Agents; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Humans; Paclitaxel; Sirolimus; Stents	2005
[Drug-eluting stents: indications, limits and future development]. Archives des maladies du coeur et des vaisseaux, 2005, Volume: 98, Issue:10 Topics: Anti-Bacterial Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Equipment Design; Humans; Paclitaxel; Sirolimus; Stents	2005
Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:2 Topics: Coronary Artery Disease; Humans; Myocardial Revascularization; Paclitaxel; Sirolimus; Stents	2006
How to revascularize patients with diabetes mellitus: bypass or stents and drugs? Clinical research in cardiology : official journal of the German Cardiac Society, 2006, Volume: 95, Issue:4 Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Humans; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sirolimus; Stents	2006
Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents. Minerva cardioangiologica, 2006, Volume: 54, Issue:5 Topics: Combined Modality Therapy; Coronary Artery Disease; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Polymers; Prosthesis Design; Randomized Controlled Trials as Topic; Sirolimus; Stents; Tubulin Modulators	2006
How to treat diabetic patients with multivesseal disease in the DES era. Minerva cardioangiologica, 2006, Volume: 54, Issue:5 Topics: Combined Modality Therapy; Coronary Artery Disease; Diabetic Angiopathies; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents; Tubulin Modulators	2006
An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial program. Journal of interventional cardiology, 2006, Volume: 19, Issue:5 Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Research Design; Stents; Ultrasonography, Interventional	2006
Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. European heart journal, 2006, Volume: 27, Issue:23 Topics: Aged; Coronary Artery Disease; Drug Implants; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Sirolimus; Stents; Tubulin Modulators	2006
XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent. Expert review of medical devices, 2007, Volume: 4, Issue:1 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents; Technology Assessment, Biomedical	2007
[Drug-eluting coronary stents]. Orvosi hetilap, 2006, Oct-29, Volume: 147, Issue:43 Topics: Cell Cycle; Cell Proliferation; Coronary Artery Disease; Coronary Restenosis; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Hungary; Muscle, Smooth, Vascular; Paclitaxel; Protein Kinases; Sirolimus; Stents; TOR Serine-Threonine Kinases; Treatment Outcome; Tubulin Modulators; United States	2006
Drug-eluting stent: a review and update. Vascular health and risk management, 2005, Volume: 1, Issue:4 Topics: Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Carriers; Growth Inhibitors; Humans; Hyperplasia; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Thrombosis; Treatment Outcome; Tunica Intima	2005
[Percutaneous coronary intervention for the elderly patients]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2007, Volume: 44, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Stenosis; Humans; Paclitaxel; Quality of Life; Risk; Sirolimus; Stents	2007
Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus. The American journal of cardiology, 2007, May-15, Volume: 99, Issue:10 Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Databases, Factual; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome	2007
Myocardial revascularization: surgery or stenting? Asian cardiovascular & thoracic annals, 2007, Volume: 15, Issue:3 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Metals; Paclitaxel; Prosthesis Design; Stents; Treatment Outcome	2007
Drug-eluting stent update 2007: part II: Unsettled issues. Circulation, 2007, Aug-21, Volume: 116, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Stents; Tacrolimus	2007
Understanding the drug-eluting stent trials. The American journal of cardiology, 2007, Sep-03, Volume: 100, Issue:5A Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Treatment Outcome; Tubulin Modulators	2007
Coronary stents, hypersensitivity reactions, and the Kounis syndrome. Journal of interventional cardiology, 2007, Volume: 20, Issue:5 Topics: Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Hypersensitivity; Drug-Eluting Stents; Humans; Paclitaxel; Risk Factors; Vasoconstriction	2007
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. Journal of the American College of Cardiology, 2007, Oct-02, Volume: 50, Issue:14 Topics: Aged; Blood Vessel Prosthesis; Comorbidity; Coronary Artery Disease; Coronary Thrombosis; Drug Delivery Systems; Global Health; Humans; Immunosuppressive Agents; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Paclitaxel; Randomized Controlled Trials as Topic; Recurrence; Sirolimus; Stents; Survival Analysis; Treatment Outcome; Tubulin Modulators	2007
Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher). Minerva cardioangiologica, 2008, Volume: 56, Issue:1 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Treatment Outcome	2008

Trials

180 trial(s) available for paclitaxel and Coronary Artery Disease

Article	Year
Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease: The BIO-RISE CHINA Study. JACC. Cardiovascular interventions, 2022, 06-27, Volume: 15, Issue:12 Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Humans; Paclitaxel; Prospective Studies; Treatment Outcome	2022
Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2022, Volume: 100, Issue:4 Topics: Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Sirolimus; Stents; Treatment Outcome	2022
Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2023, Volume: 101, Issue:1 Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Humans; Paclitaxel; Prospective Studies; Treatment Outcome; Vascular Diseases	2023
Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up. JACC. Cardiovascular interventions, 2023, 05-08, Volume: 16, Issue:9 Topics: Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Risk Factors; Treatment Outcome; Vascular Diseases	2023
Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions. International journal of cardiology, 2020, 02-15, Volume: 301 Topics: Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Fatty Acids; Female; Humans; Immunosuppressive Agents; Long Term Adverse Effects; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Prosthesis Design; Sirolimus; Treatment Outcome	2020
A drug-eluting Balloon for the trEatment of coronarY bifurcatiON lesions in the side branch: a prospective multicenter ranDomized (BEYOND) clinical trial in China. Chinese medical journal, 2020, Apr-20, Volume: 133, Issue:8 Topics: Aged; China; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Treatment Outcome	2020
A Prospective Multicenter Randomized Trial to Assess the Effectiveness of the MagicTouch Sirolimus-Coated Balloon in Small Vessels: Rationale and Design of the TRANSFORM I Trial. Cardiovascular revascularization medicine : including molecular interventions, 2021, Volume: 25 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Humans; Paclitaxel; Prospective Studies; Sirolimus; Treatment Outcome	2021
A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions. Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:4 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Prospective Studies; Stents; Treatment Outcome	2022
Temporal Course of Vascular Response After Fluoropolymer Paclitaxel-Eluting Stent Implantation for Femoropopliteal Artery Lesions. Circulation journal : official journal of the Japanese Circulation Society, 2021, 11-25, Volume: 85, Issue:12 Topics: Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Femoral Artery; Humans; Neointima; Paclitaxel; Tomography, Optical Coherence; Treatment Outcome	2021
Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis. American heart journal, 2021, Volume: 241 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cardiac Catheters; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Paclitaxel; Randomized Controlled Trials as Topic; Reoperation	2021
Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation. Atherosclerosis, 2017, Volume: 259 Topics: Aged; Cardiovascular Agents; Cell Proliferation; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Japan; Male; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Vascular Calcification	2017
Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2017, Sep-01, Volume: 52, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Practice Patterns, Physicians'; Quality Improvement; Time Factors; United States	2017
A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease. Clinical research in cardiology : official journal of the German Cardiac Society, 2017, Volume: 106, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Prospective Studies; Prosthesis Design; Time Factors; Treatment Outcome; Tubulin Modulators	2017
Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis. Cardiovascular revascularization medicine : including molecular interventions, 2017, Volume: 18, Issue:8 Topics: Adolescent; Adult; Aged; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Egypt; Female; Humans; Male; Metals; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Stents; Time Factors; Treatment Outcome; Young Adult	2017
Paclitaxel-eluting stents versus everolimus-eluting coronary stents in a diabetic population: two-year follow-up of the TUXEDO-India trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2017, Nov-20, Volume: 13, Issue:10 Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; India; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Treatment Outcome	2017
Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019, 02-01, Volume: 93, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome	2019
Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial. JACC. Cardiovascular interventions, 2018, 12-10, Volume: 11, Issue:23 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; China; Coated Materials, Biocompatible; Constriction, Pathologic; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome	2018
Paclitaxel Drug-Coated Balloon After Bare-Metal Stent Implantation, an Alternative Treatment to Drug-Eluting Stent in High Bleeding Risk Patients (The Panelux Trial). The Journal of invasive cardiology, 2019, Volume: 31, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Disease Progression; Drug-Eluting Stents; France; Hemorrhage; Humans; Male; Outcome Assessment, Health Care; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Adjustment; Time	2019
Prospective randomized trial of paclitaxel-coated balloon versus bare-metal stent in high bleeding risk patients with de novo coronary artery lesions. Coronary artery disease, 2019, Volume: 30, Issue:6 Topics: Aged; Angioplasty, Balloon; Cardiac Catheters; Cardiovascular Agents; Clinical Decision-Making; Coated Materials, Biocompatible; Coronary Artery Disease; Dual Anti-Platelet Therapy; Female; Fractional Flow Reserve, Myocardial; Hemorrhage; Humans; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome; Vascular Patency	2019
Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial. Lancet (London, England), 2019, 07-20, Volume: 394, Issue:10194 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Single-Blind Method; Stents; Tubulin Modulators	2019
Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2013, Volume: 43, Issue:5 Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Treatment Outcome	2013
Zotarolimus- and paclitaxel-eluting stents in an all-comer population in China: the RESOLUTE China randomized controlled trial. JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:7 Topics: Aged; Cardiovascular Agents; China; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Time Factors; Treatment Outcome	2013
The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent. JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:4 Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States	2013
Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: the comparison of efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial. American heart journal, 2013, Volume: 165, Issue:5 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Sirolimus; Time Factors; Treatment Outcome	2013
Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Dec-01, Volume: 82, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2013
Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial). Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2014, Feb-15, Volume: 83, Issue:3 Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Thrombosis; Diabetic Angiopathies; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2014
Long-term clinical performance of paclitaxel-eluting stents coated with a bioactive polymer (P-5) containing a triflusal derivative: results of the REWAC registry. The Journal of invasive cardiology, 2013, Volume: 25, Issue:8 Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Prospective Studies; Registries; Salicylates; Thrombosis; Treatment Outcome	2013
Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up. International journal of cardiology, 2013, Oct-12, Volume: 168, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Reproducibility of Results; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Tunica Intima	2013
Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYN International journal of cardiology, 2013, Oct-15, Volume: 168, Issue:6 Topics: Coronary Artery Bypass; Coronary Artery Disease; Creatine Kinase; Creatine Kinase, MB Form; Drug-Eluting Stents; Female; Humans; Incidence; Male; Paclitaxel; Percutaneous Coronary Intervention; Prognosis; Prospective Studies; Risk Factors; Treatment Outcome; Tubulin Modulators	2013
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease). JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:10 Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Feasibility Studies; Female; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Registries; Sirolimus; Time Factors; Treatment Outcome	2013
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months? EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Volume: 9, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Time Factors; Treatment Outcome	2013
5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patient JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:12 Topics: Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Humans; Kaplan-Meier Estimate; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States	2013
A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE study. Journal of Korean medical science, 2013, Volume: 28, Issue:11 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Sirolimus; Thrombosis; Treatment Outcome	2013
Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery American heart journal, 2013, Volume: 166, Issue:6 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Failure; Single-Blind Method; Sirolimus; Treatment Outcome; Tubulin Modulators	2013
Prospective 'real world' registry for the use of the 'PCB only' strategy in small vessel de novo lesions. Heart (British Cardiac Society), 2014, Volume: 100, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Guideline Adherence; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Treatment Outcome	2014
Safety and efficacy of low-dose paclitaxel utilizing the cobra-P drug-eluting stent system with a novel biodegradable coating in de novo coronary lesions: the PLUS-ONE first-in-man study. Cardiovascular revascularization medicine : including molecular interventions, 2014, Volume: 15, Issue:1 Topics: Absorbable Implants; Aged; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Time Factors; Treatment Outcome	2014
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. JACC. Cardiovascular interventions, 2014, Volume: 7, Issue:1 Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2014
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardi JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:12 Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Humans; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Risk Factors; Stroke; Time Factors; Treatment Outcome	2013
Comparison of cost-effectiveness of oral rapamycin plus bare-metal stents versus first generation of drug-eluting stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 trial). The American journal of cardiology, 2014, Mar-01, Volume: 113, Issue:5 Topics: Administration, Oral; Aged; Coronary Artery Disease; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Stents; Treatment Outcome	2014
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation, 2014, Jun-10, Volume: 129, Issue:23 Topics: Adult; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Paclitaxel; Percutaneous Coronary Intervention; Risk Factors; Treatment Outcome; Tubulin Modulators	2014
Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a r Cardiovascular intervention and therapeutics, 2015, Volume: 30, Issue:2 Topics: Aged; Anti-Bacterial Agents; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Japan; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome; Tubulin Modulators	2015
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015, Volume: 11, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Germany; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Retreatment; Stents; Time Factors; Treatment Outcome; Vascular Access Devices	2015
Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Circulation. Cardiovascular interventions, 2014, Volume: 7, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Germany; Humans; Male; Metals; Middle Aged; Neointima; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Single-Blind Method; Sirolimus; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Access Devices	2014
Determinants of neointimal proliferation and stent coverage after intracoronary therapy with drug-eluting devices in stable coronary artery disease: role of endothelial progenitor cells and interleukin-1 family cytokines. The Journal of invasive cardiology, 2014, Volume: 26, Issue:12 Topics: Aged; Cell Count; Cell Proliferation; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Endothelial Progenitor Cells; Everolimus; Female; Humans; Interleukin-1; Male; Middle Aged; Neointima; Paclitaxel; Prognosis; Tomography, Optical Coherence	2014
Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents. Circulation. Cardiovascular interventions, 2015, Volume: 8, Issue:1 Topics: Aged; Blood Vessel Prosthesis Implantation; Body Mass Index; Comorbidity; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Obesity; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional; United States	2015
A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study. International journal of cardiology, 2015, Apr-01, Volume: 184 Topics: Aged; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiography; Single-Blind Method; Treatment Outcome	2015
Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up. Journal of the American College of Cardiology, 2015, Mar-24, Volume: 65, Issue:11 Topics: Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Smoking; Stroke; Treatment Outcome	2015
Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial. JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome	2015
3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO). JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:8 Topics: Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Humans; Italy; Kaplan-Meier Estimate; Paclitaxel; Predictive Value of Tests; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome	2015
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revasculariza JACC. Cardiovascular interventions, 2015, Aug-17, Volume: 8, Issue:9 Topics: Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Thrombosis; Time Factors; Treatment Outcome	2015
Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial. Journal of interventional cardiology, 2015, Volume: 28, Issue:4 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Stents	2015
A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2016, Volume: 88, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Brazil; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Germany; Humans; Male; Metals; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Retreatment; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2016
Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes. The New England journal of medicine, 2015, Oct-29, Volume: 373, Issue:18 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Everolimus; Female; Humans; Intention to Treat Analysis; Logistic Models; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Retreatment; Sirolimus; Treatment Outcome	2015
Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal C JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:13 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Retreatment; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome	2015
Paclitaxel-coated balloon plus bare-metal stent for de-novo coronary artery disease: final 5-year results of a randomized prospective multicenter trial. Coronary artery disease, 2016, Volume: 27, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Artery Disease; Disease-Free Survival; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Single-Blind Method; Stents; Treatment Outcome; Tubulin Modulators	2016
Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2016, Volume: 87, Issue:4 Topics: Aged; Atherectomy, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome; Vascular Calcification	2016
Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial. Journal of interventional cardiology, 2015, Volume: 28, Issue:6 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Equipment Failure; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Recurrence	2015
DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015, Volume: 11, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; France; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Time Factors; Treatment Outcome	2015
Impact of coronary artery calcification in percutaneous coronary intervention with paclitaxel-eluting stents: Two-year clinical outcomes of paclitaxel-eluting stents in patients from the ARRIVE program. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2016, Nov-15, Volume: 88, Issue:6 Topics: Aftercare; Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Registries; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; United States; Vascular Calcification	2016
Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial. JACC. Cardiovascular interventions, 2016, Jan-11, Volume: 9, Issue:1 Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Sirolimus; Stainless Steel; Surface Properties; Time Factors; Treatment Outcome	2016
Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2016, Volume: 87 Suppl 1 Topics: Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; China; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome	2016
Time course of vascular response after an a priori strategy of bare metal stent implantation post-dilated with a paclitaxel-coated balloon: Implementation of a three-dimensional analysis algorithm with optical coherence tomography. Cardiology journal, 2016, Volume: 23, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Male; Paclitaxel; Prospective Studies; Prosthesis Design; Reproducibility of Results; Time Factors; Tomography, Optical Coherence; Vasodilation	2016
Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study. Circulation. Cardiovascular interventions, 2016, Volume: 9, Issue:4 Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Czech Republic; Disease-Free Survival; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome; Vascular Access Devices	2016
12-month intravascular ultrasound observations from BiOSS® first-in-man studies. The international journal of cardiovascular imaging, 2016, Volume: 32, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Non-ST Elevated Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Registries; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2016
Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography. Clinical research in cardiology : official journal of the German Cardiac Society, 2017, Volume: 106, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Equipment Design; Feasibility Studies; Female; Fractional Flow Reserve, Myocardial; Germany; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Remodeling	2017
Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease. International journal of cardiology, 2016, Nov-01, Volume: 222 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Treatment Outcome	2016
10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents. Journal of the American College of Cardiology, 2017, Feb-14, Volume: 69, Issue:6 Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Time Factors; Treatment Outcome	2017
Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation. Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:2 Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Artery Disease; Drug-Eluting Stents; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Time Factors; Treatment Outcome	2009
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery L Circulation, 2009, Feb-10, Volume: 119, Issue:5 Topics: Aged; Angioplasty; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Treatment Outcome	2009
A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial. Journal of the American College of Cardiology, 2009, Mar-17, Volume: 53, Issue:11 Topics: Aged; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Saphenous Vein; Stents; Ticlopidine	2009
TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 4, Issue:5 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coated Materials, Biocompatible; Coronary Artery Disease; Double-Blind Method; Drug-Eluting Stents; Europe; Humans; Kaplan-Meier Estimate; Metals; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome	2009
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. Journal of the American College of Cardiology, 2009, May-12, Volume: 53, Issue:19 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Incidence; Male; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Risk; Sirolimus; Ticlopidine; Tubulin Modulators	2009
Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials. JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Vessels; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Stents; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional	2008
The GENESIS (Randomized, Multicenter Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries) trial. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:3 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Survival Analysis; Tacrolimus	2009
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Nov-01, Volume: 74, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Linear Models; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Sex Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Women's Health	2009
Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:6 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Disease Progression; Double-Blind Method; Drug-Eluting Stents; Humans; Metals; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Treatment Outcome	2009
Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 5, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Product Surveillance, Postmarketing; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Time Factors; Treatment Outcome; United States	2009
Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of p Journal of the American College of Cardiology, 2009, Aug-25, Volume: 54, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome; Tubulin Modulators	2009
Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:8 Topics: Aged; Alloys; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Cobalt; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Phosphorylcholine; Prosthesis Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; United States	2009
SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease. American heart journal, 2009, Volume: 158, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Electrocardiography; Everolimus; Follow-Up Studies; Humans; Immunosuppressive Agents; Myocardial Revascularization; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome	2009
Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. Circulation, 2009, Oct-13, Volume: 120, Issue:15 Topics: Adult; Aged; Cohort Studies; Coronary Artery Disease; Coronary Restenosis; Delayed-Action Preparations; Double-Blind Method; Drug Delivery Systems; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Polymers; Prospective Studies; Survival Rate; Treatment Outcome	2009
Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: a post hoc analysis of the SPIRIT III randomized trial. American heart journal, 2009, Volume: 158, Issue:6 Topics: Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus	2009
Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; United States	2009
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; India; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; New Zealand; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2009
Interventional therapy of bifurcation lesions: a TIMI flow-guided concept to treat side branches in bifurcation lesions--a prospective randomized clinical study (Thueringer bifurcation study, THUEBIS study as pilot trial). Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Prospective Studies; Single-Blind Method; Thrombosis; Time Factors; Treatment Outcome	2009
A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program. Trials, 2010, Jan-07, Volume: 11 Topics: Angioplasty, Balloon, Coronary; Australia; Bayes Theorem; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Data Interpretation, Statistical; Drug-Eluting Stents; Humans; New Zealand; Paclitaxel; Platelet Aggregation Inhibitors; Platinum; Prospective Studies; Prosthesis Design; Research Design; Severity of Illness Index; Singapore; Single-Blind Method; Stents; Time Factors; Treatment Outcome; United States	2010
Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. Journal of the American College of Cardiology, 2010, Mar-16, Volume: 55, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Treatment Outcome; Tubulin Modulators	2010
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States	2009
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic End JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Constriction, Pathologic; Coronary Angiography; Coronary Artery Disease; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Health Care Costs; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Models, Economic; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Quality of Life; Quality-Adjusted Life Years; Risk Assessment; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States	2009
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent). JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Diabetes Complications; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Treatment Outcome	2009
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. Journal of the American College of Cardiology, 2010, Feb-09, Volume: 55, Issue:6 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Single-Blind Method; Sirolimus; Treatment Outcome	2010
Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry. Journal of the American College of Cardiology, 2010, Apr-20, Volume: 55, Issue:16 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Korea; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Registries; Retrospective Studies; Sirolimus; Survival Rate; Treatment Outcome	2010
A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:4 Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; England; Female; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Prospective Studies; Prosthesis Design; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2010
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. The New England journal of medicine, 2010, May-06, Volume: 362, Issue:18 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Glycoprotein GPIIb-IIIa Complex; Retreatment; Single-Blind Method; Sirolimus; Thrombosis; Treatment Failure	2010
Evaluation of the effects of everolimus-eluting and paclitaxel-eluting stents on target lesions with jailed side branches: 2-year results from the SPIRIT III randomized trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Nov-01, Volume: 76, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Creatine Kinase, MB Form; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States	2010
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and C Circulation, 2010, Jun-22, Volume: 121, Issue:24 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Endpoint Determination; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Stroke; Treatment Outcome	2010
First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 6, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Europe; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; New Zealand; Paclitaxel; Prospective Studies; Prosthesis Design; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2010
Choice of stenting strategy in true coronary artery bifurcation lesions. Coronary artery disease, 2010, Volume: 21, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2010
Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circulation. Cardiovascular interventions, 2010, Volume: 3, Issue:4 Topics: Absorbable Implants; Aged; Angioplasty; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Pilot Projects; Polymers; Postoperative Complications; Tomography, Optical Coherence; Ultrasonography, Interventional	2010
One-year clinical outcome after treatment of bare-metal stent in-stent restenosis with the paclitaxel-eluting stent in an unselected cohort. International journal of cardiology, 2010, Dec-03, Volume: 145, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cohort Studies; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel	2010
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 6, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus	2010
Angiographic and intravascular ultrasound follow up of paclitaxel- and sirolimus-eluting stent after poststent high-pressure balloon dilation: from the poststent optimal stent expansion trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Jan-01, Volume: 77, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2011
Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries). The American journal of cardiology, 2010, Nov-15, Volume: 106, Issue:10 Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Prospective Studies; Registries; Sirolimus; Stents; Survival Rate; Time Factors; Treatment Outcome	2010
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. Circulation. Cardiovascular interventions, 2010, Volume: 3, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Ultrasonography, Interventional	2010
Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System). Journal of the American College of Cardiology, 2010, Dec-14, Volume: 56, Issue:25 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Diabetic Angiopathies; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Treatment Failure	2010
Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial). The American journal of cardiology, 2011, Mar-15, Volume: 107, Issue:6 Topics: Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Logistic Models; Male; Middle Aged; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Survival Rate; Treatment Outcome; Tubulin Modulators; United States	2011
Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions. The American journal of cardiology, 2011, Apr-01, Volume: 107, Issue:7 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cilostazol; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Tetrazoles	2011
A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 6, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Chromium Compounds; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Equipment Failure Analysis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platinum Compounds; Prospective Studies	2011
Efficacy of paclitaxel-eluting stent in patients with impaired glucose tolerance--comparison with sirolimus-eluting stent. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Body Mass Index; Cholesterol, LDL; Coronary Artery Disease; Drug-Eluting Stents; Female; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus	2011
Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions. Circulation. Cardiovascular interventions, 2011, Apr-01, Volume: 4, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Ultrasonography, Interventional	2011
Rationale and design of the randomized, multicenter EREMUS trial, a study that investigates how to achieve low restenosis and early reendothelialization after percutaneous coronary interventions. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Jul-01, Volume: 78, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Endothelial Cells; Humans; Italy; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Research Design; Risk Assessment; Stem Cells; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2011
Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Aug-01, Volume: 78, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Stem Cells; Stents; Thrombosis; Time Factors; Treatment Outcome	2011
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug-Eluting Stents; Europe; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome; United States	2011
Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis. The American journal of cardiology, 2011, Aug-15, Volume: 108, Issue:4 Topics: Aged; Angioplasty; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome	2011
Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial. Circulation, 2011, Jun-21, Volume: 123, Issue:24 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome	2011
Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 6 Suppl J Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States	2010
Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS). EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Oct-30, Volume: 7, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Europe; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Registries; Regression Analysis; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Vascular Patency	2011
Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Oct-30, Volume: 7, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Equipment Design; Female; Humans; Logistic Models; Male; Metals; Middle Aged; Netherlands; Paclitaxel; Pilot Projects; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2011
Sirolimus- vs. paclitaxel-eluting stent to coronary intervention in dialysis patients. International journal of cardiology, 2013, May-25, Volume: 165, Issue:3 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Radiography; Renal Dialysis; Sirolimus; Treatment Outcome	2013
The PICCOLETO study and beyond. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7 Suppl K Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Equipment Design; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Time Factors; Treatment Outcome	2011
Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7 Suppl K Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Catheters; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Equipment Design; Female; Germany; Humans; Male; Metals; Middle Aged; Paclitaxel; Pilot Projects; Prospective Studies; Prosthesis Design; Stents; Thrombosis; Time Factors; Treatment Outcome	2011
Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7 Suppl K Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Catheters; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Equipment Design; Humans; Paclitaxel; Single-Blind Method; Time Factors; Treatment Outcome	2011
A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclita EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7 Suppl K Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Endothelial Cells; Everolimus; Germany; Humans; Metals; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Research Design; Sirolimus; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Tunica Intima	2011
Comparison of the efficacy and safety of paclitaxel-eluting coroflex please stents and paclitaxel-eluting stents in patients with coronary artery disease: a randomized PIPA trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Nov-01, Volume: 80, Issue:5 Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Republic of Korea; Single-Blind Method; Time Factors; Treatment Outcome	2012
Are paclitaxel-eluting stents better in unprotected left main coronary artery disease? Three-year clinical and intravascular imaging results from a randomized study. Medicina (Kaunas, Lithuania), 2011, Volume: 47, Issue:10 Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Tubulin Modulators; Ultrasonography, Interventional	2011
A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions. Journal of the American College of Cardiology, 2012, Apr-10, Volume: 59, Issue:15 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Single-Blind Method; Treatment Outcome; Ultrasonography, Interventional	2012
Safety and efficacy of the XIENCE V everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice. The American journal of cardiology, 2012, May-01, Volume: 109, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prosthesis Design; Retrospective Studies; Sirolimus; Treatment Outcome	2012
One-year clinical outcome of a randomized trial of polymer-free paclitaxel-eluting stents versus biodegradable polymer-based rapamycin-eluting stents in patients with coronary heart disease. Journal of interventional cardiology, 2012, Volume: 25, Issue:6 Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Patient Readmission; Polymers; Sirolimus; Thrombosis	2012
Treatment of coronary bifurcation lesions with drug-eluting stents: insights from the first phase of the prospective multicenter german drug-eluting stent registry. Journal of interventional cardiology, 2012, Volume: 25, Issue:4 Topics: Aged; Antineoplastic Agents, Phytogenic; Cohort Studies; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Sirolimus; Treatment Outcome	2012
A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of th Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Dec-01, Volume: 80, Issue:7 Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Europe; Feasibility Studies; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Risk Factors; Single-Blind Method; Stents; Time Factors; Treatment Outcome	2012
Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clini EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, Volume: 7, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Length of Stay; Male; Middle Aged; Paclitaxel; Prospective Studies; Tubulin Modulators	2012
Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years. The American journal of cardiology, 2012, Jul-01, Volume: 110, Issue:1 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Everolimus; Follow-Up Studies; Humans; Immunosuppressive Agents; Paclitaxel; Prospective Studies; Prosthesis Design; Reproducibility of Results; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome	2012
Impact of drug-eluting stents on distal vessels. Circulation. Cardiovascular interventions, 2012, Volume: 5, Issue:2 Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Coronary Occlusion; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Ultrasonography, Interventional; Wound Healing	2012
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons. Circulation. Cardiovascular quality and outcomes, 2012, Volume: 5, Issue:3 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Health Status; Humans; Male; Middle Aged; Paclitaxel; Patient Satisfaction; Prosthesis Design; Quality of Life; Reoperation; Retreatment; Risk Assessment; Risk Factors; Surveys and Questionnaires; Time Factors; Treatment Outcome	2012
INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial. Trials, 2012, May-06, Volume: 13 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Catheters; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Endothelial Cells; Equipment Design; Humans; Hyperplasia; Italy; Metals; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Research Design; Stem Cells; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2012
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, May-15, Volume: 8, Issue:1 Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2012
Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial). The American journal of cardiology, 2012, Sep-15, Volume: 110, Issue:6 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Cost-Benefit Analysis; Drug-Eluting Stents; Everolimus; Female; Health Care Costs; Hospitalization; Humans; Male; Myocardial Revascularization; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; United States	2012
Intracoronary local paclitaxel delivery by X-ray contrast media for in-stent restenosis: a clinical pilot study to assess safety and tolerability. Minerva cardioangiologica, 2012, Volume: 60, Issue:4 Topics: Aged; Algorithms; Cardiac Catheterization; Cardiovascular Agents; Contrast Media; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Female; Germany; Humans; Injections, Intra-Arterial; Iohexol; Male; Middle Aged; Paclitaxel; Pilot Projects; Recurrence; Stents; Treatment Outcome	2012
Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: two-year subgroup analysis of the ZEST randomized trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Jun-01, Volume: 81, Issue:7 Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2013
Mid-term results of everolimus-eluting stent in a Japanese population compared with a US randomized cohort: SPIRIT III Japan Registry with harmonization by doing. The Journal of invasive cardiology, 2012, Volume: 24, Issue:9 Topics: Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Japan; Male; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Sirolimus; Survival Analysis; Treatment Outcome; United States	2012
Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study. JACC. Cardiovascular interventions, 2012, Volume: 5, Issue:9 Topics: Angioplasty, Balloon, Coronary; Bayes Theorem; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing	2012
The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform. Kardiologia polska, 2012, Volume: 70, Issue:10 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Stents; Treatment Outcome	2012
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, Volume: 8, Issue:6 Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Japan; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Registries; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional; United States	2012
Coronary arterial remodeling and out-stent plaque change after drug-eluting stent implantation--comparison between zotarolimus-eluting stents and paclitaxel-eluting stents. Circulation journal : official journal of the Japanese Circulation Society, 2013, Volume: 77, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Eosinophils; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Risk Factors; Sirolimus; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional; Vasculitis; Ventricular Remodeling	2013
Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry. The American journal of cardiology, 2013, Feb-15, Volume: 111, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Aspirin; Clopidogrel; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Follow-Up Studies; Humans; Immunosuppressive Agents; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recurrence; Registries; Retrospective Studies; Sirolimus; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome; United States	2013
Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions. Coronary artery disease, 2013, Volume: 24, Issue:1 Topics: Angioplasty, Balloon, Coronary; Asia; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Humans; Kaplan-Meier Estimate; Logistic Models; Myocardial Infarction; New Zealand; Paclitaxel; Propensity Score; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States	2013
High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Time Factors; Treatment Outcome; Vascular Calcification	2013
Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry). The American journal of cardiology, 2013, Mar-01, Volume: 111, Issue:5 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Paclitaxel; Registries; Retrospective Studies; Sirolimus; Spain; Time Factors; Treatment Outcome	2013
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. Lancet (London, England), 2013, Mar-09, Volume: 381, Issue:9869 Topics: Absorbable Implants; Aged; Coronary Artery Disease; Drug Delivery Systems; Female; Humans; Magnesium; Male; Paclitaxel; Prospective Studies; Prostheses and Implants; Prosthesis Design; Time Factors	2013
Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Jan-22, Volume: 8, Issue:9 Topics: Aspirin; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Compliance; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Surveys and Questionnaires; Treatment Outcome	2013
Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Jan-22, Volume: 8, Issue:9 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Sirolimus; Treatment Outcome	2013
TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation, 2003, Jan-07, Volume: 107, Issue:1 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Demography; Double-Blind Method; Drug Implants; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Stents; Ultrasonography	2003
Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation, 2003, Feb-04, Volume: 107, Issue:4 Topics: Cell Division; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Drug Implants; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Stents; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional	2003
[Clinical trial of paclitaxel-eluting stents. Results of ASPECT]. Kardiologiia, 2003, Volume: 43, Issue:6 Topics: China; Coronary Artery Disease; Graft Occlusion, Vascular; Humans; Korea; Paclitaxel; Stents; Treatment Outcome	2003
Altered trafficking of CD8+ memory T cells after implantation of rapamycin-eluting stents in patients with coronary artery disease. Immunology letters, 2005, Jan-15, Volume: 96, Issue:1 Topics: Aged; CD8-Positive T-Lymphocytes; Cell Movement; Coronary Artery Disease; Flow Cytometry; Humans; Immunologic Memory; Immunosuppressive Agents; Middle Aged; Paclitaxel; Sirolimus; Stents	2005
A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. Journal of the American College of Cardiology, 2005, Jan-18, Volume: 45, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Stents; Treatment Outcome	2005
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. Journal of the American College of Cardiology, 2005, Mar-15, Volume: 45, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2005
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. Journal of the American College of Cardiology, 2005, Mar-15, Volume: 45, Issue:6 Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Equipment Design; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Postoperative Complications; Sirolimus; Stents; Survival Analysis; Time Factors; Treatment Outcome	2005
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. Journal of the American College of Cardiology, 2005, Mar-15, Volume: 45, Issue:6 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Equipment Design; Follow-Up Studies; Humans; Paclitaxel; Postoperative Complications; Risk Factors; Sirolimus; Statistics as Topic; Stents; Treatment Outcome	2005
Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. Journal of the American College of Cardiology, 2005, May-17, Volume: 45, Issue:10 Topics: Administration, Topical; Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2005
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA, 2005, Sep-14, Volume: 294, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Polymers; Radiography; Stents	2005
Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation, 2005, Nov-22, Volume: 112, Issue:21 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Polymers; Stents; Treatment Outcome	2005
Angiographic and clinical outcome following paclitaxel-eluting stent (taxus) implantation: a single center experience. International heart journal, 2006, Volume: 47, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Treatment Outcome	2006
Sirolimus-versus paclitaxel-eluting stents: a comparison of two consecutive series in routine clinical practice. Journal of interventional cardiology, 2006, Volume: 19, Issue:1 Topics: Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Stents; Treatment Outcome	2006
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA, 2006, Feb-22, Volume: 295, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Implants; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Survival Analysis; Treatment Outcome	2006
"Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study". Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 67, Issue:6 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug Delivery Systems; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Stents; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; Vascular Patency	2006
Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation, 2006, Nov-14, Volume: 114, Issue:20 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Equipment Design; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retreatment; Sirolimus; Treatment Outcome	2006
Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study. Clinical cardiology, 2007, Volume: 30, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Nanoparticles; Paclitaxel; Prospective Studies; Stents; Time Factors; Treatment Outcome	2007
Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Jul-01, Volume: 70, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Female; Humans; Italy; Korea; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Radiography, Interventional; Severity of Illness Index; Sirolimus; Stents; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency	2007
Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results. Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:8 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Odds Ratio; Paclitaxel; Prosthesis Design; Research Design; Risk Assessment; Risk Factors; Severity of Illness Index; Stents; Time Factors; Treatment Outcome	2007
Rational use of drug-eluting stents: a comparison of different policies. Critical pathways in cardiology, 2007, Volume: 6, Issue:2 Topics: Coronary Artery Disease; Coronary Restenosis; Cost-Benefit Analysis; Drug Administration Routes; Female; Humans; Immunosuppressive Agents; Male; Paclitaxel; Sirolimus; Stents	2007
The paclitaxel-eluting Coroflex Please stent pilot study (PECOPS I) : the one-year clinical follow-up. Clinical research in cardiology : official journal of the German Cardiac Society, 2007, Volume: 96, Issue:11 Topics: Aged; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Death; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Survival Rate; Thrombosis; Ticlopidine; Tubulin Modulators	2007
Outlook of drug-eluting stent implantation for unprotected left main disease: insights on long-term clinical predictors. The Journal of invasive cardiology, 2007, Volume: 19, Issue:9 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Paclitaxel; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Sirolimus; Stents; Survival Rate; Treatment Outcome	2007
Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial). The American journal of cardiology, 2007, Oct-01, Volume: 100, Issue:7 Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug Delivery Systems; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Tunica Intima	2007
TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. European heart journal, 2007, Volume: 28, Issue:21 Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Epidemiologic Methods; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Polymers; Ticlopidine	2007
Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction. Heart (British Cardiac Society), 2008, Volume: 94, Issue:5 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Sirolimus; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional	2008
[The incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease in the real world: a single center registry study]. Zhonghua xin xue guan bing za zhi, 2007, Volume: 35, Issue:12 Topics: Coronary Artery Disease; Drug-Eluting Stents; Follow-Up Studies; Humans; Incidence; Male; Paclitaxel; Thrombosis	2007
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. Journal of the American College of Cardiology, 2008, Apr-22, Volume: 51, Issue:16 Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Chromium Alloys; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Polymers; Risk; Thromboembolism; Ticlopidine; Time Factors	2008
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA, 2008, Apr-23, Volume: 299, Issue:16 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Ultrasonography, Interventional	2008
The SPIRIT V diabetic study: a randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions. American heart journal, 2012, Volume: 163, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Asia; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug-Eluting Stents; Europe; Evaluation Studies as Topic; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Prospective Studies; Risk Assessment; Single-Blind Method; Sirolimus; Statistics, Nonparametric; Survival Analysis; Taxus; Treatment Outcome	2012

Other Studies

376 other study(ies) available for paclitaxel and Coronary Artery Disease

Article	Year
Mathematical modelling of endovascular drug delivery: Balloons versus stents. International journal of pharmaceutics, 2022, May-25, Volume: 620 Topics: Coated Materials, Biocompatible; Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2022
Harnessing drug-coated balloons for the management of left main coronary disease: A promising strategy? Kardiologia polska, 2022, Volume: 80, Issue:6 Topics: Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Stents; Treatment Outcome	2022
Limus-Coated Balloons in "de Novo" Coronary Lesions: Quo Vadis? JACC. Cardiovascular interventions, 2022, 06-27, Volume: 15, Issue:12 Topics: Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Treatment Outcome	2022
Clinical Performance of a Paclitaxel Drug-Coated Balloon in Real-World Percutaneous Coronary Intervention Practice: The PEARL Registry. The Journal of invasive cardiology, 2022, Volume: 34, Issue:6 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Humans; Paclitaxel; Percutaneous Coronary Intervention; Registries; Treatment Outcome	2022
Response to pre-dilatation with POBA can predict target lesion revascularization after DCB angioplasty for de novo small coronary artery lesions. The Journal of international medical research, 2022, Volume: 50, Issue:8 Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Dilatation; Humans; Paclitaxel; Retrospective Studies	2022
Analysis of Inhibitory Effect of the Double-layer Nano-infusion on Vascular Restenosis in Animal Models of Coronary Atherosclerosis. Cellular and molecular biology (Noisy-le-Grand, France), 2022, Mar-31, Volume: 68, Issue:3 Topics: Animals; Apolipoproteins E; Constriction, Pathologic; Coronary Artery Disease; Mice; Models, Animal; Nanoparticle Drug Delivery System; Nanoparticles; Paclitaxel; Vascular Endothelial Growth Factor A	2022
Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice. Clinical research in cardiology : official journal of the German Cardiac Society, 2023, Volume: 112, Issue:9 Topics: Angina, Stable; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Treatment Outcome	2023
Experience with Optical Coherence Tomography Enhanced by a Novel Software (Ultreon™ 1.0 Software)-The First One Hundred Cases. Medicina (Kaunas, Lithuania), 2022, Sep-05, Volume: 58, Issue:9 Topics: Antimitotic Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Creatinine; Drug-Eluting Stents; Humans; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Software; Stents; Tomography, Optical Coherence; Treatment Outcome	2022
Real-world outcomes of Cook Zilver PTX in femoro-popliteal district from multicenter experience. International angiology : a journal of the International Union of Angiology, 2023, Volume: 42, Issue:1 Topics: Aged; Chronic Limb-Threatening Ischemia; Coronary Artery Disease; Drug-Eluting Stents; Femoral Artery; Humans; Male; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prosthesis Design; Retrospective Studies; Treatment Outcome; Vascular Patency	2023
Single-Antiplatelet Treatment After Coronary Angioplasty With Drug-Coated Balloon. Journal of the American Heart Association, 2023, 03-21, Volume: 12, Issue:6 Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Humans; Myocardial Revascularization; Paclitaxel; Treatment Outcome	2023
Sustained Lumen Area by Paclitaxel-Coated Balloon Following Rotational Atherectomy for Napkin-Ring Left Main Trunk Ostial Lesion. Texas Heart Institute journal, 2023, 03-01, Volume: 50, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Disease; Female; Humans; Paclitaxel; Percutaneous Coronary Intervention; Treatment Outcome	2023
Crystalline sirolimus-coated balloon (cSCB) angioplasty in an all-comers, patient population with stable and unstable coronary artery disease including chronic total occlusions: rationale, methodology and design of the SCORE trial. BMC cardiovascular disorders, 2023, 03-31, Volume: 23, Issue:1 Topics: Angioplasty; Cardiovascular Agents; Clinical Trials as Topic; Constriction, Pathologic; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Sirolimus; Treatment Outcome	2023
Clinical and Angiographic Outcomes of Elective Paclitaxel-Coated Balloon Angioplasty in Comparison with Drug-Eluting Stents for De Novo Coronary Lesions in Large Vessels. International heart journal, 2023, Volume: 64, Issue:2 Topics: Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Retrospective Studies; Stents; Treatment Outcome	2023
Safety and Efficacy of a Hybrid Approach Combining a Paclitaxel-Coated Balloon With a New Generation Drug-Eluting Stent in Patients With De Novo True Coronary Bifurcation Lesions. Cardiovascular revascularization medicine : including molecular interventions, 2023, Volume: 54 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Treatment Outcome	2023
Drug-Coated Balloon for De Novo Lesions: Back to the Past or Back to the Future? JACC. Cardiovascular interventions, 2023, 07-24, Volume: 16, Issue:14 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Humans; Paclitaxel; Treatment Outcome	2023
The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2023, Volume: 102, Issue:6 Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel; Prospective Studies; Sirolimus; Treatment Outcome	2023
Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis. Cardiovascular revascularization medicine : including molecular interventions, 2020, Volume: 21, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Equipment Design; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Risk Factors; Spain; Stents; Tomography, Optical Coherence; Treatment Outcome	2020
Acute and mid-term outcomes of drug-coated balloon following rotational atherectomy. Cardiovascular intervention and therapeutics, 2020, Volume: 35, Issue:3 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Postoperative Complications; Retrospective Studies; Treatment Outcome; Tubulin Modulators; Vascular Access Devices; Vascular Calcification	2020
Clinical outcomes of SeQuent Please paclitaxel-coated balloons for de novo small coronary artery lesion in a Japanese multicenter post-approval registry. Coronary artery disease, 2020, Volume: 31, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Female; Humans; Japan; Male; Middle Aged; Paclitaxel; Product Surveillance, Postmarketing; Registries; Retrospective Studies; Treatment Outcome	2020
Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions. The international journal of cardiovascular imaging, 2020, Volume: 36, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Equipment Design; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Registries; Severity of Illness Index; Stents; Time Factors; Treatment Outcome	2020
Reduced histologic neo in-stent restenosis after use of a paclitaxel-coated cutting balloon in porcine coronary arteries. Histology and histopathology, 2020, Volume: 35, Issue:7 Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Paclitaxel; Sus scrofa	2020
First-in-Human Study of Paclitaxel Drug-Coated Chocolate Coronary Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in De Novo Coronary Artery Lesions. JACC. Cardiovascular interventions, 2019, 12-23, Volume: 12, Issue:24 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Feasibility Studies; Female; Humans; Male; Middle Aged; Paclitaxel; Preliminary Data; Risk Factors; Time Factors; Treatment Outcome	2019
Percutaneous Coronary Intervention With the Agent Paclitaxel-Coated Balloon: A Real-World Multicenter Experience. The Journal of invasive cardiology, 2020, Volume: 32, Issue:3 Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Humans; Italy; Paclitaxel; Percutaneous Coronary Intervention; Treatment Outcome	2020
Excimer laser coronary atherectomy prior to paclitaxel-coated balloon angioplasty for de novo coronary artery lesions. Lasers in medical science, 2021, Volume: 36, Issue:1 Topics: Aged; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Coronary Artery Disease; Female; Humans; Lasers, Excimer; Male; Paclitaxel; Retrospective Studies; Treatment Outcome	2021
Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2021, 07-01, Volume: 98, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Treatment Outcome	2021
Causes of death after treatment of small coronary artery disease with paclitaxel-coated balloons. Clinical research in cardiology : official journal of the German Cardiac Society, 2021, Volume: 110, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cause of Death; Coated Materials, Biocompatible; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Paclitaxel; Postoperative Period; Switzerland	2021
Comparison of drug-eluting stents vs. drug-coated balloon after rotational atherectomy for severely calcified lesions of nonsmall vessels. Heart and vessels, 2021, Volume: 36, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Retrospective Studies; Treatment Outcome	2021
Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study. Clinical research in cardiology : official journal of the German Cardiac Society, 2021, Volume: 110, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cause of Death; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Time Factors; Treatment Outcome; United Kingdom	2021
Serial optical coherence tomography findings after drug-coated balloon treatment in de novo coronary bifurcation lesion. Cardiology journal, 2020, Volume: 27, Issue:4 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Humans; Paclitaxel; Pharmaceutical Preparations; Tomography, Optical Coherence; Treatment Outcome	2020
A left main disease repeatedly treated with drug-coated balloon in a patient with poor adherence to medications. Cardiology journal, 2020, Volume: 27, Issue:4 Topics: Angioplasty, Balloon; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Humans; Paclitaxel; Pharmaceutical Preparations; Treatment Outcome	2020
Impact of Dissection after Drug-Coated Balloon Treatment of De Novo Coronary Lesions: Angiographic and Clinical Outcomes. Yonsei medical journal, 2020, Volume: 61, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dissection; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Postoperative Complications; Retrospective Studies; Treatment Outcome	2020
Long-Term Follow-Up of Percutaneous Coronary Intervention With Paclitaxel-Eluting Balloon Catheter. Angiology, 2021, Volume: 72, Issue:4 Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Equipment Design; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Time Factors; Treatment Outcome	2021
Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2021, 07-01, Volume: 98, Issue:1 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Humans; Paclitaxel; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome	2021
Do we really understand how drug eluted from stents modulates arterial healing? International journal of pharmaceutics, 2021, May-15, Volume: 601 Topics: Arteries; Coronary Artery Disease; Coronary Restenosis; Humans; Paclitaxel; Pharmaceutical Preparations; Stents	2021
Results of paclitaxel-drug-coated balloons (Pantera Lux) for coronary in-stent restenosis: Italian experience from REGistry of Paclitaxel Eluting Balloon in ISR study. Journal of cardiovascular medicine (Hagerstown, Md.), 2021, 06-01, Volume: 22, Issue:6 Topics: Aftercare; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Italy; Male; Outcome and Process Assessment, Health Care; Paclitaxel; Percutaneous Coronary Intervention; Registries; Reoperation; Time	2021
Predictors of Favorable Angiographic Outcomes After Drug-Coated Balloon Use for de novo Small Vessel Coronary Disease (DCB-ONLY). Angiology, 2021, Volume: 72, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Equipment Design; Female; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Prospective Studies; Registries; Republic of Korea; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2021
Effect of Paclitaxel-Coated Balloon Angioplasty on Side Branch Lesion and Cardiovascular Outcomes in Patients with De Novo True Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention. Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:5 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Percutaneous Coronary Intervention; Treatment Outcome	2022
Ten-year outcomes of early generation sirolimus- versus paclitaxel-eluting stents in patients with left main coronary artery disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2021, 11-01, Volume: 98, Issue:5 Topics: Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2021
Paclitaxel Drug-Coated Balloon for the Treatment of De Novo Small-Vessel and Restenotic Coronary Artery Lesions: 12-Month Results of the Prospective, Multicenter, Single-Arm PREVAIL Study. The Journal of invasive cardiology, 2021, Volume: 33, Issue:11 Topics: Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Humans; Paclitaxel; Pharmaceutical Preparations; Prospective Studies; Treatment Outcome	2021
A case of severely calcified neoatherosclerosis after paclitaxel eluting stent implantation. Cardiovascular revascularization medicine : including molecular interventions, 2017, Volume: 18, Issue:6S1 Topics: Aged; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Male; Paclitaxel; Treatment Outcome; Vascular Calcification	2017
Influence of Drugs Carried in Lipid Nanoparticles in Coronary Disease of Rabbit Transplanted Heart. The Annals of thoracic surgery, 2017, Volume: 104, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Cytokines; Disease Models, Animal; Drug Carriers; Gene Expression Regulation; Graft Rejection; Graft Survival; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Injections, Intravenous; Methotrexate; Myocardium; Nanoparticles; Paclitaxel; Rabbits; Real-Time Polymerase Chain Reaction; RNA	2017
Drug Eluting Stents for Very Long Lesions: Go Long, But Know the Risks. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017, Volume: 89, Issue:6 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Time Factors; Treatment Outcome	2017
Drug-coated balloon: Long-term outcome from a real world three-center experience. Journal of interventional cardiology, 2017, Volume: 30, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Postoperative Complications; Registries; Retrospective Studies; Treatment Outcome	2017
Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis. BMC cardiovascular disorders, 2017, 06-26, Volume: 17, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Case-Control Studies; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metals; Middle Aged; Odds Ratio; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stents; Time Factors; Treatment Outcome	2017
Drug-coated balloons: "Do they still have a role in treating coronary artery disease?" Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017, 09-01, Volume: 90, Issue:3 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Propensity Score; Prosthesis Design; Treatment Outcome	2017
Effect of drug-coated balloon on stent restenosis, neointimal proliferation, and coronary dissection: an optical coherence tomography analysis. Coronary artery disease, 2018, Volume: 29, Issue:1 Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Tomography, Optical Coherence; Tubulin Modulators	2018
SYNTAX score based on coronary computed tomography angiography may have a prognostic value in patients with complex coronary artery disease: An observational study from a retrospective cohort. Medicine, 2017, Volume: 96, Issue:37 Topics: Aged; Cerebrovascular Disorders; Combined Modality Therapy; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Heart Diseases; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Predictive Value of Tests; Prognosis; Retrospective Studies	2017
Analysis of the effect of paclitaxel-eluting stents and paclitaxel-eluting balloon in the treatment of in-stent restenosis. Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:4(Suppl.) Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; China; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2017
Treatment with 48-mm everolimus-eluting stents : Procedural safety and 12-month patient outcome. Herz, 2019, Volume: 44, Issue:5 Topics: Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Retrospective Studies; Sirolimus; Treatment Outcome	2019
Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels: initial experience with the Essential paclitaxel-coated balloon. Coronary artery disease, 2018, Volume: 29, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Equipment Design; Female; Humans; Male; Middle Aged; Paclitaxel; Quebec; Risk Factors; Spain; Time Factors; Treatment Outcome	2018
A serial three- and nine-year optical coherence tomography evaluation of neoatherosclerosis progression after sirolimus- and paclitaxel- -eluting stent implantation. Kardiologia polska, 2018, Volume: 76, Issue:8 Topics: Aged; Atherosclerosis; Coronary Artery Disease; Coronary Restenosis; Disease Progression; Drug-Eluting Stents; Female; Humans; Longitudinal Studies; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Period; Sirolimus; Tomography, Optical Coherence	2018
Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis. JACC. Cardiovascular interventions, 2018, 05-28, Volume: 11, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Registries; Republic of Korea; Retreatment; Risk Factors; Time Factors; Treatment Outcome	2018
Long-term clinical observations for a biofunctionalized stent: Yet to deliver their theoretical benefits. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018, Volume: 91, Issue:7 Topics: Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Endothelial Progenitor Cells; Follow-Up Studies; Humans; Paclitaxel; Pilot Projects; Prospective Studies; Stents; Treatment Outcome	2018
Drug-coated balloon angioplasty for de novo small vessel disease including chronic total occlusion and bifurcation in real-world clinical practice. Cardiovascular intervention and therapeutics, 2019, Volume: 34, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Coronary Restenosis; Female; Humans; Japan; Male; Paclitaxel	2019
Coronary artery treatment with a urea-based paclitaxel-coated balloon: the European-wide FALCON all-comers DCB Registry (FALCON Registry). EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2019, Jul-20, Volume: 15, Issue:4 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Humans; Paclitaxel; Prospective Studies; Registries; Treatment Outcome; Urea	2019
Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute. Clinical research in cardiology : official journal of the German Cardiac Society, 2019, Volume: 108, Issue:3 Topics: Antineoplastic Agents, Phytogenic; China; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Hospitals, University; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Time Factors; Treatment Outcome	2019
Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons. Coronary artery disease, 2018, Volume: 29, Issue:8 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Excipients; Female; Humans; Iohexol; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome	2018
Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019, 04-01, Volume: 93, Issue:5 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Paclitaxel; Registries; Retrospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome	2019
Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons. Angiology, 2019, Volume: 70, Issue:5 Topics: Aged; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome	2019
Clinical outcomes following implantation of the ION™ paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-approval study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019, 09-01, Volume: 94, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Platinum; Product Surveillance, Postmarketing; Prospective Studies; Prosthesis Design; Registries; Time Factors; Treatment Outcome; United States	2019
Clinical and angiographic outcomes of coronary dissection after paclitaxel-coated balloon angioplasty for small vessel coronary artery disease. Cardiovascular intervention and therapeutics, 2019, Volume: 34, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Aortic Dissection; Coated Materials, Biocompatible; Coronary Aneurysm; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Male; Paclitaxel; Retrospective Studies	2019
Paclitaxel Eluting Endovascular Technology and Long-Term Mortality: Safety Concern or a Reminder of an Obvious Literature Gap? European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2019, Volume: 57, Issue:3 Topics: Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel	2019
Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis. Heart and vessels, 2019, Volume: 34, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome	2019
12-Month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm. The international journal of cardiovascular imaging, 2019, Volume: 35, Issue:4 Topics: Aged; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Equipment Design; Feasibility Studies; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome	2019
Beware of large treatment effects in small clinical trials: lessons from trials of coronary atheroablative devices. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Volume: 81, Issue:2 Topics: Atherectomy, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Vascular Calcification	2013
Large coronary pseudoaneurysm with pulmonary artery fistula, six months after left main trunk stenting with paclitaxel-eluting stent. Medical ultrasonography, 2013, Volume: 15, Issue:1 Topics: Aged; Aneurysm, False; Arterio-Arterial Fistula; Coronary Artery Disease; Diagnosis, Differential; Drug-Eluting Stents; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Pulmonary Artery; Radiography; Treatment Outcome	2013
Outcomes of overlapping heterogeneous drug-eluting stents versus homogeneous drug-eluting stents for diffuse lesions in small coronary arteries. Journal of interventional cardiology, 2013, Volume: 26, Issue:3 Topics: Adult; Aged; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Survival Analysis; Treatment Outcome; Tubulin Modulators	2013
Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Volume: 9, Issue:6 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Follow-Up Studies; Humans; Paclitaxel; Prospective Studies; Sirolimus; Stents; Taxus; Treatment Outcome	2013
Diabetes and everolimus-eluting stents: good offense scores but defense wins tough games. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Volume: 81, Issue:5 Topics: Cardiovascular Agents; Coronary Artery Disease; Diabetic Angiopathies; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus	2013
Acute and long-term outcomes of ostial stentings among bare-metal stents, sirolimus-eluting stents, and paclitaxel-eluting stents. Coronary artery disease, 2013, Volume: 24, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome	2013
Angioscopic assessment of early phase arterial repair after paclitaxel-coated nitinol drug-eluting stent implantation in the superficial femoral artery. Circulation journal : official journal of the Japanese Circulation Society, 2013, Volume: 77, Issue:7 Topics: Aged; Aged, 80 and over; Alloys; Angioscopy; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies	2013
One-year clinical outcomes of percutaneous treatment with drug-eluting balloons: results from a multicenter registry. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2013, Volume: 32, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Registries; Time Factors; Treatment Outcome	2013
Severe right coronary artery kinking treated with stent placement. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10 Topics: Aged; Chest Pain; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Male; Myocardial Perfusion Imaging; Paclitaxel; Percutaneous Coronary Intervention; Tomography, Emission-Computed, Single-Photon	2013
Drug-eluting balloons: the path is made by walking. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2013, Volume: 32, Issue:5 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention	2013
Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis. Coronary artery disease, 2013, Volume: 24, Issue:5 Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Hospitals, High-Volume; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Propensity Score; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2013
The "final voyage" of the Endeavor stent. JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:5 Topics: Cardiovascular Agents; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Metals; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Stents	2013
Drug-eluting stents and diabetes: a generation gap? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Jun-01, Volume: 81, Issue:7 Topics: Cardiovascular Agents; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus	2013
Stent paleology: diabetic lessons from extinct stents. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Jun-01, Volume: 81, Issue:7 Topics: Cardiovascular Agents; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus	2013
Stent thrombosis with second- versus first-generation drug-eluting stents in real-world percutaneous coronary intervention: analysis of 3806 consecutive procedures from a large-volume single-center prospective registry. The Journal of invasive cardiology, 2013, Volume: 25, Issue:7 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Endpoint Determination; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Sirolimus; Treatment Outcome	2013
Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents. The American journal of cardiology, 2013, Oct-15, Volume: 112, Issue:8 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; District of Columbia; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prosthesis Design; Retrospective Studies; Sirolimus; Treatment Outcome	2013
Is there a need for distal protection during native vessel percutaneous coronary intervention in patients with stable coronary artery disease? Journal of cardiovascular medicine (Hagerstown, Md.), 2014, Volume: 15, Issue:2 Topics: Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Embolic Protection Devices; Embolism; Humans; Male; Middle Aged; Paclitaxel; Patient Selection; Percutaneous Coronary Intervention; Predictive Value of Tests; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Spectroscopy, Near-Infrared; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional	2014
The relationship between re-endothelialization and endothelial function after DES implantation: comparison between paclitaxcel eluting stent and zotarolims eluting stent. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2014, Feb-15, Volume: 83, Issue:3 Topics: Acetylcholine; Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Re-Epithelialization; Retrospective Studies; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents	2014
Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Aug-22, Volume: 9, Issue:4 Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Constriction, Pathologic; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Iohexol; Neointima; Paclitaxel; Polymers; Swine	2013
The impact of main branch restenosis on long term mortality following drug-eluting stent implantation in patients with de novo unprotected distal left main bifurcation coronary lesions: the Milan and New-Tokyo (MITO) Registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2014, Sep-01, Volume: 84, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Italy; Male; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Failure; Registries; Retrospective Studies; Survival Rate; Time Factors; Tokyo; Treatment Outcome	2014
[SICI-GISE position paper on drug-coated balloon use in the coronary district]. Giornale italiano di cardiologia (2006), 2013, Volume: 14, Issue:10 Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Coronary Restenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Equipment Design; Evidence-Based Medicine; Humans; Multicenter Studies as Topic; Myocardial Infarction; Neointima; Paclitaxel; Platelet Aggregation Inhibitors; Registries	2013
Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation, 2014, Jan-14, Volume: 129, Issue:2 Topics: Aged; Aged, 80 and over; Autopsy; Biocompatible Materials; Chromium Alloys; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Neointima; Paclitaxel; Prevalence; Registries; Retrospective Studies; Sirolimus	2014
Left main percutaneous coronary intervention: growing in maturity. JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:12 Topics: Cardiovascular Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Imaging, Three-Dimensional; Male; Paclitaxel; Percutaneous Coronary Intervention; Radiographic Image Interpretation, Computer-Assisted	2013
Comparison of paclitaxel-eluting vs. everolimus-eluting stents implanted simultaneously in different lesions of the same coronary artery: 12-month follow-up with optical coherence tomography. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Volume: 9, Issue:8 Topics: Aged; Aged, 80 and over; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Tomography, Optical Coherence; Treatment Outcome	2013
Second-generation versus first-generation drug-eluting stents for the treatment of patients with acute coronary syndromes and obstructive coronary artery disease. Coronary artery disease, 2014, Volume: 25, Issue:3 Topics: Aged; Comparative Effectiveness Research; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Everolimus; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Portugal; Proportional Hazards Models; Registries; Sirolimus; Stents; Treatment Outcome	2014
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial. Cardiovascular revascularization medicine : including molecular interventions, 2014, Volume: 15, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2014
Polymer-free stents in diabetic patients-not so sweet after all! Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2014, Feb-15, Volume: 83, Issue:3 Topics: Cardiovascular Agents; Coronary Artery Disease; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Sirolimus	2014
Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending artery disease: a 10-year follow-up, single-center, propensity score analysis. The Journal of thoracic and cardiovascular surgery, 2014, Volume: 148, Issue:4 Topics: Aged; Cause of Death; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Immunosuppressive Agents; Male; Middle Aged; Minimally Invasive Surgical Procedures; Paclitaxel; Percutaneous Coronary Intervention; Propensity Score; Retrospective Studies; Sirolimus; Survival Rate; Treatment Outcome; Tubulin Modulators	2014
Treatment of coronary de novo bifurcation lesions with DCB only strategy. Clinical research in cardiology : official journal of the German Cardiac Society, 2014, Volume: 103, Issue:6 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Time Factors; Treatment Outcome	2014
Neoatherosclerosis after paclitaxel-coated balloon angioplasty for in-stent restenosis. Circulation, 2014, Feb-25, Volume: 129, Issue:8 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel; Recurrence; Tubulin Modulators; Ultrasonography	2014
Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study. International journal of cardiology, 2014, May-01, Volume: 173, Issue:2 Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Tomography, Optical Coherence; Treatment Outcome; Tubulin Modulators; Wound Healing	2014
Comparison of 2-year clinical outcomes between zotarolimus-, sirolimus-, and paclitaxel-eluting stents in real life clinical practice. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2014, Feb-15, Volume: 83, Issue:3 Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2014
Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stents. Cardiovascular revascularization medicine : including molecular interventions, 2014, Volume: 15, Issue:2 Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; District of Columbia; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prevalence; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome	2014
Everolimus-eluting stents: redefining the risk for very late stent thrombosis. Coronary artery disease, 2014, Volume: 25, Issue:5 Topics: Cardiovascular Agents; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Sirolimus	2014
Long-term safety and efficacy of the everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice. The Journal of invasive cardiology, 2014, Volume: 26, Issue:4 Topics: Aged; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Sirolimus; Treatment Outcome	2014
Coronary artery disease: Similar 5-year outcomes with CABG surgery or PCI for left main disease. Nature reviews. Cardiology, 2014, Volume: 11, Issue:6 Topics: Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention	2014
Coronary vasomotion one year after drug-eluting stent implantation: comparison of everolimus-eluting and paclitaxel-eluting coronary stents. Journal of cardiovascular translational research, 2014, Volume: 7, Issue:4 Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Europe; Everolimus; Female; Hemodynamics; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Time Factors; Treatment Outcome	2014
Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease. Journal of biomedical nanotechnology, 2014, Volume: 10, Issue:7 Topics: Animals; Biocompatible Materials; Calcium Phosphates; Calorimetry, Differential Scanning; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Lactic Acid; Male; Materials Testing; Nanoparticles; Paclitaxel; Polyesters; Polymers; Radiography; Swine; Swine, Miniature	2014
Drug-eluting balloon in the treatment of in-stent restenosis and diffuse coronary artery disease: real-world experience from our registry. Journal of interventional cardiology, 2014, Volume: 27, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Outcome Assessment; Registries; Retrospective Studies; Stents	2014
Differences in clinical and angiographic profiles between Asian and Western patients with coronary artery disease: insights from the prospective "real world" paclitaxel-coated balloon registry. International journal of cardiology, 2014, Jul-15, Volume: 175, Issue:1 Topics: Aged; Asian People; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; France; Germany; Humans; Internationality; Italy; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; White People	2014
Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch? JACC. Cardiovascular interventions, 2014, Volume: 7, Issue:5 Topics: Absorbable Implants; Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnesium; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prosthesis Design; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2014
Long-term clinical and angiographic outcomes after sirolimus- and paclitaxel-eluting stent placement following rotablation for severely calcified lesions: a retrospective nonrandomized study. Cardiovascular intervention and therapeutics, 2015, Volume: 30, Issue:1 Topics: Aged; Aged, 80 and over; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Sirolimus; Treatment Outcome; Vascular Calcification	2015
Comparison of long-term clinical outcomes between sirolimus- and paclitaxel-eluting stents in real-world clinical practice. Heart and vessels, 2015, Volume: 30, Issue:6 Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Sirolimus; Thrombosis; Treatment Outcome	2015
Distal left main restenosis: dodging that bullet. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2014, Sep-01, Volume: 84, Issue:3 Topics: Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Registries	2014
Neointimal hemorrhage after drug-eluting stent implantation: possible role for development of neoatherosclerosis. JACC. Cardiovascular interventions, 2014, Volume: 7, Issue:10 Topics: Autopsy; Cardiovascular Agents; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Fatal Outcome; Hemorrhage; Humans; Male; Middle Aged; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Prosthesis Design; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional	2014
Cost-effectiveness of drug-eluting vs. bare-metal stents in patients with coronary artery disease from the Korean National Health Insurance Database. Yonsei medical journal, 2014, Volume: 55, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Asian People; Coronary Artery Disease; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; National Health Programs; Paclitaxel; Republic of Korea; Retrospective Studies; Risk; Sirolimus; Stents; Treatment Outcome	2014
Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. Clinical research in cardiology : official journal of the German Cardiac Society, 2015, Volume: 104, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Female; Humans; Hyperplasia; Male; Middle Aged; Neointima; Paclitaxel; Retrospective Studies; Time Factors; Treatment Outcome; Vascular Remodeling	2015
First experience with paclitaxel-coated balloon angioplasty in patients with adult transplant coronary artery disease: is it an alternative to drug-eluting stents? The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2015, Volume: 34, Issue:2 Topics: Adult; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Graft Rejection; Heart Transplantation; Humans; Male; Middle Aged; Paclitaxel	2015
Angiographic patterns of restenosis with 2nd generation drug-eluting stent: comparative analysis from a 10-year single-center experience . International heart journal, 2015, Volume: 56, Issue:1 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Registries; Republic of Korea; Sirolimus; Treatment Outcome; Vascular Patency	2015
Prognostic value of plasma pentraxin-3 levels in patients with stable coronary artery disease after drug-eluting stent implantation. Mediators of inflammation, 2014, Volume: 2014 Topics: Aged; C-Reactive Protein; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Percutaneous Coronary Intervention; Prognosis; Serum Amyloid P-Component; Sirolimus	2014
Treatment of symptomatic coronary artery disease in patients with end-stage renal disease on hemodialysis with paclitaxel-eluting TAXUS stent. Hemodialysis international. International Symposium on Home Hemodialysis, 2015, Volume: 19, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Renal Dialysis; Treatment Outcome	2015
Learning from mistakes: the case of drug-coated balloons. International journal of cardiology, 2015, Mar-01, Volume: 182 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Artery Disease; Equipment Design; Humans; Paclitaxel	2015
The STENTYS® paclitaxel-eluting stent in the treatment of unprotected distal left main. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Volume: 86, Issue:3 Topics: Aged; Alloys; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Italy; Japan; Male; Paclitaxel; Percutaneous Coronary Intervention; Pilot Projects; Treatment Outcome	2015
Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial. International journal of cardiology, 2015, Volume: 186 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Saphenous Vein; Time Factors	2015
Clinical and angiographic outcomes of paclitaxel-eluting coronary stent implantation in hemodialysis patients: A prospective multicenter registry: The OUCH-TL study (outcome in hemodialysis of TAXUS Liberte). Journal of cardiology, 2015, Volume: 66, Issue:6 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Renal Dialysis; Treatment Outcome; Tubulin Modulators; United States	2015
The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term. Heart and vessels, 2016, Volume: 31, Issue:6 Topics: Aged; Angioscopy; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Immunohistochemistry; Male; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Retreatment; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing	2016
Long-Term Results of Drug-Coated Balloons for Drug-Eluting In-Stent Restenosis: Gaining Perspective. JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:7 Topics: Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention	2015
Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016, Jun-20, Volume: 12, Issue:3 Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Risk Factors; Sirolimus; Time; Treatment Outcome	2016
Serial changes of coronary endothelial function and arterial healing after paclitaxel-eluting stent implantation. Cardiovascular intervention and therapeutics, 2016, Volume: 31, Issue:1 Topics: Acetylcholine; Aged; Angina, Stable; Angioscopy; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Paclitaxel; Percutaneous Coronary Intervention; Tunica Intima; Vasodilator Agents	2016
Drug coated balloon angioplasty in elderly patients with small vessel coronary disease. Therapeutic advances in cardiovascular disease, 2015, Volume: 9, Issue:6 Topics: Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Asia; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Comorbidity; Coronary Artery Disease; Equipment Design; Europe; Female; Humans; Kaplan-Meier Estimate; Male; Paclitaxel; Prospective Studies; Registries; Risk Factors; Time Factors; Treatment Outcome	2015
Development of Late Stent Malapposition After Paclitaxel-Coated Balloon Angioplasty for In-Stent Neoatherosclerosis. JACC. Cardiovascular interventions, 2015, Aug-24, Volume: 8, Issue:10 Topics: Angioplasty, Balloon; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2015
Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2016, Volume: 88, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Equipment Design; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Registries; Republic of Korea; Time Factors; Treatment Outcome; Vascular Patency	2016
Two-year clinical outcome in patients with small coronary artery disease treated with everolimus- versus paclitaxel-eluting stenting. Journal of cardiology, 2016, Volume: 68, Issue:3 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Japan; Male; Paclitaxel; Percutaneous Coronary Intervention; Registries; Retreatment; Thrombosis	2016
Comparison of Long-Term Outcomes in Real-World Patients Between Resolute Zotarilumus-Eluting and Paclitaxel-Eluting Stents in Small Vessel. Angiology, 2016, Volume: 67, Issue:5 Topics: Adult; Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Sirolimus; Treatment Outcome	2016
Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis. Clinical research in cardiology : official journal of the German Cardiac Society, 2016, Volume: 105, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Risk Factors; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2016
Stent failure due to simultaneous aggressive neoatherosclerosis of first- and current-generation drug-eluting stents. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015, Volume: 11, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Prosthesis Design; Prosthesis Failure; Retreatment; Thrombectomy; Tomography, Optical Coherence; Treatment Outcome	2015
The Leipzig Prospective Drug-Eluting Balloon-Registry - Outcome of 484 Consecutive Patients Treated for Coronary In-Stent Restenosis and De Novo Lesions Using Paclitaxel-Coated Balloons. Circulation journal : official journal of the Japanese Circulation Society, 2016, Volume: 80, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Follow-Up Studies; Germany; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries	2016
Characteristics of Late-Acquired Incomplete Stent Apposition: A Comparison With First-Generation and Second-Generation Drug-Eluting Stents. The Journal of invasive cardiology, 2016, Volume: 28, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Long Term Adverse Effects; Male; Middle Aged; Outcome and Process Assessment, Health Care; Paclitaxel; Sirolimus; Ultrasonography, Interventional; United States	2016
Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2016, Volume: 88, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Retreatment; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome	2016
The Importance of Subgroup Analysis in Drug-Eluting Stent Trials. JACC. Cardiovascular interventions, 2016, Jan-11, Volume: 9, Issue:1 Topics: Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Time Factors; Treatment Outcome	2016
Anatomical and Physiological Changes after Paclitaxel-Coated Balloon for Atherosclerotic De Novo Coronary Lesions: Serial IVUS-VH and FFR Study. PloS one, 2016, Volume: 11, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Paclitaxel; Plaque, Atherosclerotic; Prospective Studies; Ultrasonography, Interventional	2016
Drug-eluting balloon: early enthusiasm being tempered by growing uncertainty. Coronary artery disease, 2016, Volume: 27, Issue:2 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Metals; Paclitaxel; Stents; Tubulin Modulators	2016
Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions. Yonsei medical journal, 2016, Volume: 57, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies	2016
Comparison of Clinical and Angiographic Outcomes After Bare Metal Stents and Drug-Eluting Stents Following Rotational Atherectomy. International heart journal, 2016, Volume: 57, Issue:2 Topics: Aged; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Incidence; Japan; Male; Paclitaxel; Percutaneous Coronary Intervention; Prognosis; Retrospective Studies; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2016
Paclitaxel-coated balloon angioplasty for de novo coronary lesions: a long-term follow-up study. Minerva cardioangiologica, 2016, Volume: 64, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries; Treatment Outcome	2016
Paclitaxel-Coated Balloons: Investigation of Drug Transfer in Healthy and Atherosclerotic Arteries - First Experimental Results in Rabbits at Low Inflation Pressure. Cardiovascular drugs and therapy, 2016, Volume: 30, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Vessels; Drug Delivery Systems; Male; Paclitaxel; Rabbits	2016
Comparison of Angiographic and 1-Year Outcomes Between a Long Single Stent and Overlapping Double Stents in Patients With Newer-Generation Drug-Eluting Stents for Long Narrowings. The American journal of cardiology, 2016, 06-01, Volume: 117, Issue:11 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prosthesis Design; Retrospective Studies; Sirolimus; Survival Rate; Time Factors; Treatment Outcome	2016
Second-Generation Drug-Eluting Balloon for Ostial Side Branch Lesions (001-Bifurcations): Mid-Term Clinical and Angiographic Results. Journal of interventional cardiology, 2016, Volume: 29, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Germany; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries; Treatment Outcome	2016
Comparison of long-term outcomes of bare-metal and paclitaxel-eluting stents in New York. Journal of evaluation in clinical practice, 2016, Volume: 22, Issue:6 Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Databases, Factual; Drug-Eluting Stents; Female; Humans; Longitudinal Studies; Male; Metals; Middle Aged; New York; Outcome Assessment, Health Care; Paclitaxel; Proportional Hazards Models; Registries	2016
Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017, Volume: 89, Issue:1 Topics: Aged; Aged, 80 and over; Area Under Curve; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Decision Support Techniques; Discriminant Analysis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Patient Selection; Percutaneous Coronary Intervention; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome	2017
Differential angioscopic findings of neointimal coverage among first-, second-, and next generation drug-eluting stents. International journal of cardiology, 2016, Nov-15, Volume: 223 Topics: Angioscopy; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Neointima; Paclitaxel; Prosthesis Design; Sirolimus	2016
Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting Stents. The American journal of cardiology, 2016, 09-15, Volume: 118, Issue:6 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blood Pressure; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Japan; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Sirolimus	2016
Sirolimus-eluting stent is superior to paclitaxel-eluting stent for coronary intervention in patients with renal insufficiency: Long-term clinical outcomes. Cardiology journal, 2016, Volume: 23, Issue:6 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Registries; Renal Insufficiency; Republic of Korea; Risk Factors; Sirolimus; Survival Rate; Time Factors	2016
Soluble adhesion molecules in patients with acute coronary syndrome after percutaneous coronary intervention with drug-coated balloon, drug-eluting stent or bare metal stent. Medical hypotheses, 2016, Volume: 95 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Atherosclerosis; Cell Adhesion Molecules; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Endothelial Cells; Humans; Inflammation; Intercellular Adhesion Molecule-1; Metals; P-Selectin; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus; Up-Regulation; Vascular Cell Adhesion Molecule-1	2016
Neoatherosclerosis after paclitaxel-eluting stent implantation: Ex vivo intravascular image and histopathology. Pathology international, 2017, Volume: 67, Issue:1 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Paclitaxel; Recurrence; Tubulin Modulators; Tunica Intima	2017
SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the Düsseldorf DCB registry. International journal of cardiology, 2017, Mar-15, Volume: 231 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cause of Death; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Germany; Humans; Incidence; Male; Paclitaxel; Registries; Retrospective Studies; Survival Rate; Treatment Outcome	2017
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017, Sep-01, Volume: 90, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Italy; Logistic Models; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Propensity Score; Proportional Hazards Models; Prosthesis Design; Randomized Controlled Trials as Topic; Registries; Risk Factors; Time Factors; Treatment Outcome	2017
Percutaneous Coronary Intervention of Complex Calcified Lesions With Drug-Coated Balloon After Rotational Atherectomy. Journal of interventional cardiology, 2017, Volume: 30, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Stents; Treatment Outcome; Vascular Calcification	2017
Comparison of 5-year outcomes of paclitaxel-eluting and endeavor zotarolimus-eluting stents in New York. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018, 01-01, Volume: 91, Issue:1 Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Comparative Effectiveness Research; Coronary Artery Disease; Databases, Factual; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; New York; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Registries; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2018
Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents. American heart journal, 2008, Volume: 155, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome	2008
Efficacy and safety of drug-eluting stents in long-term follow-up. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:11 Topics: Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Follow-Up Studies; Humans; Paclitaxel; Safety; Sirolimus; Stents	2008
The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. European heart journal, 2008, Volume: 29, Issue:15 Topics: Aged; Angioplasty, Balloon, Coronary; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Immunosuppressive Agents; Male; Paclitaxel; Sirolimus; Treatment Outcome; Ultrasonography, Interventional	2008
Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation - the Meo:DrugStar-1 study. Vascular health and risk management, 2008, Volume: 4, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Prosthesis Design; Stainless Steel; Treatment Outcome	2008
Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). International journal of cardiology, 2009, Sep-11, Volume: 137, Issue:1 Topics: Aged; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Registries; Retrospective Studies; Sirolimus; Survival Rate; Time Factors; Treatment Outcome	2009
Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Oct-01, Volume: 72, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Proportional Hazards Models; Registries; Risk Assessment; Time Factors; Treatment Outcome; United States	2008
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Oct-01, Volume: 72, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Registries; Retrospective Studies; Risk Assessment; Sirolimus; Time Factors; Treatment Outcome	2008
"Neither horseshoes nor hand grenades"--does close count in percutaneous coronary revascularization? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Oct-01, Volume: 72, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel; Risk Assessment; Sirolimus; Time Factors; Treatment Outcome	2008
Results of the U.S. ARRIVE 1 registry: 2-year outcomes. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Oct-01, Volume: 72, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Registries; Risk Assessment; Time Factors; Treatment Outcome; United States	2008
One-year outcomes with the Taxus Liberté stent in the real world: the Taxus Olympia registry (phase I). Journal of interventional cardiology, 2008, Volume: 21, Issue:6 Topics: Adult; Aged; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Asia; Cardiac Catheterization; Central America; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Middle East; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Product Surveillance, Postmarketing; Prospective Studies; Registries; South America; Taxus; Treatment Outcome; Tubulin Modulators	2008
[Comparison of different drug-eluting stents in the treatment of coronary artery disease: a single center four-year clinical follow-up]. Zhonghua nei ke za zhi, 2008, Volume: 47, Issue:7 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Treatment Outcome	2008
Status of drug-eluting coronary stents. Medicine and health, Rhode Island, 2008, Volume: 91, Issue:10 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Consensus; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Sirolimus	2008
Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Feb-01, Volume: 73, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2009
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Jan-01, Volume: 73, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; California; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Critical Illness; Drug-Eluting Stents; Feasibility Studies; Female; Hospital Mortality; Humans; Italy; Kaplan-Meier Estimate; Male; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome	2009
Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!". Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Jan-01, Volume: 73, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Bypass; Coronary Artery Disease; Critical Illness; Drug-Eluting Stents; Hospital Mortality; Humans; Myocardial Infarction; Paclitaxel; Research Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome	2009
Early systemic inflammatory response to drug-eluting stents implantation: the heart of the difference? Editorial to: "Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation" by Li et al. Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:2 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Humans; Inflammation Mediators; Paclitaxel; Sirolimus; Time Factors	2009
[Side branch occlusion rate at sites of overlapping sirolimus- or paclitaxel-eluting stents for treating long coronary lesions]. Zhonghua xin xue guan bing za zhi, 2008, Volume: 36, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Treatment Outcome	2008
"Gender paradox" in outcome after percutaneous coronary intervention with paclitaxel eluting stents. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2008, Volume: 4, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Databases, Factual; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Paclitaxel; Predictive Value of Tests; Risk Factors; Sex Distribution; Sex Factors; Treatment Outcome	2008
[Benefit-risk ratio of coronary drug-eluting stents: 2nd part: evaluation in the diabetic population]. Revue medicale de Liege, 2008, Volume: 63, Issue:11 Topics: Coronary Artery Disease; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Humans; Incidence; Paclitaxel; Postoperative Complications; Risk Assessment; Sirolimus; Thrombosis	2008
Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease. The American journal of cardiology, 2009, Jan-15, Volume: 103, Issue:2 Topics: China; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Registries; Risk Factors; Stents; Treatment Outcome; Tubulin Modulators	2009
Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients. The American journal of cardiology, 2009, Jan-15, Volume: 103, Issue:2 Topics: Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Radiography; Sirolimus; Stents; Survival Rate; Treatment Outcome	2009
Inflation time and drug-eluting stent: the longer, the better... Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Feb-01, Volume: 73, Issue:2 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2009
Direct comparison of the short-term clinical performance of Z Guidant and Taxus stents. International journal of cardiology, 2010, Dec-03, Volume: 145, Issue:3 Topics: Angioplasty; Antineoplastic Agents, Phytogenic; Chromium Alloys; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel	2010
A novel paclitaxel-eluting dedicated bifurcation stent: a case report from the first human use Taxus Petal trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Apr-01, Volume: 73, Issue:5 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Severity of Illness Index; Treatment Outcome; Ultrasonography, Interventional	2009
Long-term outcomes of left main coronary intervention with drug-eluting stents. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Feb-15, Volume: 73, Issue:3 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Recurrence; Sirolimus; Treatment Outcome	2009
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Feb-15, Volume: 73, Issue:3 Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Proportional Hazards Models; Recurrence; Sirolimus; Treatment Outcome	2009
Drug-eluting stents for saphenous vein graft lesions: the limits of evidence. Journal of the American College of Cardiology, 2009, Mar-17, Volume: 53, Issue:11 Topics: Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Saphenous Vein	2009
Observational studies of drug-eluting stents--some are more equal than others. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 4, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Cohort Studies; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Humans; Metals; Netherlands; Paclitaxel; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Sirolimus; Stents; Time Factors; Treatment Outcome	2009
The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129). EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 4, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Cohort Studies; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Netherlands; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Risk Assessment; Sirolimus; Stents; Time Factors; Treatment Outcome	2009
The need for a dedicated bifurcation stenting system. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Apr-01, Volume: 73, Issue:5 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel; Prosthesis Design; Severity of Illness Index; Treatment Outcome	2009
The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Jul-01, Volume: 74, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Odds Ratio; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Treatment Failure; Ultrasonography, Interventional	2009
Incidence of stent thrombosis in patients with drug eluting stents and short-term dual antiplatelet therapy. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 4, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Artery Disease; Databases as Topic; Drug Administration Schedule; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2009
Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). Journal of the American College of Cardiology, 2009, May-05, Volume: 53, Issue:18 Topics: Aged; Case-Control Studies; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Databases as Topic; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Paclitaxel; Proportional Hazards Models; Registries; Risk; Sirolimus; Sweden; Tubulin Modulators	2009
Left main coronary artery stenting: crossing the Rubicon. Journal of the American College of Cardiology, 2009, May-12, Volume: 53, Issue:19 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Sirolimus; Tubulin Modulators	2009
Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry. Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Cost Savings; Cost-Benefit Analysis; Drug Costs; Drug-Eluting Stents; Female; Hospital Costs; Humans; Male; Metals; Middle Aged; Models, Economic; Paclitaxel; Prosthesis Design; Registries; Sicily; Sirolimus; Stents; Time Factors; Treatment Outcome	2009
Cross-sectional and longitudinal positive remodeling after subintimal drug-eluting stent implantation: multiple late coronary aneurysms, stent fractures, and a newly formed stent gap between previously overlapped stents. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Coronary Aneurysm; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel; Tunica Intima; Ultrasonography, Interventional	2009
Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long-term outcome after implantation of drug-eluting stents. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome	2009
Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Inflammation; Oxidative Stress; Paclitaxel; Swine	2009
Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Germany; Humans; Hyperplasia; Logistic Models; Male; Middle Aged; Paclitaxel; Polymers; Prospective Studies; Prosthesis Design; Risk Assessment; Sirolimus; Time Factors; Treatment Outcome	2009
Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing? JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Hyperplasia; Paclitaxel; Polymers; Prosthesis Design; Risk Assessment; Sirolimus; Time Factors; Treatment Outcome; Tunica Intima	2009
Heterogeneous arterial healing in patients following paclitaxel-eluting stent implantation: comparison with sirolimus-eluting stents. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Aspirin; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine	2009
Coronary artery disease: Complex coronary disease in the post-SYNTAX era. Nature reviews. Cardiology, 2009, Volume: 6, Issue:6 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Humans; Multicenter Studies as Topic; Paclitaxel; Patient Selection; Prospective Studies; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Treatment Outcome	2009
Treatment of left main coronary trifurcation lesions with the paclitaxel drug-eluting stent: mid-term outcomes from a tertiary medical center. The Journal of invasive cardiology, 2009, Volume: 21, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Paclitaxel; Retrospective Studies; Time Factors; Treatment Outcome	2009
The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry. Journal of the American College of Cardiology, 2009, Jul-14, Volume: 54, Issue:3 Topics: Case-Control Studies; Confidence Intervals; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Multivariate Analysis; Netherlands; Odds Ratio; Paclitaxel; Prospective Studies; Registries; Regression Analysis; Sirolimus; Surveys and Questionnaires; Survival Analysis; Time Factors	2009
The carina angle-new geometrical parameter associated with periprocedural side branch compromise and the long-term results in coronary bifurcation lesions with main vessel stenting only. Journal of interventional cardiology, 2009, Volume: 22, Issue:6 Topics: Aged; Analysis of Variance; Antineoplastic Agents, Phytogenic; Clopidogrel; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Image Interpretation, Computer-Assisted; Immunosuppressive Agents; Male; Mathematics; Multivariate Analysis; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Poland; Registries; Retrospective Studies; Sirolimus; Statistics as Topic; Ticlopidine; Time Factors	2009
Side balloon stenting of the left main bifurcation: a three-year angiographic follow-up. Journal of interventional cardiology, 2009, Volume: 22, Issue:6 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Time Factors	2009
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry). The American journal of cardiology, 2009, Nov-15, Volume: 104, Issue:10 Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Occlusion; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Sirolimus; Stents; Stroke	2009
Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Feb-15, Volume: 75, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Internet; Male; Middle Aged; Paclitaxel; Propensity Score; Registries; Retrospective Studies; Sirolimus	2010
Comparison of long-term outcomes following sirolimus-eluting stent vs paclitaxel-eluting stent implantation in patients with long calcified coronary lesions. Clinical cardiology, 2009, Volume: 32, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Calcinosis; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Republic of Korea; Retrospective Studies; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome	2009
Comparison of sirolimus and paclitaxel-eluting stents for complex coronary lesions: an intravascular ultrasound study. The Korean journal of internal medicine, 2009, Volume: 24, Issue:4 Topics: Adult; Aged; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Sirolimus; Tunica Intima; Ultrasonography, Interventional	2009
Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo. Journal of the American College of Cardiology, 2009, Dec-08, Volume: 54, Issue:24 Topics: Animals; Cells, Cultured; Constriction, Pathologic; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Paclitaxel; rho-Associated Kinases; Swine	2009
Response to drug-eluting stents do we need drugs to recompense drug elution? Journal of the American College of Cardiology, 2009, Dec-08, Volume: 54, Issue:24 Topics: Animals; Constriction, Pathologic; Coronary Artery Disease; Drug-Eluting Stents; Paclitaxel; rho-Associated Kinases; Swine	2009
Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. The American journal of cardiology, 2009, Dec-15, Volume: 104, Issue:12 Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscle, Smooth, Vascular; Paclitaxel; Sirolimus; Tacrolimus; Treatment Outcome	2009
Letter to the editor. Paclitaxel-Induced ST-segment elevations: A manifestation of allergic acute coronary syndrome (Kounis Syndrome) [corrected]. Clinical cardiology, 2009, Volume: 32, Issue:12 Topics: Acute Coronary Syndrome; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug Hypersensitivity; Humans; Paclitaxel; Syndrome	2009
Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Registries; Sirolimus; Thrombosis; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Tunica Intima	2010
High incidence of intramural thrombus after overlapping paclitaxel-eluting stent implantation: angioscopic and histopathologic analysis in porcine coronary arteries. Circulation. Cardiovascular interventions, 2008, Volume: 1, Issue:1 Topics: Angioscopy; Animals; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Incidence; Male; Paclitaxel; Swine; Thrombosis; Vasodilation	2008
Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Creatine Kinase, MB Form; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardium; Necrosis; Paclitaxel; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2009
Long-term paclitaxel-eluting stent outcomes in elderly patients. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Evidence-Based Medicine; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Patient Selection; Proportional Hazards Models; Randomized Controlled Trials as Topic; Registries; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome	2009
Off-label use and the spectre of drug-eluting stent thrombosis. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Myocardial Infarction; Off-Label Use; Paclitaxel; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome	2009
Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients. Circulation. Cardiovascular quality and outcomes, 2009, Volume: 2, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Artery Disease; Diabetic Angiopathies; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Ontario; Paclitaxel; Proportional Hazards Models; Registries; Sirolimus; Tubulin Modulators	2009
In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with the use of sirolimus- or paclitaxel-eluting stents. Kardiologia polska, 2009, Volume: 67, Issue:12 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Sirolimus; Treatment Outcome	2009
3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Mar-01, Volume: 75, Issue:4 Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Disease-Free Survival; Drug-Eluting Stents; England; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Thrombosis; Time Factors; Treatment Outcome	2010
Percutaneous coronary intervention in heavily calcified lesions using rotational atherectomy and paclitaxel-eluting stents: outcomes at one year. Revista espanola de cardiologia, 2010, Volume: 63, Issue:1 Topics: Aged; Atherectomy, Coronary; Calcinosis; Coronary Artery Disease; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome	2010
Major adverse cardiac events in patients with moderate to severe renal insufficiency treated with first-generation drug-eluting stents. The American journal of cardiology, 2010, Feb-01, Volume: 105, Issue:3 Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Renal Insufficiency; Retrospective Studies; Sirolimus	2010
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Metals; Middle Aged; Odds Ratio; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; ROC Curve; Stents; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency	2009
3-Dimensional bifurcation angle analysis in patients with left main disease: a substudy of the SYNTAX trial (SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery). JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:1 Topics: Aged; Algorithms; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Cineangiography; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Diastole; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Randomized Controlled Trials as Topic; Retrospective Studies; Systole; Time Factors; Treatment Outcome	2010
Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Logistic Models; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Odds Ratio; Paclitaxel; Prospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Up-Regulation	2010
Sirolimus versus paclitaxel-eluting stents in small coronary vessels: long-term outcomes from a single-center registry. Journal of cardiovascular medicine (Hagerstown, Md.), 2010, Volume: 11, Issue:5 Topics: Aged; Antineoplastic Agents; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Organ Size; Paclitaxel; Retrospective Studies; Sirolimus; Treatment Outcome	2010
Is diabetes a leveler of efficacy of DES types? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Feb-15, Volume: 75, Issue:3 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Sirolimus; Treatment Outcome	2010
[Are stents eluting sirolimus and paclitaxel equally efficacious?]. Kardiologia polska, 2009, Volume: 67, Issue:12 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel; Sirolimus; Treatment Outcome	2009
Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Jul-01, Volume: 76, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2010
Bifurcation stenting: a commitment to always kiss. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Mar-01, Volume: 75, Issue:4 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Coronary Artery Disease; Disease-Free Survival; Drug-Eluting Stents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Assessment; Thrombosis; Time Factors; Treatment Outcome	2010
Everolimus-eluting versus paclitaxel-eluting stents. Lancet (London, England), 2010, Apr-03, Volume: 375, Issue:9721 Topics: Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Thrombosis	2010
"Over-and-under" pericardial covered stent with paclitaxel balloon in a saphenous vein graft. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, May-01, Volume: 75, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Graft Occlusion, Vascular; Humans; Male; No-Reflow Phenomenon; Paclitaxel; Pericardium; Prosthesis Design; Saphenous Vein; Stents; Sutures; Tubulin Modulators; Ultrasonography, Interventional	2010
Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis. The Journal of invasive cardiology, 2010, Volume: 22, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug Resistance; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Retreatment; Sirolimus; Survival Analysis; Treatment Outcome	2010
Second-generation drug-eluting coronary stents. The New England journal of medicine, 2010, May-06, Volume: 362, Issue:18 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Cost-Benefit Analysis; Diabetes Complications; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Prosthesis Design; Sirolimus; Thrombosis; Treatment Outcome	2010
Long-term outcome after the V stenting technique in de novo bifurcation lesions using drug-eluting stents. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 5, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2009
[Biodegradable polymer-coated - new step in coronary arteriosclerosis intervention]. Kardiologia polska, 2010, Volume: 68, Issue:5 Topics: Absorbable Implants; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Hyperplasia; Paclitaxel; Polymers; Tunica Intima	2010
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 5, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Denmark; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2010
Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry). EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 5, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Europe; Female; Follow-Up Studies; Hospital Mortality; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Thrombosis; Time Factors; Treatment Outcome	2010
Clinical and angiographic outcomes of drug-eluting stents in patients with large vessel and single coronary artery lesion. Clinical cardiology, 2010, Volume: 33, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Hospital Mortality; Hospitals, University; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2010
New stent designs improve results without compromising safety. The new devices may solve the problems that cause many people to choose bypass surgery over stenting. DukeMedicine healthnews, 2010, Volume: 16, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Decision Making; Drug-Eluting Stents; Humans; Paclitaxel; Polymers; Safety	2010
Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Jul-01, Volume: 76, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Prospective Studies; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Stroke; Thrombosis; Time Factors; Treatment Outcome	2010
Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Jul-01, Volume: 76, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Stroke; Thrombosis; Time Factors; Treatment Outcome	2010
An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: a pooled analysis from the SPIRIT II and SPIRIT III trials. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Jul-01, Volume: 76, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome	2010
Another small step for small vessels. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Jul-01, Volume: 76, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome	2010
Comparison of the effect of preinterventional arterial remodeling on intimal hyperplasia after implantation of a sirolimus- or paclitaxel-eluting stent. Cardiology, 2010, Volume: 116, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Regression Analysis; Sirolimus; Tubulin Modulators; Tunica Intima; Ultrasonography, Interventional	2010
Efficacy of sirolimus-eluting stents compared with paclitaxel-eluting stents in an unselected population with coronary artery disease: 24-month outcomes of patients in a prospective non-randomized registry in Southern Turkey. International journal of medical sciences, 2010, Jun-10, Volume: 7, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Treatment Outcome; Turkey	2010
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry). The American journal of cardiology, 2010, Aug-15, Volume: 106, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Artery Disease; Coronary Thrombosis; Diabetes Complications; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Registries; Sirolimus; Treatment Outcome	2010
Five-year outcomes of sirolimus-eluting versus paclitaxel-eluting stents: a propensity matched study: clinical evidence of late catch-up? International journal of cardiology, 2011, Nov-03, Volume: 152, Issue:3 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Propensity Score; Registries; Sirolimus; Time Factors; Treatment Outcome	2011
Everolimus-eluting stents: insights from the SPIRIT IV and COMPARE trials. Expert review of cardiovascular therapy, 2010, Volume: 8, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome	2010
Clinical outcome and angiographic results with novel polysulfone polymer coating paclitaxel eluting stent in real-world clinical practice: a clinical centre registry. Medical science monitor : international medical journal of experimental and clinical research, 2010, Volume: 16, Issue:10 Topics: Aged; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Registries; Sulfones; Time Factors; Treatment Outcome	2010
The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEA JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2010
More openness and a little less strut: two good ideas for stents and the people who implant them. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Nov-01, Volume: 76, Issue:5 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Evidence-Based Medicine; Humans; Myocardial Infarction; Necrosis; Paclitaxel; Patient Selection; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome	2010
Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results. The international journal of cardiovascular imaging, 2011, Volume: 27, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Republic of Korea; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2011
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry. Journal of interventional cardiology, 2011, Volume: 24, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Confidence Intervals; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Finland; Humans; Male; Middle Aged; Odds Ratio; Paclitaxel; Propensity Score; Prospective Studies; Registries; Time Factors; Titanium; Treatment Outcome	2011
Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies. Journal of pharmaceutical and biomedical analysis, 2011, Mar-25, Volume: 54, Issue:4 Topics: Animals; Antineoplastic Agents; Aorta, Abdominal; Calcium Phosphates; Coronary Artery Disease; Coronary Restenosis; Drug Combinations; Drug-Eluting Stents; Kinetics; Lactic Acid; Male; Microscopy, Electron, Scanning; Paclitaxel; Pilot Projects; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Sirolimus; Solubility; Surface Properties; Tubulin Modulators	2011
Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: insights from an optical coherence tomography study in humans. International journal of cardiology, 2012, May-17, Volume: 157, Issue:1 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neointima; Paclitaxel; Radiography; Retrospective Studies; Sirolimus; Tomography, Optical Coherence; Treatment Outcome	2012
Effect of intravascular ultrasound-guided adjuvant high-pressure non-compliant balloon post-dilation after drug-eluting stent implantation. Heart and vessels, 2011, Volume: 26, Issue:6 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Japan; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Pressure; Prosthesis Design; Sirolimus; Treatment Outcome; Ultrasonography, Interventional	2011
Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 6, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9. International journal of cardiology, 2012, Jun-14, Volume: 157, Issue:3 Topics: Absorbable Implants; Aged; Coronary Artery Disease; Drug Carriers; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Polymers; Prospective Studies; Radiography; Sirolimus; Tomography, Optical Coherence; Treatment Outcome	2012
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Arte JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:12 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Clopidogrel; Confidence Intervals; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Risk Reduction Behavior; Sirolimus; Ticlopidine; Time Factors	2010
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:12 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Time Factors; United States	2010
Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysis. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Confidence Intervals; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Poisson Distribution; Registries; Risk Factors; Sex Factors; Time Factors; Treatment Outcome	2010
Sex-related outcomes after drug-eluting stent: should we "never mind" or "mind" the gap? JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:12 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Risk Assessment; Sex Factors; Treatment Outcome	2010
Two-year outcome of Turkish patients treated with Zotarolimus versus Paclitaxel eluting stents in an unselected population with coronary artery disease in the real world: a prospective non-randomized registry in southern Turkey. International journal of medical sciences, 2011, Jan-08, Volume: 8, Issue:1 Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Follow-Up Studies; Humans; Middle Aged; Paclitaxel; Patient Selection; Postoperative Complications; Prospective Studies; Random Allocation; Registries; Retrospective Studies; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Turkey	2011
Left main stenting: don't forget the angiographic follow-up! EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 6, Issue:7 Topics: Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Humans; Paclitaxel	2011
Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients. Heart and vessels, 2011, Volume: 26, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome	2011
Drug-eluting balloon (DEB) for de-novo coronary artery disease and in-stent restenosis: immediate and intermediate term results from a prospective registry. JPMA. The Journal of the Pakistan Medical Association, 2011, Volume: 61, Issue:2 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Pakistan; Prospective Studies; Registries; Time Factors; Treatment Outcome	2011
Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directions. American heart journal, 2011, Volume: 161, Issue:3 Topics: Algorithms; Angioplasty, Balloon, Coronary; Calibration; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Health Status Indicators; Humans; Outcome Assessment, Health Care; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Taxus	2011
Serial angioscopic evaluation of neointimal coverage and incidence of thrombus formation after Paclitaxel-eluting stent implantation: comparison between 6- and 18-month follow-up. Clinical cardiology, 2011, Volume: 34, Issue:5 Topics: Aged; Angioscopy; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Incidence; Male; Neointima; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Ticlopidine; Time Factors; Treatment Outcome	2011
Treatment of coronary atherosclerosis aneurysm with a combination of stent-graft and in-stent drug-eluting stent. The Journal of invasive cardiology, 2011, Volume: 23, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Aneurysm; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Paclitaxel; Stents; Treatment Outcome; Ultrasonography, Interventional	2011
Two-Year outcomes after utilization of the TAXUS paclitaxel-eluting stent in bifurcations and multivessel stenting in the ARRIVE registries. Journal of interventional cardiology, 2011, Volume: 24, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Prospective Studies; Registries; Treatment Outcome	2011
Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents. The American journal of cardiology, 2011, Jun-15, Volume: 107, Issue:12 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis; Treatment Outcome	2011
Simultaneous drug-eluting and bare-metal stent implantation: long-term clinical outcome and findings of clinically indicated coronary angiography. Clinical cardiology, 2011, Volume: 34, Issue:5 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Statistics as Topic; Ticlopidine; Time Factors; Treatment Outcome	2011
Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions. Clinical cardiology, 2011, Volume: 34, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et al. Diabetes & vascular disease research, 2011, Volume: 8, Issue:2 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Humans; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome	2011
Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model. Journal of veterinary science, 2011, Volume: 12, Issue:2 Topics: Angioplasty; Animals; Aorta, Thoracic; Coronary Artery Disease; Drug-Eluting Stents; Histocytochemistry; Male; Microscopy, Electron, Scanning; Models, Animal; Neointima; Paclitaxel; Rats; Rats, Sprague-Dawley	2011
Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation. The international journal of cardiovascular imaging, 2012, Volume: 28, Issue:4 Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Registries; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2012
Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7, Issue:2 Topics: Angioplasty, Balloon; Coronary Artery Disease; Humans; Paclitaxel; Peripheral Vascular Diseases	2011
Five-year outcomes of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: are they equally good (or bad)? Circulation, 2011, Jun-21, Volume: 123, Issue:24 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Treatment Outcome	2011
Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation. The international journal of cardiovascular imaging, 2012, Volume: 28, Issue:4 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Lipid Metabolism; Male; Middle Aged; Neointima; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2012
A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:6 Topics: Aged; Angioplasty; Antineoplastic Agents, Phytogenic; Cardiac Surgical Procedures; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Risk Assessment; Statistics, Nonparametric; Taxus; Treatment Outcome	2011
Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Jul-01, Volume: 80, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Creatinine; Drug-Eluting Stents; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney; Male; Metals; Middle Aged; Multivariate Analysis; Netherlands; Paclitaxel; Patient Safety; Proportional Hazards Models; Prosthesis Design; Registries; Renal Insufficiency; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Stents; Time Factors; Treatment Outcome	2012
Genous™ endothelial progenitor cell capturing stent: thrombus-resistant but vulnerable to restenosis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Aug-01, Volume: 78, Issue:2 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Male; Paclitaxel; Stem Cells; Stents	2011
Kissing drug eluting balloons for in-stent restenosis complicating bifurcations treated with drug-eluting stents. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Feb-15, Volume: 79, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Prosthesis Design; Treatment Outcome; Ultrasonography, Interventional	2012
Is diabetes the achilles' heel of limus-eluting stents? Circulation, 2011, Aug-23, Volume: 124, Issue:8 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Diabetic Angiopathies; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Sirolimus	2011
The Petal dedicated bifurcation stent. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 6 Suppl J Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Humans; Materials Testing; Paclitaxel; Patient Selection; Prosthesis Design; Treatment Outcome	2010
Drug-eluting balloons and bifurcations, a new future? EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 6 Suppl J Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Drug Carriers; Equipment Design; Humans; Paclitaxel; Treatment Outcome	2010
Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, Volume: 7, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Contraindications; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Prospective Studies; Registries; Sirolimus; Stents; Thrombosis; Titanium; Treatment Outcome	2012
Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries. Circulation. Cardiovascular interventions, 2011, Oct-01, Volume: 4, Issue:5 Topics: Animals; Blood Vessel Prosthesis Implantation; Cell Movement; Coronary Artery Disease; Coronary Vessels; Diabetes Complications; Disease Progression; Drug-Eluting Stents; Humans; Hypercholesterolemia; Inflammation; Models, Animal; Neointima; Paclitaxel; Platelet Aggregation; Platelet Aggregation Inhibitors; Swine; T-Lymphocytes	2011
Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry. Heart and vessels, 2012, Volume: 27, Issue:6 Topics: Age Factors; Aged; Aged, 80 and over; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Italy; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2012
Two-year clinical outcomes of patients with long segments drug-eluting stents: comparison of sirolimus-eluting stent with paclitaxel-eluting stent. Journal of Korean medical science, 2011, Volume: 26, Issue:10 Topics: Aged; Aged, 80 and over; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome	2011
Local drug delivery - the early Berlin experience: single drug administration versus sustained release. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7 Suppl K Topics: Angioplasty, Balloon, Coronary; Animals; Berlin; Cardiovascular Agents; Catheters; Cell Proliferation; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug-Eluting Stents; Equipment Design; Humans; Models, Animal; Paclitaxel; Sirolimus; Swine; Time Factors; Treatment Outcome	2011
Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, Volume: 7, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Cholesterol; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Paclitaxel; Regression Analysis; Retrospective Studies; Sex Characteristics; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome	2012
Intravascular ultrasound assessment of postprocedural incomplete stent apposition. The Journal of invasive cardiology, 2012, Volume: 24, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Calcinosis; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Retrospective Studies; Sirolimus; Ultrasonography, Interventional	2012
Clinical outcome after saphenous vein stenting with Taxus Liberté stent: results from the OLYMPIA Registry (TAXUS Liberté Postapproval Global Program). Angiology, 2012, Volume: 63, Issue:8 Topics: Aged; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Registries; Saphenous Vein; Treatment Outcome	2012
[A retrospective analysis of our paclitaxel-eluting stent (Genius TAXCOR I) implantations and follow-up results]. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2011, Volume: 39, Issue:8 Topics: Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2011
In-stent restenosis of bifurcation lesions: experience with drug-eluting balloons. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Feb-15, Volume: 79, Issue:3 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel	2012
Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease. Clinical research in cardiology : official journal of the German Cardiac Society, 2012, Volume: 101, Issue:7 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Catheters; Coated Materials, Biocompatible; Computer Simulation; Coronary Artery Disease; Coronary Restenosis; Cost Savings; Cost-Benefit Analysis; Drug Costs; Drug-Eluting Stents; Equipment Design; Germany; Health Care Costs; Humans; Markov Chains; Metals; Models, Economic; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Stents; Time Factors; Treatment Outcome	2012
No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry. JACC. Cardiovascular interventions, 2012, Volume: 5, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Body Mass Index; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Obesity; Paclitaxel; Proportional Hazards Models; Prospective Studies; Registries; Risk Factors; Sirolimus; Statistics as Topic	2012
Comparison of 5-year clinical outcomes between sirolimus-versus paclitaxel-eluting stent: Korean multicenter network analysis of 9000-patient cohort. Circulation. Cardiovascular interventions, 2012, Volume: 5, Issue:2 Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Postoperative Complications; Sirolimus; Survival Analysis; Treatment Outcome	2012
On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes. Texas Heart Institute journal, 2012, Volume: 39, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Drug-Eluting Stents; Female; Guideline Adherence; Hospital Mortality; Humans; Iran; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Practice Guidelines as Topic; Product Labeling; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2012
Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization. The American journal of cardiology, 2012, Jun-01, Volume: 109, Issue:11 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Registries; Retreatment; Sirolimus; Stroke	2012
Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Volume: 81, Issue:2 Topics: Aged; Aged, 80 and over; Atherectomy, Coronary; Cardiovascular Agents; Comorbidity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Incidence; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Factors; Sirolimus; Stroke; Thrombosis; Time Factors; Treatment Outcome; Vascular Calcification	2013
Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Volume: 81, Issue:5 Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Diabetic Angiopathies; Disease-Free Survival; District of Columbia; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2013
Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis. Heart and vessels, 2013, Volume: 28, Issue:3 Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Renal Dialysis; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Vascular Cell Adhesion Molecule-1	2013
Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation, 2012, Jun-12, Volume: 125, Issue:23 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Risk Factors; Sirolimus; Time; Treatment Outcome; Tubulin Modulators	2012
Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté versus TAXUS express stents. Journal of interventional cardiology, 2012, Volume: 25, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Cost-Benefit Analysis; Drug-Eluting Stents; Humans; Markov Chains; Models, Economic; Paclitaxel; Retrospective Studies; Treatment Outcome	2012
Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, Dec-20, Volume: 8, Issue:8 Topics: Acute Coronary Syndrome; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cohort Studies; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Equipment Failure; Female; Humans; Longitudinal Studies; Male; Middle Aged; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prospective Studies; Risk Factors; Sirolimus; Stents; Treatment Outcome	2012
Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries. Cardiovascular diabetology, 2012, Jun-21, Volume: 11 Topics: Animals; Apoptosis; Cardiovascular Agents; Cells, Cultured; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Eluting Stents; Endothelial Cells; Everolimus; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Necrosis; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Sirolimus; Swine; Time Factors; Wound Healing	2012
Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial). The American journal of cardiology, 2012, Oct-15, Volume: 110, Issue:8 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome; Tubulin Modulators; United States	2012
Comparison of long-term clinical outcomes between sirolimus-eluting stents and paclitaxel-eluting stents following rotational atherectomy. International heart journal, 2012, Volume: 53, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Atherectomy, Coronary; Cause of Death; Coronary Artery Disease; Disease-Free Survival; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Sirolimus	2012
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, Jul-20, Volume: 8, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries	2012
Paclitaxel- and sirolimus-eluting stents in older patients with diabetes mellitus: results of a real-life multicenter registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Jun-01, Volume: 81, Issue:7 Topics: Age Factors; Aged; Aged, 80 and over; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Italy; Kaplan-Meier Estimate; Logistic Models; Male; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Propensity Score; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome	2013
Coronary rupture and pseudoaneurysm formation after extravascular migration of a paclitaxel eluting stent implanted in the left circumflex coronary artery. Herz, 2013, Volume: 38, Issue:2 Topics: Aneurysm, False; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel	2013
Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation Paclitaxel-eluting stents for unprotected left main disease. Journal of the American College of Cardiology, 2012, Oct-02, Volume: 60, Issue:14 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Death; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Registries; Sirolimus; Treatment Outcome	2012
Drug-eluting stenting of saphenous vein graft versus native coronary artery supplying the same myocardial perfusion territory: a pilot retrospective 3-year follow-up. The Journal of invasive cardiology, 2012, Volume: 24, Issue:10 Topics: Aged; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Death, Sudden, Cardiac; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Pilot Projects; Retrospective Studies; Saphenous Vein; Sirolimus; Treatment Outcome	2012
Comparison of paclitaxal vs. sirolimus eluting stents with bio-degradable polymer for the treatment of coronary bifurcation lesions: subgroup analysis from DKCRUSH-I and DKCRUSH-II studies. Chinese medical journal, 2012, Volume: 125, Issue:19 Topics: Absorbable Implants; Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Polymers; Sirolimus	2012
Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: insights from a nationwide coronary intervention register. JACC. Cardiovascular interventions, 2012, Volume: 5, Issue:11 Topics: Aged; Coronary Artery Disease; Diabetic Angiopathies; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Registries; Retrospective Studies; Sirolimus; Sweden	2012
Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent. European heart journal, 2013, Volume: 34, Issue:12 Topics: Alkaline Phosphatase; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Sirolimus; Tubulin Modulators	2013
Disappearing stents--DREAMS of a sorcerer's apprentice? Lancet (London, England), 2013, Mar-09, Volume: 381, Issue:9869 Topics: Coronary Artery Disease; Drug Delivery Systems; Female; Humans; Male; Paclitaxel; Prostheses and Implants	2013
Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents. The Korean journal of internal medicine, 2013, Volume: 28, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Propensity Score; Prosthesis Design; Registries; Republic of Korea; Retrospective Studies; Risk Factors; Stainless Steel; Time Factors; Treatment Outcome	2013
Assessment of efficacy and safety of combining "paclitaxel" eluting balloon and "limus" eluting stent in the same lesion. Journal of interventional cardiology, 2013, Volume: 26, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Survival Rate; Treatment Outcome; Tubulin Modulators	2013
Human internal mammary artery organ culture model of coronary stenting: a novel investigation of smooth muscle cell response to drug-eluting stents. Clinical science (London, England : 1979), 2002, Volume: 103, Issue:4 Topics: Cell Division; Coated Materials, Biocompatible; Coronary Artery Disease; Drug Delivery Systems; Graft Occlusion, Vascular; Humans; Mammary Arteries; Models, Cardiovascular; Muscle, Smooth, Vascular; Organ Culture Techniques; Paclitaxel; Phosphorylcholine; Recurrence; Stents	2002
The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. Journal of the American College of Cardiology, 2005, Apr-05, Volume: 45, Issue:7 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Netherlands; Paclitaxel; Prospective Studies; Registries; Severity of Illness Index; Sirolimus; Stents; Survival Analysis; Treatment Outcome	2005
Delayed healing of a coronary artery plaque ulceration associated with acute myocardial infarction related to a paclitaxel-eluting stent. The Journal of invasive cardiology, 2005, Volume: 17, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Diagnosis, Differential; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Stents; Ultrasonography, Interventional	2005
Plaque sealing--a concept waiting for support. International journal of cardiovascular interventions, 2005, Volume: 7, Issue:2 Topics: Coronary Artery Disease; Coronary Restenosis; Humans; Paclitaxel; Stents	2005
Paclitaxel eluting stents for the treatment of angiographically non-significant atherosclerotic lesions. International journal of cardiovascular interventions, 2005, Volume: 7, Issue:2 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Male; Paclitaxel; Stents	2005
Paclitaxel-eluting stents in complex lesions. JAMA, 2005, Sep-14, Volume: 294, Issue:10 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Stents	2005
Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography. Zeitschrift fur Kardiologie, 2005, Volume: 94, Issue:10 Topics: Aged; Blood Vessel Prosthesis; Cardiac Catheterization; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Delivery Systems; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Paclitaxel; Prosthesis Implantation; Stents; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography	2005
[Short-term effect of paclitaxel-eluting stent in the treatment of coronary heart disease due to coronary arteriosclerosis]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2005, Volume: 25, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Paclitaxel; Stents	2005
Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels. The American journal of cardiology, 2005, Nov-15, Volume: 96, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Biomarkers; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2005
Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. The American journal of cardiology, 2005, Nov-15, Volume: 96, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Korea; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Treatment Outcome	2005
Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 67, Issue:2 Topics: Analysis of Variance; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Female; Humans; Logistic Models; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Stents	2006
Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation, 2006, Jan-24, Volume: 113, Issue:3 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Echocardiography; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Logistic Models; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Stents	2006
Cost-effectiveness of the Taxus paclitaxel-eluting stent in the Swedish healthcare system. Scandinavian cardiovascular journal : SCJ, 2006, Volume: 40, Issue:1 Topics: Clinical Trials as Topic; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Cost-Benefit Analysis; Delivery of Health Care; Drug Delivery Systems; Health Care Costs; Humans; Models, Economic; Myocardial Revascularization; Paclitaxel; Reoperation; Stents; Sweden; Taxus; Ticlopidine	2006
Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. Journal of the American College of Cardiology, 2006, Feb-07, Volume: 47, Issue:3 Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Follow-Up Studies; Humans; Paclitaxel; Sirolimus; Stents	2006
Editorial comment: which is the preferred drug-eluting stent? Journal of interventional cardiology, 2006, Volume: 19, Issue:1 Topics: Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2006
Wish list and REALITY: choice of stents and end points for treatment of de novo coronary artery lesions. JAMA, 2006, Feb-22, Volume: 295, Issue:8 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug Implants; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents	2006
[Stent therapy with diabetic patients who have coronary artery disease]. Clinical research in cardiology : official journal of the German Cardiac Society, 2006, Volume: 95 Suppl 1 Topics: Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Humans; Paclitaxel; Prognosis; Risk Factors; Sirolimus; Stents	2006
Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy. The American journal of cardiology, 2006, Apr-15, Volume: 97, Issue:8 Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Reoperation; Sirolimus; Stents; Survival Analysis; Treatment Outcome	2006
C-Reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents. The American journal of cardiology, 2006, May-01, Volume: 97, Issue:9 Topics: Anti-Inflammatory Agents; C-Reactive Protein; Coronary Artery Disease; Coronary Restenosis; Dexamethasone; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiography; Sirolimus; Stents; Treatment Outcome	2006
Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 68, Issue:1 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Disease-Free Survival; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Treatment Outcome	2006
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. American heart journal, 2006, Volume: 151, Issue:6 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Artery Disease; Humans; Multicenter Studies as Topic; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Stents	2006
CYPHER versus TAXUS stent for bifurcation lesions beyond 30 days-long-term follow-up results. International journal of cardiology, 2007, May-02, Volume: 117, Issue:3 Topics: Combined Modality Therapy; Coronary Artery Disease; Drug Delivery Systems; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Time Factors	2007
All drug-eluting stents are equal, but some drug-eluting stents are more equal than others. Journal of the American College of Cardiology, 2006, Oct-03, Volume: 48, Issue:7 Topics: Anti-Inflammatory Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Delivery Systems; Humans; Paclitaxel; Reproducibility of Results; Sirolimus; Stents	2006
Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. Journal of the American College of Cardiology, 2006, Oct-03, Volume: 48, Issue:7 Topics: Aged; Anti-Inflammatory Agents; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Treatment Outcome	2006
Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 68, Issue:5 Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prospective Studies; Registries; Risk Factors; Sirolimus; Stents; Taxus; Treatment Outcome	2006
Randomized trial versus registry data--comparing apples and ORCHIDs. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 68, Issue:5 Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Sirolimus; Stents	2006
A complete metal jacket case using ten paclitaxel-eluting stents for multiple de novo coronary artery lesions. International journal of cardiology, 2007, Feb-07, Volume: 115, Issue:2 Topics: Aged; Combined Modality Therapy; Coronary Artery Disease; Drug Delivery Systems; Female; Humans; Paclitaxel; Prosthesis Design; Stents	2007
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA, 2007, Jan-10, Volume: 297, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Treatment Outcome	2007
Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Feb-15, Volume: 69, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; California; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Research Design; Retrospective Studies; Severity of Illness Index; Sirolimus; Stents; Treatment Outcome	2007
Does clopidogrel each day keep stent thrombosis away? JAMA, 2007, Jan-10, Volume: 297, Issue:2 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Drug Delivery Systems; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Thrombosis; Ticlopidine	2007
Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results. The Journal of invasive cardiology, 2007, Volume: 19, Issue:2 Topics: Abciximab; Aged; Antibodies, Monoclonal; Anticoagulants; Coronary Artery Disease; Costs and Cost Analysis; Drug Delivery Systems; Drug Therapy, Combination; Eptifibatide; Female; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Length of Stay; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Peptide Fragments; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Retrospective Studies; Sirolimus; Stents; Tirofiban; Treatment Outcome; Tyrosine	2007
Long-term outcomes in treating left main trifurcation coronary artery disease with the Paclitaxel-eluting stent. The Journal of invasive cardiology, 2007, Volume: 19, Issue:2 Topics: Aged; Catheterization; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug Delivery Systems; Female; Humans; Logistic Models; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome; Tubulin Modulators	2007
Bivalirudin and DES: a PCI strategy that pays. The Journal of invasive cardiology, 2007, Volume: 19, Issue:2 Topics: Anticoagulants; Coronary Artery Disease; Costs and Cost Analysis; Drug Delivery Systems; Heparin; Hirudins; Humans; Immunosuppressive Agents; Length of Stay; Myocardial Infarction; Paclitaxel; Peptide Fragments; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Sirolimus; Stents	2007
Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique". Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Jun-01, Volume: 69, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Databases as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2007
Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease. The American journal of cardiology, 2007, Mar-15, Volume: 99, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Incidence; Korea; Male; Medical Records; Middle Aged; Paclitaxel; Retrospective Studies; Risk Factors; Sirolimus; Stents; Treatment Outcome	2007
Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first six months: outcomes with drug-eluting stents versus bare metal stents. The American journal of cardiology, 2007, Mar-15, Volume: 99, Issue:6 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Incidence; Korea; Male; Middle Aged; Paclitaxel; Postoperative Period; Risk Factors; Sirolimus; Stents; Treatment Outcome	2007
Possible predictors of target lesion revascularization after drug-eluting stent implantation. Journal of cardiology, 2007, Volume: 49, Issue:2 Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Female; Forecasting; Humans; Logistic Models; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Renal Dialysis; Sirolimus; Stents	2007
Late coronary thrombosis in paclitaxel-eluting stents. Case reports. Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:4 Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Delayed-Action Preparations; Drug Administration Schedule; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Stents; Thrombosis; Time Factors	2007
Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry). The American journal of cardiology, 2007, Jul-01, Volume: 100, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Registries; Retrospective Studies; Sirolimus; Stents; Time Factors; Treatment Outcome	2007
Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group. Journal of the American College of Cardiology, 2007, Sep-25, Volume: 50, Issue:13 Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Outcome Assessment, Health Care; Paclitaxel; Prospective Studies; Registries; Sirolimus; Stents; United States	2007
The Emperor's new clothes: another cypher versus taxus post-hoc meta-analysis. Journal of the American College of Cardiology, 2007, Oct-02, Volume: 50, Issue:14 Topics: Blood Vessel Prosthesis; Coronary Artery Disease; Coronary Thrombosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Meta-Analysis as Topic; Outcome and Process Assessment, Health Care; Paclitaxel; Randomized Controlled Trials as Topic; Recurrence; Sirolimus; Stents; Treatment Outcome; Tubulin Modulators	2007
Patients with in-stent restenoses: comparison of intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter with the polymer-based paclitaxel-eluting taxus-express stent. Nuklearmedizin. Nuclear medicine, 2007, Volume: 46, Issue:5 Topics: Aged; Brachytherapy; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Male; Middle Aged; Paclitaxel; Radioisotopes; Radionuclide Imaging; Rhenium; Stents	2007
Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use. Journal of the American College of Cardiology, 2007, Nov-20, Volume: 50, Issue:21 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Consumer Product Safety; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Sirolimus; Treatment Outcome	2007
Successful local antiproliferative paclitaxel delivery in a repeatedly restenosed lesion of the right coronary artery after drug eluting-stent implantation. Clinical research in cardiology : official journal of the German Cardiac Society, 2008, Volume: 97, Issue:1 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Catheterization; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel	2008
Two-year outcome of the use of paclitaxel-eluting stents in aorto-ostial lesions. International journal of cardiology, 2008, Oct-13, Volume: 129, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Radiography; Survival Rate; Time Factors; Treatment Outcome	2008
A case of very late stent thrombosis at high altitude. Thrombosis and haemostasis, 2007, Volume: 98, Issue:6 Topics: Adult; Altitude; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Contraceptives, Oral; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Dehydration; Drug-Eluting Stents; Exercise; Female; Genetic Predisposition to Disease; Humans; Hypoxia; Myocardial Infarction; Paclitaxel; Risk Factors; Time Factors; Treatment Outcome	2007
Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Mar-01, Volume: 71, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Paclitaxel; Patient Selection; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome	2008
Stenting unprotected left main: the outcome is not always favorable. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Mar-01, Volume: 71, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2008
Crush stenting in treating coronary bifurcate lesions: paclitaxel eluting stents versus sirolimus eluting stents. Chinese medical journal, 2008, Mar-20, Volume: 121, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus	2008
Next-generation drug-eluting stents: a spirited step forward or more of the same. JAMA, 2008, Apr-23, Volume: 299, Issue:16 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus	2008
Percutaneous unprotected left main angioplasty with drug-eluting stents in a nonagenarian: feasible and safe despite recurrent restenosis. Minerva cardioangiologica, 2008, Volume: 56, Issue:1 Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Feasibility Studies; Humans; Immunosuppressive Agents; Male; Paclitaxel; Radiography; Recurrence; Retreatment; Treatment Outcome; Tubulin Modulators	2008
Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008. (PEPCAD, LokalTax, INH, German ablation registry, German device registry, DES.DE registry, DHR, Reality, SWEETHEART registry, ADMA, GERSHWIN). Clinical research in cardiology : official journal of the German Cardiac Society, 2008, Volume: 97, Issue:6 Topics: Ablation Techniques; Angina Pectoris; Antineoplastic Agents, Phytogenic; Cardiology; Clinical Trials as Topic; Coronary Artery Disease; Drug-Eluting Stents; Equipment Design; Germany; Heart Failure; Humans; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Registries; Societies, Medical	2008
Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinase C. Basic research in cardiology, 2002, Volume: 97, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cattle; Cell Division; Cells, Cultured; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Cyclosporine; Enzyme Activation; Immunosuppressive Agents; Muscle, Smooth, Vascular; Paclitaxel; Protein Kinase C	2002
Commentary: Does the SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score even matter? The Journal of thoracic and cardiovascular surgery, 2023, Volume: 165, Issue:4 Topics: Cardiac Surgical Procedures; Coronary Angiography; Coronary Artery Disease; Humans; Percutaneous Coronary Intervention; Risk Factors; Taxus; Treatment Outcome	2023
Sex, Region, and Outcomes After Revascularization. Circulation. Cardiovascular interventions, 2017, Volume: 10, Issue:5 Topics: Angioplasty; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Taxus	2017
Left main or multivessel coronary revascularization: applying both anatomy and physiology to individualize care. Future cardiology, 2017, Volume: 13, Issue:4 Topics: Cardiac Surgical Procedures; Coronary Artery Disease; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Taxus	2017
Complete Revascularization in Patients Before Undergoing Transcatheter Aortic Valve Replacement: Desirable or Superfluous? Circulation. Cardiovascular interventions, 2018, Volume: 11, Issue:3 Topics: Aortic Valve; Aortic Valve Stenosis; Coronary Artery Disease; Humans; Percutaneous Coronary Intervention; Taxus; Transcatheter Aortic Valve Replacement	2018
Coronary stenting in a patient with single coronary artery and double-vessel disease! The Journal of invasive cardiology, 2013, Volume: 25, Issue:7 Topics: Comorbidity; Coronary Angiography; Coronary Artery Disease; Coronary Vessel Anomalies; Drug-Eluting Stents; Female; Humans; Middle Aged; Percutaneous Coronary Intervention; Taxus; Treatment Outcome	2013
The SYNTAX trial: a perspective. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:5 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Europe; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Taxus; Treatment Outcome; United States	2009